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Abstract
The adaptive immune system must be able to respond to virtually any
pathogen that the body encounters. T cell immunity is able to do so by devel-
oping a diverse repertoire of T cell receptors and maintaining large numbers
of T cells. These two quantitative properties are fundamental for the ability
of T cell-mediated immunity to clear infections and generate memory cells
for future protection. The aims of this thesis are to quantify the sizes of T cell
populations, to develop tools to measure the diversity of T cell repertoires,
and to describe how T cell populations develop in neonatal mice.
We studied the development of T cell populations in neonatal mice by
measuring cell counts and Ki67 expression in thymocyte and peripheral T
cell subsets from mice soon after birth to late adulthood. The presumed
lymphopenic environment of the neonatal mouse is thought to cause T cells
to undergo lymphopenia-induced proliferation, and we wanted to quantify
the balance between thymic output and peripheral expansion in the naive T
cell compartment during development with mathematical modeling.We also
used modeling to ﬁnd the most parsimonious description of differentiation
within the thymus that explains the dynamically growing thymus.
We then sought to quantify the sizes of the peripheral T cell compart-
ments in the adult mouse. Understanding the characteristics of healthy T cell
immunity requires knowing the precise numbers of the different T cell sub-
sets found in the body. We performed thoracic duct cannulations in adult
mice to collect recirculating T cells and reduce cell numbers in the lymph
nodes and spleens; by counting the number of collected T cells and its ef-
fect on cell numbers on the secondary lymphoid organs, we sought to back-
calculate the total number of T cells in the mouse. Finally, we developed
tools that provide high-throughput and cost-effective methods for identi-
fying paired TCR sequences. By using computational techniques, we were
able to adapt standard sequencing protocols to identify many paired TCR
sequences without resorting to large and expensive single-cell sequencing
techniques. By leveraging experimental design with mathematical methods,
we were able to quantify and characterize many properties of effective T cell
immunity.
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Introduction
1.1 overview
The adaptive immune system has the extraordinary task of responding to vir-
tually any pathogen without reacting to self molecules. This feat is achieved
by creating a diverse repertoire of receptors—each with its own antigen
speciﬁcity—that is vetted for self-reactive receptors. In the case of T lym-
phocytes, each T cell clonotype is the set of all T cells that expresses the
same unique T cell receptor (TCR), which is created by a random gene re-
arrangement process that can potentially form 1015 different TCRs in mice
and 1018 in humans. T cells use their TCRs to recognize antigens as short
peptides presented on major histocompatibility complex (MHC) molecules.
When a pathogen enters peripheral tissues, local antigen-presenting cells
(APCs) such as dendritic cells (DCs) take up the pathogen and other patho-
genic antigens and migrate to the local secondary lymphoid organ (SLO).
In the SLO, the DCs process their antigens and present them to T cells. T
cells whose TCRs can react with these peptide-MHC (pMHC) epitopes be-
come activated, differentiate, and proliferate, producing up to 107 progeny
cells to clear the pathogens [2, 3]. When the infection is cleared, many of
the responding T cells die and leave behind memory cells. These include
two recirculating subsets called central memory T cells (TCM) and effector
memory T cells (TEM) and one subset called tissue-resident memory T cells
(TRM) that permanently remain in peripheral tissues. TCM cells are deﬁned
by expression of CCR7 and CD62L in humans and CD44 and CD62L in
mice whereas TEM cells do not express CD62L. TCM primarily recirculating
through SLOs while TEM recirculate through peripheral tissues. These mem-
ory T cells recirculate in order to provide immediate responses to subsequent
exposure to the same pathogens.
In order for the immune system to able to mount robust T cell responses,
the T cell repertoire must be able to respond to any given pathogenic anti-
gen and respond vigorously enough to clear the pathogen. The naive T cell
repertoire achieves this property by maintaining a high number of unique
TCRs that must be distributed across a large but limited number of T cells.
Detailed quantiﬁcation of the T cell repertoire is emerging with the develop-
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ment of advanced experimental and quantitative tools, but many questions
about T cell repertoires are still open. How can we identify the numerous
unique T cell clonotypes that respond to a given epitope? How many naive
T cells does the body maintain, and how are the TCRs distributed across
the naive pool? How is this diverse naive T cell compartment formed during
development in neonates? In this thesis, we explore these questions by com-
bining careful experimental design with mathematical and computational
methods to quantitatively analyze and interpret immunological data.
1.2 t cell receptors
1.2.1 Structure of the αβ T cell receptor
The interaction between the αβ T cell receptor (henceforth referred to sim-
ply as TCR) and a peptide-MHC (pMHC) molecule is fundamental to the
function of the adaptive immune system. The TCR is composed of an α
chain (TCRα) and an β chain (TCRβ), each which have three hypervari-
able complementarity-determining regions (CDRs) that determine the set of
pMHC antigens recognized by the TCR (Figure 1.1). In a TCR-pMHC inter-
action, the CDR1 and CDR2 loops primarily make contacts with the MHC
portion of the pMHCmolecule, and the CDR3 loops make contacts with the
peptide portion of the pMHC [4, 5]. Since the CDR3 loops of the TCR have
the most contact with the peptide, the CDR3 regions make the major con-
tributions to determining the epitope speciﬁcity of the TCR [6]. When the
TCR interacts with a cognate pMHC molecule, the TCR transmits signals
to the CD3 complex and triggers cascades of signaling that lead to robust T
cell responses [7].
Studies of many TCR-pMHC crystal structures have demonstrated that
both the CDR3α and CDR3β loops interact with the peptide portion of
pMHCmolecules. In 34 different TCR-pMHC-I structures, both chains con-
tribute to interactions between the TCR and the pMHC, as measured by
buried surface area (BSA) (as percentages of BSA: TCRα, 33–78%; CDR3α,
4.6–34.7%; TCRβ, 22–67%; CDR3β, 8.3–42%) [9]. In 22 different TCR-
pMHC-II structures, both chains also contribute to interactions between the
TCR and the pMHC (as percentages of BSA: TCRα, 26.4–61.3%; CDR3α,
3–37%; TCRβ, 38.7–73.6%; CDR3β, 16.2–49.4%) [9]. These data demon-
strate that both the TCRα chain and TCRβ chain (in particular, both the
4
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CD4
TCRβ TCRα
A B
Figure 1.1: Structure of the αβ T cell receptor. (A) The αβ T cell receptor is a het-
erodimer of a TCRα chain and a TCRβ chain. The TCR interacts with peptides presented
onMHCmolecules (depicted here is a TCR from CD4+ T cell interacting with pMHC-II).
The CDR3 regions of both chains contribute to the interactions with the peptide por-
tion of the pMHC epitope. (B) Crystal structure of a TCR–pMHC–CD4 complex where
the TCRα chain is shown in dark blue and the TCRβ chain is shown in cyan (imagemod-
iﬁed from Li et al. [8], released under CC BY 4.0).
CDR3α and CDR3β regions) determine the antigen speciﬁcity of the TCR.
1.2.2 Rearrangement of T cell receptor genes
The wide diversity of receptors found in the TCR repertoire is created by a
gene rearrangement process called V(D)J recombination that chooses ran-
dom gene segments and combines them to create unique receptors (Fig-
ure 1.3). This process combines one random variable (V) gene segment to
either one random J segment in the TCRα chain or one random diversity
(D) and one joining (J) segment in the TCRβ chain [10] and is mediated by
the RAG-1/RAG-2 enzymes [11]. In the germline conﬁguration, the human
TCRβ locus contains 76 different TRBV segments, 2 TRBD segments, and
14 TRBJ segments, and the murine TCRβ locus contains 35 different TRBV
segments, 2 TRBD segments, and 14 TRBJ segments (Figure 1.2) [12]. The
human TCRα locus contains 54 TRAV segments and 61 TRAJ segments, and
the murine TCRα locus contains 98 TRAV genes and 60 TRAJ genes [12].
The TCRα locus also has one constant TRAC gene, and the TCRβ locus has
5
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Jα: 61 genes Cα
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Dβ2 Cβ2Jβ2:14 genes
( )( )
( )
Figure 1.2: Germline conﬁguration of the TCRα and TCRβ loci. The TCRα and TCRβ
loci contain different V segments, D segments (in the TCRβ locus only), and J segments
that are randomly chosen to formTCRs. In humans, the TCRα locus contains 54 Vα gene
segments, 61 Jα segments, and one Cα segment. It is unknown how many of the Vα
segments are functional. The TCRβ locus contains 76 Vβ segments, and two clusters
containing one Dβ segments in front of 6–7 Jβ segments and a single Cβ segment. The
TCRδ locus is found in between the V and J segments of the TCRα (not shown here).
two TRBC genes that are homologues with no functional differences; the
C-region codes for the transmembrane polypeptides of the TCR.
Additional diversity is introduced at the junctions between the different
gene segments by random addition and subtraction of nucleotides. One type
of nucleotide, called N-nucleotides, are added to the junctions by the enzyme
Tdt [13, 14]. N-nucleotides are non-template-encoded nucleotides that are
randomly added to the junctions during the joining process of the gene seg-
ments. The combinatorial diversity produced by joining random V(D)J seg-
ments and the junctional diversity provided by these added/subtracted nu-
cleotides at the junctions can create a theoretical diversity of ~1015 TCRs [15].
The CDR1 and CDR2 regions of the TCR chains are encoded entirely
by the TRAV and TRBV genes [15]. The CDR3 region is encoded by the
junction of the V(D)J segments [5]. Hence, the site of the most diversity—
diversity that derives from the combinatorial diversity of the different V(D)J
segments and junctional diversity from the addition and deletion of nucleo-
tides—determines the peptide-recognizing loops of TCRs whereas the germ-
line V segments predominantly determine MHC-speciﬁcity. Since the theo-
retical maximum diversity of ~1015 is much greater than the number of T
cells in the mouse (~108), the T cell repertoire contains a small fraction of
all of the possible CDR3 sequences.
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Figure 1.3: V(D)J recombination. TCRα and TCRβ are created by combining different
segments together, and the resulting TCRα and TCRβ pair to form a complete TCR. In
the upper half of the ﬁgure, the TCRα chain is formed by combining a Vα segment
with a Jα segment and a Cα segment. In the lower half of the ﬁgure, the TCRβ chain is
formed by combining a Vβ segment with a Dβ segment, Jβ segment, and a Cβ segment.
The CDR3 of TCRα chain is encoded by the V segment, the J segment, and the junction
between the two segments, and the CDR3 of the TCRβ chain is encoded by the V, D,
and J segments and the VD and DJ junctions.
1.2.3 Diversity of the TCR repertoire
Direct measurement of the total diversity of the TCR repertoire has eluded
the ﬁeld due to two features of the naive T cell repertoire. The large num-
ber of unique TCRs and the skewed frequency distribution of these TCRs
prevent a blood sample from representing the full diversity of the reper-
toire [16]. Estimates of the diversity of the human T cell repertoire have
been made using various approaches, including spectratyping (described in
Section 1.5.1) and TCRβ sequencing (described in Section 1.5.2). One of the
ﬁrst estimates was made by Arstila et al. [17], who sequenced a few hundred
CDR3β sequences and then used spectratyping to extrapolate these numbers
to the entire repertoire. Their approach yielded a lower-bound estimate of
approximately 106 different CDR3β sequences. Robins et al. [18] used high-
throughput sequencing (HTS) of the CDR3β and estimated the diversity in
the peripheral blood to be 3–4×106 T cell clonotypes. Warren et al. [19]
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found ~106 TCRβ sequences in the blood of one patient, corroborating this
lower bound. Finally, Qi et al. [20] found a higher estimate of 100×106
unique CDR3β sequences in the naive T cell repertoire. The differences in
these estimates reﬂect the difficulty of making inferences about the whole
repertoire based on blood samples that capture only a small fraction of its
diversity. The different methods used to extrapolate estimates of diversity in
small samples to that of the full repertoire is out of the scope of this thesis
(an overview is presented in Reference [16]).
Simply quantifying the number of unique T cell receptors in the T cell
repertoire does not fully describe the diversity of the “peptide” repertoire
to which the TCR repertoire is capable of responding [21]. The adaptive
immune system does not have to create an unique TCR for each pathogenic
peptide encountered by the body. Instead, a given TCR can respond to a
range of different peptides through cross-reactivity. Cross-reactivity is me-
diated by mechanisms such as induced ﬁt by pMHC ligands [22] and ﬂex-
ibility in the pMHC ligand to conform to the conﬁrmation of a TCR [23].
Thus, cross-reactivities of the TCRs would need to considered to quantify
the range of peptides that the TCR repertoire can respond to and to fully
characterize the functional capacity of the TCR repertoire.
In addition, measurements of diversity of TCR repertoires will be af-
fected by factors that are intrinsic and extrinsic to the individual that is stud-
ied. First, diversity differs between mice and humans in absolute numbers of
unique TCRs and in clonal sizes. The murine T cell repertoire is estimated to
have approximately 2 × 106 unique TCRs [24] that are distributed across
approximately 108 T cells, and the human T cell repertoire has 108 unique
TCRs [20] distributed across 1011 T cells. By dividing the number of T cells
by the number of unique TCRs, clone sizes on average are expected to be
roughly orders of magnitude of 10 cells in mice and 1000 cells in humans.
Second, TCR diversity decreases with age [25], presumably due to decreases
in thymic output from thymic involution and the expansion of existing mem-
ory T cells [26, 27]. Finally, the history of infections and antigen exposure
of an individual is reﬂected in the TCR repertoire [28].
With the ability to quantify TCR diversity with all of the considerations
mentioned in this section, we would be able to answer many fundamental
questions about T cell mediated immunity. We would obtain quantitative
characterizations of healthy T cell immunity and how changes diversity af-
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fect the function immune system. For example, tracking changes in diversity
with age could provide immense insights into how the function of the whole
T cell population changes with aging. These types of insight will not only
expand our knowledge of T cell physiology but also can motivate clinical
applications in designing immunotherapies and other T cell dependent ap-
proaches.
1.3 t cell development
The diverse set of TCRs produced by V(D)J recombination must be vetted
so that the chosen TCRs can interact with the MHC molecules found in the
body yet not react strongly against self peptides. This ﬁltering process occurs
in the thymus, where developing T cell precursors called thymocytes rear-
range their TCRs and test their TCRs on self-pMHC molecules presented
by thymic epithelial cells.
T cell development begins with in the bone marrow (BM), from which
BM-derived precursors migrate to the thymus [29]. In the thymus, T cell pro-
genitors rearrange their TCR genes to commit to either the γ:δ or the α:β lin-
eage. They then sample self-peptide:self-MHCmolecules to ensure MHC re-
striction through a process called positive selection and self-tolerance through
a process called negative selection. Positive selection selects for thymocytes
whose TCRs have speciﬁcity for the self-MHC molecules, and negative se-
lection deletes thymocytes with TCRs that react strongly to self-peptides.
These two selection processes create a repertoire of TCRs that can react
to peptides presented by MHC molecules in the body but does not react
strongly to self-antigens.
1.3.1 Thymocyte development
Development of the αβ T cell lineage in the thymus can be split up into three
broad stages deﬁned by the expression of CD4 and CD8: double-negative
(CD4–CD8–), double-positive (CD4+CD8+), and single-positive (CD4+CD8–
or CD4–CD8+).
Progenitor cells enter the thymus at the cortico-medullary junction (CMJ)
and begin as double-negative (DN) thymocytes [31]. In mice, the double-
negative stage is split into four substages based on CD44 and CD25 expres-
sion. DN1 cells are CD44+ and CD25–, and DN2 cells are CD44+CD25+.
9
DN1
γδ
DN2
DN3
DN4
Cortex
Cortico-medullary junctionMedulla
DP
SP
Figure 1.4: The journey of thymocyte development. BM-derived precursors enter
the CMJ and start as DN thymocytes. DN thymocytes travel through the cortex, rear-
range the TCRβ chain. Successful TCRβ rearrangement results in maturation into the
DP stage, in which the coexpression of CD4 and CD8 and TCRα rearrangement occur.
DP thymocytes undergo positive and negative selection in the cortex. Once a DP thy-
mocyte receives a positive selection signal, it moves to the medulla and enters the SP
stage, where it matures and undergoes negative selection. SP thymocytes that pass
selection leave the thymus through the CMJ to enter the periphery. (Figure adapted
from [30]).
These cells move from the CMJ to the cortex, where the thymocytes enter
DN3 (CD44+CD25+) at the subcapsular epithelium. DN2 thymocytes begin
rearranging their β, γ, and δ loci, and it is thought that these cells commit to
the αβ or γδ lineages depending on whether a β chain or a functional γδ chain
is rearranged ﬁrst (γδ T cell development will not be discussed further) [32].
For the DN3 thymocytes that successfully rearrange their β chain ﬁrst,
the expressed β chain pairs with the invariant pre-T-cell α chain (pTα) to
form a pre-T-cell receptor (preTCR), whichmarks the entrance into the DN4
stage (CD44–CD25+) [33]. The preTCR complex signals the downregula-
tion of RAG1/2 to stop TCRβ chain rearrangement, signals the expression
of CD4 and CD8, and causes the thymocytes to proliferate 6–9 times in
mice [34, 35, 36, 37]. Thus, each DN3 thymocyte will yield many daugh-
ter DN4 cells with an identical TCRβ chain. The co-expression of CD4 and
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CD8 deﬁne the beginning of the double positive (DP) stage.
Once proliferation from the DN4 stage has ceased and CD4/CD8 co-
expression occurs, DP thymocytes will begin rearranging the TCRα loci on
both chromosomes. When a thymocyte forms a complete TCR after success-
fully rearranging a TCRα locus, it begins to sample self-pMHC presented
by thymic epithelial cells. TCRs must recognize self-peptide:self-MHC to
pass positive selection, ensuring that the TCR can interact with the MHC
molecules used by the body. A DP thymocyte makes multiple attempts at re-
arranging the TCRα genes until it passes positive selection or until it receives
a signal to die. Since thymocytes attempt to rearrange the TCRα locus on
both chromosomes until they receive a positive selection signal, T cells can
have two in-frame TCRα rearrangements, which we will discuss in more de-
tail in Section 5.1.3. DP thymocytes that pass positive selection then down-
regulate either CD4 or CD8, move from the thymic cortex to the medulla,
and become CD4 single-positive (SP4) or CD8 single-positive (SP8) thymo-
cytes. In the medulla, SP thymocytes undergo negative selection, in which
thymocytes with TCRs that bind too strongly to self-pMHC are signaled
to die. Studies have estimated that 75–80% of DP thymocytes fail positive
selection [38, 39] and that 20–50% of the positively-selected thymocytes
survive negative selection [38, 39, 40], yielding approximately 5% of DP
thymocytes that survive selection. Finally, thymocytes that pass both posi-
tive and negative selection undergo 2–4 divisions before leaving the thymus
[38]. Key events in murine thymocyte development are shown in Figure 1.5.
The DP stage can divided into three stages based on expression levels of
TCR and CD5 [41]. DP1 thymocytes are TCRloCD5lo and consist of thymo-
cytes that have not undergone selection. DP2 thymocytes are TCRintCD5hi
and consist of a mix of thymocytes that give rise to CD4 and CD8 lineages.
DP3 thymocytes are TCRhiCD5int and consist of just cells of the CD8 lin-
eage. Mathematical modeling by Sinclair et al. has shown that DP1 cells give
rise to DP2 cells, which give rise to DP3 cells; SP4 thymocytes differentiate
from DP2 thymocytes only, and SP8 thymocytes differentiate from DP3 thy-
mocytes only [38]. They estimated residence times of 3.5, 1.4, and 7 days
for DP1, DP2, and DP3 thymocytes respectively.
SP thymocytes can be divided into two stages based on CD62L and heat-
stable antigen (HSA) expression: immature SPs (CD62LloHSAhi) andmature
SPs (CD62LhiHSAlo) [42, 43]. SP cells that are ready to emigrate from the
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Figure 1.5: Key events in the different stages of thymocyte development. The
6–9 divisions in the DN4 stage results in multiple daughter cells with the same TCRβ
chain, each of which then undergoes independent TCRα rearrangement. Most TCRs
produced by V(D)J rearrangement will not pass selection. The ~5% of DP thymocytes
that survive selection and become SP thymocytes, which can undergo 2–4 divisions
before emigrating from the thymus.
thymus express Kruppel-like factor 2 (KLF2), which is a transcription fac-
tor that drives the expression of sphingosine-1-phosphate receptor-1 (S1P1).
The mature SP thymocytes are associated with a phenotype that is less sus-
ceptible to apoptosis and poised to proliferate; only mature SP thymocytes
emigrate from the thymus [43]. Mature SP thymocytes, by expressing S1P1,
follow a S1P gradient created by neural-crest-derived pericytes and leave
the thymus through the CMJ [44]. SP4 and SP8 thymocytes have been es-
timated to have residence times of 4.4 and 4.6 days respectively [43, 41]
whereas Sinclair et al. [38] estimated SP4 and SP8 residence times of 5 and
3.7 days respectively.
Human thymocyte development also follow the progression from DN to
DP to SP, but subdivisions within these stages are not as well-characterized
compared to murine thymocyte development. The double negative stage is
subdivided into three stages based on CD45, CD38, and CD1a expression.
DN1 thymocytes are CD34+CD38–CD1a– and are equivalent to murine
DN1 thymocytes. DN2 thymocytes are CD34+CD38+CD1a–, and DN3 thy-
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mocytes are CD34+CD38+CD1a+; these latter two stages correspond to the
murine DN2, DN3, and DN4 stages. The double positive stage is subdi-
vided into two stages based on CD3 expression. DP3– thymocytes (CD4+
CD8+CD3–) differentiate into DP3+ (CD4+CD8+CD3+) thymocytes, which
become single positive thymocytes that are CD3+ and either CD4+ or CD8+.
1.3.2 Development of peripheral T cell compartments in neonatal mice
The development of peripheral T cell compartments depends on the ex-
port of T cells from the thymus and possibly the expansion of peripheral
T cells [45, 46]. Peripheral T cell populations in mice grow in numbers
from ~0.02×106 cells at birth to ~50×106 cells at 2 months of age [45].
It has been suggested that thymic export is more important than periph-
eral expansion in establishing peripheral T cell compartments [45], but the
presumed lymphopenic environment of neonatal mice may also support pe-
ripheral expansion through a mechanism called lymphopenia-induced pro-
liferation (LIP) [46].
LIP occurs when naive T cells are placed in a lymphopenic environment—
whether naturally occurring following an insult to the immune system such
an HIV infection or experimentally introduced through drugs or irradiation.
The “open space” in the lymphopenic environment causes naive T cells to
proliferate and take on a memory-like phenotype. This process is driven by
signals such as IL-7 and self-pMHC complexes, and it is thought that naive T
cells have greater access to these signals in a lymphopenic environment [47].
These observations led to the question of whether LIP occurs in neonates
as a physiological mechanism for rapidly growing T cells compartments.
Since the peripheral T cell compartments in neonates contain very few T
cells, Min et al. [46] asked whether the neonatal environment supports LIP.
They adoptively transferred CFSE-labeled CD4+ T cells from adult mice into
1 day old pups and observed 17–19 days after the transfer that a signiﬁcant
proportion of transferred cells dividedmany times andwere CD44bright. Sim-
ilar results occurred when adult CD44dull CD4+ T cells and CD4+ SP thy-
mocytes from 2-week old mice were transferred into 1-day old neonates.
These observations indicate that neonates have lymphopenic environments
that allow for LIP of CD4+ T cells. However, most of the data from this
study looked at transferred T cells from older animals and thus do not nec-
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essarily indicate that peripheral expansion is a physiological mechanism for
the development of neonatal peripheral T cell compartments. As argued by
others, too much peripheral expansion in relation to thymic output during
T cell ontogeny would result in a T cell repertoire with relatively few over-
represented clones that is not diverse enough for adequate protection [45].
In Chapter 3, we attempt to quantify the balance between thymic output
and peripheral expansion in naive T cells during ontogeny.
1.4 recirculation of t cells
1.4.1 Anatomy of the lymphatic system
The lymphatic system is responsible for returning interstitial ﬂuid from tis-
sues into systemic circulation, absorbing digested fats from the intestines,
and playing a major role in the immune system. The major secondary lym-
phoid organs (SLOs) of the mouse are the lymph nodes, spleen, and Peyer’s
patches. In lymph nodes, afferent lymphatic vessels drain ﬂuid from sur-
rounding tissues and bring in pathogens and antigen-bearing DCs. Lympho-
cytes enter the lymph node from the blood through walls of blood vessels
called high endothelial venules. Peyer’s patches are specialized lymph-node-
like structures in the small intestine where antigens from the gut are sampled
in order to develop protective mucosal immunity. Lymphocytes enter Peyer’s
patches through high endothelial venules, and efferent lymphatics connect
naive and activated lymphocytes to the mesenteric lymph nodes. The spleen
does not have any direct connections to the lymphatic system; lymphocytes
enter and leave the spleen through the blood.
Interstitial ﬂuid from tissue is drained by afferent lymphatics to lymph
nodes, which in turn are drained by efferent lymphatics into larger lym-
phatic vessels that return lymph to the blood [48]. In both humans and mice,
the thoracic duct is the biggest vessel of the lymphatic system and collects
lymph from the body (approximately 3/4 of all interstitial ﬂuid) other than
the right thorax, arm, head, and neck. The latter regions are drained by the
right lymphatic duct (the other 1/4 of all interstitial ﬂuid). The thoracic duct
travels from the abdomen and ascends to the thorax, where it drains into
the venous angle of the left subclavian vein and the internal jugular veins.
The mesenteric lymph nodes drain into the thoracic duct. In mice and rats,
other lymph nodes, such as the inguinal, axillary, and cervical lymph nodes,
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Figure 1.6: An illustration of the lymphatics of the thorax and neck of themouse.
This ﬁgure illustrates how inguinal, axillary, cervical, and mesenteric lymph nodes are
drained by the lymphatic system and how the draining major lymphatic vessels enter
back into venous blood [50, 48, 49].
are drained by other large ducts that return lymph back to the system cir-
culation without connecting to the thoracic duct [48]. In the rat, the right
inguinal lymph nodes drain into the axillary lymph nodes, which then drain
through the subclavian duct into the right lymphatic duct before returning
back into venous blood [48].1 The left inguinal lymph nodes drain into the
axillary lymph node, which then drain into the subclavian duct to return
to venous blood in the left subclavian vein [48]. The cervical lymph nodes
have their own cervical ducts on either side that eventually drain into the
systemic circulation via the subclavian veins. We assume that the anatomy
of the lymphatics of rat and mice are similar (Figure 1.6) [50].
1This contrasts with humans, where the inguinal lymph nodes are drained by the exter-
nal and common iliac lymph nodes, which eventually drain into the cisterna chyli and the
thoracic duct [49].
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1.4.2 Recirculation of T cells
The diverse naive T cell repertoire can recognize virtually any pathogen, but
the naive T cells must come in contact with their cognate antigen to mount
a response to foreign antigens. Naive T cells must be constantly surveying
different foreign antigens in order for this to happen. Since these interactions
happen in the SLOs—particularly in lymph nodes—T cell recirculate from
lymph node to lymph node in order to survey many antigens. This is espe-
cially true since estimates for the number of naive T cells that can respond to
a given foreign antigen is 200–1400 in mice [2, 51, 52], and these antigen-
speciﬁc precursors will be distributed across ~30 lymph nodes [38, 50], the
spleen, and other SLOs. Thus, naive T cells must recirculate between blood
and SLOs in order for all of these antigen-speciﬁc precursors to be recruited
and respond to a pathogenic insult [53, 54] Central memory T cells and some
effector memory T cells also recirculate between blood and SLOs [55]. TCM
cells, which express CD62L, enter lymph nodes through HEVs and spend
6–16 hours sampling different antigens before entering the efferent lymphat-
ics to return to the systemic circulation [56]. TEM cells migrate between the
spleen, blood, and peripheral tissues. These memory subsets contrasts with
TRM cells, which permanently reside in peripheral tissues of the site of infec-
tion [55]. By recirculating from site to site, T cells are able to sample different
antigens, facilitating the recognition of foreign antigens by T cells to mount
an efficient response. We attempt to quantify the number of circulating T
cells in the SLOs of the mouse in Chapter 4.
1.5 sequencing
Numerous techniques exist for identifying TCR sequences and probing the
diversity of the repertoire of T cell populations. These methods can be di-
vided into four broad categories: anti-TRBV antibodies and spectratyping,
TCRα- or TCRβ-only sequencing, single-cell paired TCRα/TCRβ sequenc-
ing, and statistical multi-cell TCRα/TCRβ sequencing.
1.5.1 Anti-V-segment antibodies and spectratyping
Flow cytometry with monoclonal antibodies against TRBV segments and
spectratyping were commonly used to probe the TCR repertoire before the
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emergence of high-throughput sequencing (HTS) techniques. One of the
original techniques employs a panel of antibodies against TRBV segments
of interest and uses ﬂow cytometry to quantify the proportion of T cells
expressing each of those TRBV segments. Although relatively simple to im-
plement, this approach suffers from two main drawbacks. First, identifying
TRBV segments used in a TCR does not identify the speciﬁcity-conferring
CDR3 sequences. Second, a panel of anti-TRBV antibodies cannot identify
all TRBV subfamilies since only a limited number of TRBV antibodies is
commercially available for mice and for humans [57].
To partially overcome these problems, CDR3 spectratyping (also known
as Immunoscope) took repertoire analysis further by identifying the distri-
bution of CDR3 lengths found in a sample of T cells [58]. Spectratyping
can be performed on entire T cell populations or in conjunction with anti-
TRBV antibodies to identify CDR3 length distributions with TRBV sub-
families. The many variations of this technique all involve using PCR to
amplify the CDR3β region of the mRNA coding for the TCRβ chain with
primers speciﬁc for each TRBV segment and a primer speciﬁc for the TRBC
region. Since β-rearrangement creates variability in CDR3 length due to the
addition of N-nucleotides during V(D)J rearrangement, CDR3β lengths can
vary by up to nine amino acids, and thus a collection of many different T
cell clonotypes should yield a distribution of CDR3β lengths. The result-
ing PCR products of different lengths are then separated and quantiﬁed by
using electrophoresis or by labeling products with ﬂuorochromes and ana-
lyzing with gel readers. The data are a series of 8–9 peaks of the frequency
of PCR products of a given length (which have been incorrectly assumed to
be normally distributed) [58], and the area of each peak gives the frequency
of PCR products associated with a given CDR3 length.
These two techniques have been used to answer questions about TCR
repertoire diversity and probing changes in T cell clonality in disease states.
Studies have estimated the diversity of the human αβ TCR repertoire by us-
ing antibodies against speciﬁc V segments [17, 24]. Many studies have used
spectratyping to associate perturbations in the distribution of CDR3 lengths
with disease states (reviewed in Reference [59]). Although these two tech-
niques probe information about TCRs indirectly, they were instrumental in
the quantiﬁcation of clonal diversity before HTS became available.
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1.5.2 TCRα- and TCRβ-sequencing
Obtaining the nucleotide and amino acid sequences of the CDR3 regions of
either only the TCRα chains or only the TCRβ chains used in T cell pop-
ulations has become common with the advent of efficient and economical
HTS techniques [18, 60, 61, 62, 63]. Standard sequencing techniques cannot
obtain paired CDRα and CDRβ sequences from a sample of T cells. Since
the TCRα and TCRβ loci are found on different chromosomes, the DNA
or mRNA encoding these genes are not anchored together and thus bulk
sequencing of a T cell population loses pairing information. This technical
obstacle has limited most studies to sequencing only one of the chains, typi-
cally the TCRβ chain (and from this point on, single-chain TCR sequencing
will be referred as TCRβ sequencing).
Many of the technical challenges in TCRβ sequencing, such as design of
primers, reduction in ampliﬁcation bias, choices in HTS technologies, and
data processing and aligning of raw sequence reads, have been solved (re-
viewed in [64]). TCRβ sequencing has been used to answer many questions
about TCR repertoires, such as estimating the total number of αβ TCRs
found in the naive repertoire [18]. Another study utilized TCRβ sequenc-
ing to study the dynamics of the TCRβ repertoire in T cells responding to
YF-17D yellow fever vaccine in human patients [62]. TCRβ sequencing was
a signiﬁcant progression from antibody and spectratyping techniques be-
cause it directly identiﬁes the peptide-recognizing region of TCRs rather than
yielding indirect measures of TCR diversity.
However, single-chain sequencing loses information about TCRs since
both chains of the TCR contribute to its antigen speciﬁcity. As we will dis-
cuss in Section 5.1.3, different clones can have TCRs that share the same
CDR3 sequence in one of the chains, and this information is lost by se-
quencing only one of the TCR chains.
1.5.3 Single-cell sequencing
Many studies have developed methods to identify paired TCR sequences
by sequencing single cells. One of the ﬁrst single-cell sequencing studies
was described by Dash et al. [65], where they performed single-cell sorting
on murine KbPB1703-speciﬁc CD8+ T cells using tetramer staining. cDNA
libraries were made using single-cell multiplex reverse transcription poly-
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merase chain reaction (RT-PCR) with TRAV-, TRBV-, TRAC-, and TRBC-
speciﬁc primers, and high-throughput sequencingwas used to obtain CDR3α
and CDR3β sequences. Similar approaches were used in both human and
murine T cell populations [66, 67], and analogous approaches have been
used for identifying paired heavy-chain and light-chain CDR3 sequences
found in B cell populations [68]. Han et al. [69] extended single-cell se-
quencing by including the sequencing of other functional genes such as those
coding for cytokines and transcription factors, allowing for the identiﬁca-
tion of paired CDR3α/CDR3β sequences and the phenotypes of the sam-
pled T cells. Software has also been developed to identify TCR sequences
(called TraCeR [70]) and BCR sequences (called BraCeR [71]) from single-
cell RNA-seq (RNA sequencing) data.
DeKosky et al. [72] avoided using single-cell sorting by using of cus-
tomized polydimethylsiloxane slides with 125 pL wells to isolate B cells
with a 95% probability of wells containing exactly one cell. Turchaninova
et al. [73] created single-cell emulsions and performed linkage RT-PCR in
the emulsion droplets, where TCRα and TCRβ transcripts were fused be-
fore being sequenced. DeKosky et al. [74] extended their approach by using
a ﬂow-focusing apparatus to create a single-cell emulsiﬁcation, performing
linkage RT-PCR to link light-chain and heavy-chain transcripts, and then
sequencing these linked transcripts. McDaniel et al. [75] designed and care-
fully described another ﬂow-focusing device to emulsify many single cells
for single-cell sequencing.
The drawbacks of these techniques include (i) limited scalability, which
risks the undersampling of rare clones and thus underestimating diversity,
(ii) imprecise and missing information regarding clonal frequencies, and (iii)
the need to use customized equipment [72, 74, 75].
1.5.4 Statistical multi-cell sequencing approaches
To overcome the sample size limitations of single-cell sequencing approaches,
an alternative strategy is to use a statistical method to associate CDR3α and
CDR3β pairs from sequences obtained from multiple subsamples of T cells
sampled from a target T cell population. Methods that employ this strategy
capitalize on the fact that chains from the same TCR will tend to appear
together in samples and use the frequencies of these co-occurrences to as-
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sociate them together. Three approaches using “frequency-based pairing”
currently exist: a preliminary attempt used to pair B cell receptors [76], a
commercial methodology called pairSEQ developed by Adaptive Biotech-
nologies [1], and our open source methodology, presented in Chapter 5 [77].
The study by Reddy et al. [76] attempted a rudimentary version of freq-
uency-based pairing in B cells by pairing the most abundant VL and VH
CDR3 sequences by matching their relative frequencies in the sampled reper-
toire. Howie et al. [1] developed amore sophisticatedmethod called pairSEQ
that samples T cells into different subsets and then uses combinatorics and
statistics to determine paired TCRα/TCRβ sequences. Finally, our approach
called alphabetr [77] uses an experimental design of sequencing multiple
subsamples of an antigen-speciﬁc T cell population and uses an algorithm
to determined paired TCRβ/TCRβ sequences. alphabetr has been designed
to capture characteristics speciﬁc to antigen-speciﬁc T cell repertoires that
have not been explicitly considered in other studies. These frequency-based
pairing methods are discussed in more detail in Chapter 5.
1.6 mathematical modeling in immunology
1.6.1 Why do we need mathematical modeling?
As immunological experiments produce more detailed and complex data,
analyzing and interpreting the results of these experiments requires care-
ful and reproducible quantitative approaches. There are least two uses for
mathematical models: (i) estimation of parameters representing biological
processes that cannot be directly measured experimentally and (ii) testing of
hypotheses about underlying biological mechanisms that cannot be achieved
experimentally. These two purposes are not necessarily mutually exclusive
and often occur in the same modeling effort. In mathematical modeling ef-
forts in T cell biology, parameters for T cell population dynamics such as
lifespans and proliferation rates of naive and memory CD4+ and CD8+ T
cells have been gleaned from bone-marrow chimeras in mice [78, 79], deu-
terium labeling experiments in mice [80], deuterium-labeling experiments
in humans [81, 82, 83, 84], deuterated-glucose-labeling experiments in hu-
mans [85, 86, 87, 88, 89], and experiments using adoptive-transfers of CSFE-
labelled T cells experiment [90, 91]. Mathematical models have also par-
tially elucidated the structure of the CD4+ and CD8+ memory compartments
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in mice, including testing different hypotheses regarding pathways of differ-
entiation from naive to memory to effector T cells [92, 79] and clarifying
the nature of heterogeneity in division and death rates found in T cell com-
partments [93, 89, 94, 95].
Interpretation of data using model-free intuition and simple statistical
tests can often lead to erroneous conclusions due to implicit assumptions
made in these interpretations [96, 97]. Mathematical modeling attempts to
overcome these problems bymaking the assumptions explicit when the mod-
els are constructed. By ﬁnding models that explain the data of interest, we
create mathematical descriptions and interpretations of the data that are
easy to scrutinize. In addition, the process of mathematical modeling often
ﬁnd many mathematical models that cannot explain the data, which also
can provide insight into interpretations about the data [98]. By combining
careful mathematical modeling with good experimental design, more infor-
mation can be drawn from data tomake richer inferences andmore informed
predictions than possible with standard statistical analyses of data.
1.7 aims
The aims of this thesis are to provide quantitative descriptions the develop-
ment, size, and diversity of T cell populations.We ﬁrst developmathematical
models that describe and quantify the ontogeny of naive T cell populations.
We then describe an attempt to quantify the sizes of various lymphocyte
compartments using a thoracic duct cannulation technique in mice to col-
lect circulating lymphocytes. Finally, we develop tools that are efficient at
identifying paired TCRα and TCRβ sequences. Our attempts to quantify the
sizes of T cell populations, to describe the mechanisms for the development
of these populations, and to provide tools for identifying the richness of
repertoires of these populations all serve the overarching goal of quantita-
tively characterizing effective T cell immunity.
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C H A P T E R  2

Materials and Methods
2.1 mice
Male C57BL/6 mice were purchased from Harlan/Envigo and maintained in
individually ventilated cages prior to surgeries. All protocols were approved
by the local ethical committee and conducted under licenses issued by the
UK Home Office, project license number PPL60-3822.
2.2 cell isolation and materials
2.2.1 Media
Cells were prepared and washed in FACS buffer, which is Dulbecco’s Phos-
phate-Buffered Saline (PBS) (Gibco) supplemented with 2% inactivated fetal
bovine serum (Invitrogen). Fetal bovine serum was added to reduce non-
speciﬁc binding by the antibodies used for staining for ﬂow cytometry.
2.2.2 Thoracic Duct Cannulation
Male 12–18 week old mice were anesthetized with continual inhalation of
isoﬂurane (Abbot Animal Health). The mice were gavaged with 200 μL of
olive oil in order to visualize the lymphatics. After the induction of anes-
thesia, a lateral incision was made through the skin and muscle of the left
side of the mouse just under the ribcage. Blunt dissection was used to vi-
sualize the thoracic duct. A small cut in the thoracic duct was made with
microscissors, and a polyurethane cannula (2 Fr, Linton Instrumentation)
was inserted into the duct. The cannula was secured to the site of insertion
with super glue (Loctite), and then the muscle layer was sutured. The can-
nula was fed through a wire tube on the back of the mouse attached to a
harness worn by the mouse in order to avoid biting and tearing of the can-
nula. For 18–24 hours after the surgery, lymph was collected on ice in 1 mL
sterile PBS (Gibco) with 20 U/mL heparin sodium (Wockhardt).
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2.2.3 Lymph nodes and spleens
Spleens and peripheral lymph nodes (cervical, axillary, inguinal, mesenteric)
were dissected from mice euthanized with carbon dioxide inhalation and
were teased between a pair of frosted slides to obtain single-cell suspen-
sions. Cells were washed with FACS buffer and centrifuged at 340×g, 4°C.
Cells were resuspended in FACS buffer and then ﬁltered through a 40μm
cell sieve (Greiner) in order to remove tissue debris. Aliquots of the sam-
ples were used for cell counting with the MACSQuant Analyzer 10 ﬂow
cytometer (Miltenyi Biotec). Cells were counted with a Neubauer Cham-
ber hemocytometer before being stained with antibodies for ﬂow cytometry
analysis.
2.2.4 Lymph
Collected lymph was ﬁltered through a 40 μm cell sieve (Greiner), and a
small aliquot was used for cell counting with theMACSQuant Analyzer. The
remaining lymph was washed with FACS buffer and centrifuged at 340×g,
4°C. The cells were then resuspended in FACS buffer and then used for an-
tibody staining and analysis. Cells were counted with a Neubauer Cham-
ber hemocytometer before being stained with antibodies for ﬂow cytometry
analysis.
2.3 flow cytometry protocols
2.3.1 Cell counting
Cell counting was performed with the volumetric MACSQuant Analyzer 10
ﬂow cytometer. 100–200 μL aliquots of each sample were diluted with FACS
buffer, and 7-AAD viability dye (BioLegend) was used for viability staining.
A ﬁxed volume was analyzed by the MACSquant ﬂow cytometer, and the
number of events in the lymphocyte forward-scatter/side-scatter gate and
live gate were used to count the number of cells.
2.3.2 Antibodies
Cells were stainedwith an antibody panel for T cell markers or stainedwith a
panel for B cell markers. The following ﬂuorochrome-conjugated antibodies
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were used for T cell markers: BV421-CD4 (RM4-5), BV510-CD8 (53-6.7),
FITC-CD44 (IM7), APC-CD62L (MEL-14), PE-CD122 (5H4), PerCP/Cy5.5-
TCRβ (H57-597), PeCy7-CD25 (PC61) (BioLegend). The following ﬂuoro-
chrome-conjugated antibodies were used for B cell markers: BV421-IgD (11-
26c.2a), BV510-CD23 (B3B4), APC-CD93 (AA4.1), PE/Cy7-IgM (RMM-
1), FITC-B220 (RA3-6B2) (BioLegend). Viability staining was performed
with Fixable Viability Dye eFluor 780 (eBioscience), which was used in a
concentration of 1 μ/mL and mixed with the antibody panel in PBS.
2.3.3 Staining for cell surface markers
1 × 106 cells were incubated with 50 μL of the panel of the ﬂurochrome-
conjugated antibodies and the viability dye on ice from 20 min in the dark
in a 96-well round-bottom polystrene plate. The cells were washed twice
with FACS buffer. Data were acquired on a LSR II or a LSR-Fortessa ﬂow
cytometer (BD Biosciences) for analysis and analyzed using FlowJo 10.4.2
(Treestar).
2.4 ontogeny experiments
The experiments described in Chapter 3 were performed by Thea V. Hogan.
Wildtype male and female mice (C57BL/6 background) were bred and main-
tained in conventional pathogen-free conditions at the animal facility at the
Royal Free Campus of University College London. All experiments were
performed in accordance with UK Home Office regulations, project license
number PPL70-8310. Mice younger than 14 days old were euthanized by
decapitation, and older mice were euthanized by either cervical disloca-
tion or by carbon dioxide inhalation. Lymph nodes and spleens were col-
lected from these mice. Cells were counted with a CASY Counter (Omni
Life Sciences) and stained with the following antibody-panel: BV510-CD5,
PerCP-Cy5.5-TCRβ, BV711-CD4, BV785-CD44 (BioLegend), FITC-Ki67,
eFluor450-HSA, APC-FoxP3, PE-CD25, PE-Cy7-NK1.1, biotin-CD122
(eBioscience), BUV395-CD8, BUV737-CD62L (BD Biosciences), PE-Texas-
Red-Streptavidin, and LIVE/DEAD nearIR (Invitrogen). Data were acquired
on a LSR-Fortessa ﬂow cytometer (BDBiosciences) and analyzed using Flow-
Jo 9.9.6 (Treestar).
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2.5 single-cell sequencing
The single-cell sequencing experiment described in Chapter 5, Section 5.1.4
was performed by Jeff E. Mold. A human volunteer was identiﬁed as HLA-
A2+/HLA-B7+ and received the live attenuated yellow fever vaccine (YFV-
17D). On day 15 post-vaccination, peripheral blood samples were taken,
and live CD3+CD8+ T cells were isolated by negative selection using mag-
netic columns (Miltenyi Biotec, CD8+ T cell negative isolation kit). Cells
were labeledwith a panel of antibodies and theHLA-A02:01/LLWNGPMAV
dextramer representing the immunodominant response [99]. Single dextra-
mer-speciﬁc CD3+CD8+ T cells were sorted into individual wells in 96 well
plates containing a lysis buffer (0.4% Triton, RNAse inhibitor, dNTP, Oli-
godT) and immediately stored on dry ice. Single cell transcriptome libraries
were subsequently generated from these cells using an adapted version of the
SMRT-Seq2 protocol [100]. Libraries were prepared for sequencing by tag-
mentation and labeling individual single cell transcriptomes with a custom
Tn5 enzyme [101] and Nextera XT dual indexes. Pooled libraries were then
sequenced using an Illumina Hiseq2500 on high output mode (2×100bp or
2×125bp reads), and individual CDR3α and CDR3β sequences were identi-
ﬁed using the MiTCR algorithm with default parameters [102]. The default
settings forMiTCRwere used to align the CDR3 sequences. These were then
manually ﬁltered to remove erroneous sequences (e.g. early stop codons and
CDR3 sequences that were greater than 30 amino aids in length), and then
BLAST was used on the remaining sequences to check for mapping to other
parts of the genome, removing as appropriate. All clones used in the com-
parative analysis of CDR3α lengths in Section 5.1.4 were curated manually
to exclude the possibility of contaminating TCR sequences.
These experimental procedures were approved by the Regional Ethical
Review Board in Stockholm, Sweden: 2008/1881-31/4, 2013/216-32, and
2014/1890-32.
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Figure 2.1: A simplemodel for peripheral T cell dynamics. This ﬁgure is a schematic
of a simple model that describes thymic export of T cells into the periphery, division,
and cell death.
2.6 mathematical and statistical analysis
A range of mathematical and statistical methods are used in this thesis to
analyze and to make inferences from data. Mathematical modeling centered
on creating ordinary differential equation (ODE) models that represent the
important processes and mechanisms occurring in different cell subsets, and
we will brieﬂy discuss how these equations are formed in Section 2.6.1. For
parameter estimation and model selection, we used a combination of fre-
quentist and Bayesian statistical approaches. We will brieﬂy describe null-
hypothesis signiﬁcance testing and bootstrapping in Sections 2.6.2–2.6.3
and spend more time describing Bayesian approaches in Section 2.7.
2.6.1 Differential equations
Creating a differential equation model ﬁrst involves identifying the key pro-
cesses that are involved in the biological system of interest. For example,
suppose we want to create a simple model for the number of T cells in the
periphery over time. We assume that the thymus exports T cells into the
periphery at a ﬁxed rate and that T cells die at some constant rate. Let’s
represent these rates with variables:
• Thymic export: let θ be the number of T cells per day that the thymus
exports into the periphery.
• Cell death: let δ rate of death of T cells where 1/δ is the mean lifetime;
this is one of many ways to model death where cells are lost with ﬁrst
order kinetics and their lifetimes are exponentially distributed.
We can draw a schematic of these two processes as arrows entering or leav-
ing a box that represents the number of N peripheral T cell (Figure 2.1).
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We now can write down a differential equation that contains mathematical
representations of these processes and describes the rate of change of the
number of T cells N over time, namely dNdt .
• Thymic export: the number of cells per day entering the T cell com-
partment from the thymus is simply θ
• Cell death: the number of cells per day that are dying is δ multiplied
by the number of T cells, namely δN.
We put these terms together to get the differential equation
dN
dt
= θ − δN .
Note the negative sign in the second term since cell death results in a loss
of cells. The solution of this equation either is determined analytically or
estimated with numerical techniques with software.
2.6.2 Null hypothesis signiﬁcance testing
Null hypothesis testing was performed using the one-sample Student’s t test
or theMann-Whitney U test. These tests were performed with R 3.4.3 [103].
p values less than 0.01 were considered statistically signiﬁcant.
2.6.3 Bootstrapping
We use a statistical tool called the bootstrap to quantify the uncertainty
around statistical estimates of data. Let X = (x1,x2, . . . , xn) be n data
points, and suppose we want to quantify the uncertainty on some statistical
estimate θ of the datasetX. The bootstrap procedure begins by creating new
datasets of size n by sampling with replacement from X. Each one of these
resampled datasets is called a bootstrap sample, and we create a large num-
ber of these bootstrap samples, say 1000. For each bootstrap sample i, we
calculate the statistical estimate θ∗i for that sample and obtain 1000 boot-
strap replicates θ∗1, θ
∗
2, . . ., θ
∗
1000. This set of bootstrap replicates allows us to
make inferences about our data. For example, determining the 2.5 percentile
and 97.5 percentile of the replicates deﬁnes a 95% conﬁdence interval for
θ, and taking the standard deviation of the bootstrap replicates gives us the
standard error for θ.
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2.7 bayesian data analysis
2.7.1 Advantages of Bayesian statistics
Two broad approaches to statistics and interpretations of probability exist.
The frequentist approach views probability as long-run frequencies over a
large number of repetitions of an experiment; a unbiased coin that has a
50% chance of showing heads after a toss means that the proportion of
tosses showing heads will approach 0.5 with a large numbers of trials. The
Bayesian approach views probability as a degree of plausibility for the event
that we are interested in; in its essence, Bayesian inference counts the number
of ways an event can occur, and events that occur in more ways are more
plausible. These descriptions can feel abstract with no practical relevance,
but the two different approaches to statistical inference give rise to profound
differences in how we quantify and understand interpretations made in data
analysis.
The interpretation of frequentist statistics often relies on imagining many
multiple samples of the data, repeating an experiment many times until we
see a pattern. For example, suppose we compute a frequentist 95% conﬁ-
dence interval on a parameter for an experiment. The strict interpretation is
that if we were to repeat the study many many times, then 95% of the com-
puted conﬁdence intervals from the repeated studies contain the true value
of the parameter. Thus in the frequentist framework, uncertainty is depen-
dent on making repeated measurements over and over again. Although this
type of resampling of measurements is not done in practice, it provides a
framework to understand uncertainty in frequentist inferences.1
The Bayesian approach counts the number of ways that the data can oc-
cur as a way to measure plausibilities, and these plausibilities are assigned
probabilities. This approach has the advantage of providing very direct in-
terpretations of inferences about data. For example, a Bayesian 95% con-
ﬁdence interval (often called credible intervals in order to be distinct from
a frequentist conﬁdence interval) is constructed such that the true parame-
1Bootstrapping is one example of the frequentist approach used in practice. The process
of resampling the data with replacement is an attempt to simulate the repeated sampling of
data. The bootstrapping procedure assumes that the collected data is representative of the
population of interest and that resampling from the data simulates multiple data sets from
the population. By having thousands of resampled data sets, we capture the thinking of the
frequentist framework.
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ter value has a 0.95 probability of being within the interval. The Bayesian
framework allows for this kind of common-sense and straightforward inter-
pretation of inferences.
In Bayesian data analysis, we aim to make inferences on unknown quan-
tities from data using probability models of observed quantities. In other
words, we want to calculate the relative plausibility of different parameter
values conditional on the observed data. For example, suppose we want to
estimate the rate of proliferation of T cells with data of T cell counts in the
spleen in 1 hour intervals for 2 days. Based on the cell count data and a
statistical model, we aim to calculate the plausibility for all possible rates
of proliferation. A Bayesian analysis would then result in inferences like the
following: there’s a 20% probability for the rate to be greater than 1 divi-
sion per 200 days, 50% probability for the rate to range from 1 division
per 201 to 300 days, and 30% probability for the rate to be greater than
1 division per 400 days. This is quite different from a frequentist analysis,
which would typically provides a best estimate and a conﬁdence interval but
does give degrees of plausibilities for different estimates.
Bayesian inference, which describes the relative plausibility of different
parameter values based on the data, is encapsulated in the posterior dis-
tribution. The posterior distribution describes all of the possible parameter
values and assigns a probability to each one, conditioned on the observed
data. Suppose θ is a parameter or a set of parameters we wish to estimate
and y is observed data. The posterior distribution is the quantity
p(θ|y) (2.1)
which is the probability of a value θ conditioned on the observed data y
and p(·) is the marginal distribution or density of the probability model.
Equation 2.1 is calculated with Bayes’ theorem:
p(θ|y) = p(y|θ)p(θ)
p(y)
. (2.2)
The ﬁrst term p(y|θ) is called the likelihood, and this is the probability of
seeing the observed data given the parameter value θ and the probability
model. Observed data or log-transformed data is often assumed to be nor-
mally distributed—particularly in biological data—and so the likelihood of-
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ten is calculated from the normal distribution. The second term p(θ) is called
the prior, and this is the initial set of plausible values for the parameter. This
is where previous evidence or intuitions regarding the parameters are incor-
porated into the model. The ﬁnal term p(y) is called the marginal likelihood
of y and is given by p(y) =
∑
θ p(θ)p(y|θ). This can be thought of as the
average likelihood of the data over the prior. This term in practice does not
need to be computed. Thus, in words,
Posterior =
Likelihood× Prior
Average Likelihood
Priors are chosen by the data analyst performing the data analysis and
reﬂect the information we have about the parameters. This can be as simple
as constraining the parameters to be positive (e.g. a negative proliferation
rate makes no physical sense) and/or ruling out unrealistic values (e.g. naive
T cells do not divide once every 10 minutes). Many frequentist approaches
implicitly utilize ﬂat priors by design (meaning all values are possible). In
contrast, Bayesian analysis allows the scientist to use prior information to
help the statistical model learn from the data more accurately and efficiently.
Bayesian statistics is often criticized for being “subjective” since the priors
are chosen by the scientist. Although much ink has been spilled about this
topic, priors should be viewed as the available information about the param-
eters, and explicitly testing how different priors affect inferences provides
much information about the data [97, 104, 105]. In the end, priors are just
part of the statistical model and thus need to be evaluated and revised just
like one would with any other type of models.
2.7.2 Steps in Bayesian data analysis
Bayesian data analysis has three generalized steps [106]:
• Setting up a full probability model: this involves describing a proba-
bility model that describes all observable data and unobservable pa-
rameters that we are interested in estimating.
• Calculating the posterior distribution: here we calculate the condi-
tional probability of all unobserved parameters conditioned on the
observed data.
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• Evaluation of the model: we attempt to answer how well the model
explains the observed data and how sensitive the model is to our as-
sumptions made in the probability model.
References [97] and [106] describe these steps in detail. Instead, we will
describe how these steps are performed in Chapter 3. For probability mod-
els used in Chapter 3, we assume that log-transformed counts and logit-
transformed Ki67 proportions are normally distributed. The means of these
values are predicted by ordinary differential equation (ODE) models, and
the unknowns are the parameters used in the ODEs. The posterior distribu-
tions are approximatedwith the Stan language [107], and priors are speciﬁed
based on information from previous modeling studies. Model ﬁts are evalu-
ated by how well the model explains the observed data while correcting for
overﬁtting, which we discuss in the next three sections.
2.7.3 Evaluating model ﬁts with log predictive densities
Suppose Eilidh wants to be the next haggis hurling champion by competing
in the Haggis Hurling World Championship at the 2018 Bearsden & Mil-
ngavie Highland Games.2 In her last training session, she threw the haggis
120 feet, 108 feet, and 105 feet in three practice throws. Based on these data,
we would like to estimate what her average haggis-throwing distance is.
Let N(μ, σ) denote a normal distribution with mean μ and variance σ2.
Suppose we have two models for her haggis-throwing arm: N(112,7) and
N(90,7). How do we evaluate how well these models ﬁt the data?
The ﬁrst approach is to use the sum of the squared errors (also known
as the sum of the squared residuals (SSR)), namely
SSR =
n∑
i=1
(
yi − E(yi|θ)
)2 (2.3)
where E(yi|θ) is the expected value for yi given by the model, and y1, y2, . . .,
yn are n data points. This equation sums up the squared differences between
each data point and the value predicted by the model for the data point.
2http://www.bearsdenmilngaviehighlandgames.com/about-the-games/
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For our haggis throwing example, the model N(112,7) predicts an av-
erage distance of 112, so
SSR1 = (120− 112)2 + (108− 112)2 + (105− 112)2 = 129 .
The model N(90,7) predicts an average distance of 90, so
SSR2 = (120− 90)2 + (108− 90)2 + (105− 90)2 = 1449 .
It’s very clear that the ﬁrst model N(112,7) explains the data much better
than the second model. Measures like SSR are easy to compute and interpret
but fail to incorporate uncertainty about parameter values. For example, in
the calculations for model N(112,7), we are stating with full certainty that
μ is 112 and σ is 7. Uncertainty quantiﬁed in posterior distributions cannot
be incorporated in measures like the SSR.
As an alternative, we use probabilistic prediction to incorporate uncer-
tainty. In particular, we use the log predictive density
log p(y|θ) .
y is the data point we are trying to predict with our model, and p(y|θ) is the
likelihood given by the data model. A deeper explanation and rationale for
this measure is beyond the scope of this section, but it has connections to the
Kullback-Leibler information measure—models with the lowest Kullback-
Leibler information have the highest expected log predictive density and thus
have the highest posterior probability. In practice, we do not know what θ
is, but we have estimates of θ and our uncertainty on θ in the posterior
distribution ppost(θ) = p(θ|y). So, we summarize the predictive density of
the model by using the posterior distribution,
log ppost(y|θ) = log
∫
p(y|θ)ppost(θ)dθ . (2.4)
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And if y is a whole data set {y1, y2, . . . , yn}, then we calculate the log
predictive density of the whole data set
lppd = log pointwise predictive density
= log
n∏
i=1
ppost (yi|θ)
=
n∑
i=1
log
∫
p(yi|θ)ppost(θ)dθ (2.5)
For our haggis throwing example, suppose we have a modelN(μ,7) and
the posterior distribution for μ is 0.75 probability for μ = 112 and 0.25
probability for μ = 108. The lppd for this model is given by
lppd = log
∫
p(120|μ)ppost(μ)dμ+
log
∫
p(108|μ)ppost(μ)dμ+
log
∫
p(105|μ)ppost(μ)dμ
Let N(y|μ, σ) denote the probability density of y for a normal distribution
with mean μ and standard deviation σ.3 Then,
lppd = log
(
N(120|112,7) · 0.75+N(120|108,7) · 0.25
)
+
log
(
N(108|112,7) · 0.75+N(108|108,7) · 0.25
)
+
log
(
N(105|112,7) · 0.75+N(105|108,7) · 0.25
)
= −9.9
To give a comparison, suppose we proposed a second (and worse) model
N(μ,7) with a posterior distribution for μ of 0.75 probability for μ = 100
and 0.25 probability for μ = 50. This model gives us a lower lppd of −14.4.
3The probability density of a normal distribution with mean μ and standard deviation σ
is given by
N(y|μ, σ) = 1√
2πσ2
e
(
− (y−μ)
2
2σ2
)
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2.7.4 Evaluating model ﬁts using out-of-sample predictive accuracy
The ideal measure for a model’s ﬁt would be a measure of how well it ﬁts
a new data point, also called its out-of-sample predictive performance. If
f is the the true data-generating model, y is the observed data, and y˜i is a
new data point from the true data-generating process, then we would like
to know the log predictive density of y˜i, namely,
log ppost(y˜i|θ) .
Since the future data y˜i are unknown, we cannot calculate this and must
instead take a step forward and calculate the expected log predictive density
for a new point,
Ef
(
log ppost(y˜i|θ)
)
=
∫ (
log ppost(y˜i|θ)
)
f(y˜i)dy˜i (2.6)
If we have a whole dataset y˜1, y˜2, . . ., y˜n, then we can calculate the expected
out-of-sample log predictive density for the whole dataset,
elpd = expected log pointwise predictive density for a new dataset
=
n∑
i=1
Ef
(
log ppost(y˜i|θ)
)
(2.7)
where we simply added up the elpd for each data point. However, we cannot
calculate these values as well since f, the true-data generating process, is also
unknown to us.
Since future new data are unknown, we are left to use the ﬁt of the model
to the observed data (such as the lppd). All models are subject to a phe-
nomenon called overﬁtting, which is when a model learns too much from
the observations and goes beyond representing its general features, result-
ing in poor predictions for future data. Thus, in order to estimate the elpd
of a model, we can use the lppd then subtract a correction to account for
overﬁtting,
elpd = lppd− correction .
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Here we describe alternative approaches to calculating the correction
term. We will also describe the equivalent information criterion forms of
these estimates of the elpd. The information criteria are simply the elpd
multiplied by −2, and this form has connections to information theory.
In mathematical modeling efforts in immunology, information criteria have
been traditionally used instead of elpd values to evaluate models, and so we
present both forms below.
Akaike information criterion (AIC) approach. Let k be the number of
parameters used by the model. The simplest approach is to subtract k from
the log predictive density given by the maximum likelihood estimate θˆmle.
This approach assumes that the more parameters that a model has, the more
prone it is to overﬁtting. Thus, we get
êlpdAIC = log p(y|θˆmle)− k (2.8)
and AIC is calculated by multiplying this quantity by −2, giving us
AIC = −2log p(y|θˆmle) + 2k (2.9)
The AIC approach has two drawbacks: the log predictive density uses only
the maximum likelihood estimate and not the full posterior distribution,
and the correction −k makes sense only when non-informative ﬂat priors
are used since even weakly informative priors reduce overﬁtting.
Watanabe-Akaike information criterion (WAIC) approach. TheWAIC is
a fully Bayesian approach that uses the full lppd and a correction that incor-
porates the posterior distribution. We estimate the elpd with the equation
êlpdWAIC = lppd− pWAIC (2.10)
where the correction pWAIC is given by
pWAIC =
n∑
i=1
varpost
(
log p(yi|θ)
)
(2.11)
This termmeasures the variance of the log predictive density across all values
of θ in the posterior distribution for each data point and then sums them all
up. Greater variance of the log predictive density indicates a more ﬂexible
38
model that is thus more prone to overﬁtting. This term is often thought of
as the effective number of parameters since the variance is a reﬂection of the
ﬂexibility of the model. WAIC is calculated by multiplying Equation 2.10 by
−2, giving us
WAIC = −2lppd+ 2pWAIC (2.12)
Leave-one-out cross-validation approach. This approach repeatedly par-
titions the data into a training set ytraining and a holdout set yholdout. The
model is ﬁt to the training set ytraining to obtain a posterior ptrain, and then
the model ﬁt is evaluated by the log predictive density of the holdout data
log ptrain(yholdout|θ) . (2.13)
Typically, yholdout is one data point and ytraining is the other n − 1 data
points; this process is called leave-one-out cross-validation (LOO-CV). Let
ppost(−i)(yi|θ) denote the posterior distribution of themodel ﬁt when yholdout =
yi. Then, the Bayesian LOO-CV estimate for the out-of-sample predictive ﬁt
is
lppdLOO-CV =
n∑
i=1
log ppost(−i)(yi|θ) . (2.14)
Similarly to the other approaches, we can calculate a correction to subtract
from lppdLOO-CV, correction can done for this value. However, in prac-
tice, overﬁtting is limited since each prediction is conditioned on n− 1 data
points instead of the whole data set. Thus, the correction is often not neces-
sary [106], giving us
elpdLOO-CV =
n∑
i=1
log ppost(−i)(yi|θ) (2.15)
For consistency, we can compute the effective number of parameters for the
Bayesian LOO-CV as
pLOO-CV = lppd− lppdLOO-CV (2.16)
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The leave-one-out information criterion (LOOIC) can be calculated by
multiplying Equation 2.14 by −2.
In practice, LOO-CV as described is very computationally expensive
since themodel needs to be ﬁtted n times. An approach called Pareto-smooth-
ed importance sampling (PSIS) provides an approximation to the LOO-CV
that is quick to compute [108]. In Chapter 4, all LOOIC values are calcu-
lated by using the PSIS approximation of the Bayesian LOO-CV using Stan,
Rstan, and the looR package [108].We use LOOIC to evaluate models since
it is considered to be the best measure of the out-of-sample performance of
a model [108, 106]
2.7.5 Using information criteria for model selection
Recent mathematical modeling efforts in immunology have used informa-
tion criteria, in particular the AIC, to evaluate models [92, 78, 79]. More
speciﬁcally, AIC values of different candidate models have been used to per-
formmodel selection, where models with sufficiently lower AIC values (and
hence higher elpd values) are chosen to be the models with the most statis-
tical support. For example, Buchholz et al. [92] created 304 mathematical
models to describe different differentiation patterns among CD8+ naive T
cell, TCM cells, TEM cells, and effector T cells and found that two models
had AIC values at least 10 units lower than all other models. One model
described a linear differentiation framework where naive → TCM → TEM
→ effector T cells, the second model added an additional partial ﬂow from
naive → TEM, and all other models were discarded due to their relatively
high AIC values.
The Bayesian statistical literature often recommends not selecting indi-
vidual models based on information criteria [109, 108]. Information is lost
when models are discarded; instead, quantifying the relative accuracy of the
models compared to each other gives us information about how conﬁdent
we should be about individual models. As an alternative to model selection,
we perform model averaging, in which information criterion values are used
to assign relative weights to candidate models.
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In Chapter 3, we use Akaike weights based on LOOIC values. Sup-
pose we have m candidate models, each evaluated with a LOOIC value of
LOOICi. We deﬁne the difference of model i’s LOOIC from the minimum
LOOIC value from set of candidate models,
ΔLOOICi = LOOICi −min
k
LOOICk . (2.17)
Then the Akaike weight for model i is given by
wi =
exp
(−12ΔLOOICi)∑m
k=1 exp
(−12ΔLOOICk) . (2.18)
The exp
(−12ΔLOOICi) term converts the information criteria to a proba-
bility (reversing the multiplication of the elpd by −2 and then reversing the
log transformation). The denominator then standardizes all values so that
all weights add up to 1. We interpret Akaike weights as follows [110, 97]:
“A model’s weight is an estimate of the probability that the model will make
the best predictions on new data, conditional on the set of models consid-
ered.” In Chapter 3, we will ﬁnd that one model out of a set of candidate
models will have an overwhelming favorable Akaike weight, allowing us to
effectively rule out out other models.
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C H A P T E R  3

Ontogeny of peripheral T cells
3.1 introduction
During early life, peripheral T cells grow in numbers from tens of thousands
at birth to tens of millions in several weeks, peaking at around 2 months in
mice [80]. This magnitude of growth during early life is possible due to a
growing thymus that exports naive T cells into the periphery at a rate that
is assumed to be proportional to the size of the SP thymocyte pool. As we
discussed in Section 1.3.2, there is evidence that the presumed lymphopenic
environment in a neonatal mouse can support the expansion of adoptively
transferred T cells through a mechanism called lymphopenia-induced pro-
liferation (LIP). However, it is unknown whether LIP makes a signiﬁcant
contribution to the growth of peripheral T cell populations during early life.
If signiﬁcant LIP does occur, the associated expansion of T cell clones pop-
ulating the periphery early in life could potentially skew the repertoire. Fur-
thermore, while the stages of thymic development are well-characterized,
the thymus itself ﬁrst grows and then involutes with age, with associated
changes in output. Little is known regarding the effect of these changes on
the dynamics of passage through the different stages of development within
the thymus.
In order to study the dynamics of T cell ontogeny, we studied cell counts
and Ki67 expression in the thymus and in the lymph nodes of mice from days
after birth into late adulthood. We confronted these data with mathemat-
ical models of thymocyte and naive T cell dynamics using Bayesian meth-
ods. Using this approach, we constructed and tested detailed quantitative
descriptions of αβ T cell development from soon after birth into old age.
3.2 experimental data
3.2.1 The players: gating strategies and developmental pathways
Cell counts and Ki67hi fractions were measured in thymocyte and peripheral
T cell subsets in mice of ages 5 days to 296 days old (total of 34 mice). Thy-
mocyte subsets included DP1, DP2, DP3, immature SP4 (iSP4) and mature
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Figure 3.1: (facing page) Cell counts and Ki67hi fractions in the SP4, SP8, and naive
CD4+ compartments. These data were obtained from thymii and lymph nodes of
mice that are 5 days to 296 days old (n = 34, data from all compartments from the
same mice). All cell counts data show a pattern of increasing in numbers and peaking
at ~50 days. From that point, cell counts slowly decline with age. In every compart-
ment except iSP4, Ki67hi fractions start at a maximum shortly after birth and rapidly
decreasewith age. In iSP4 thymocytes, Ki67 expression starts lower and then increases
into adulthood.
SP4 (mSP4), and immature SP8 (iSP8) and mature SP8 (mSP8) thymocytes
(subsets deﬁned in Table 3.1, gating strategy shown in Figure 3.4). Periph-
eral T cell subsets included naive CD4+, CD4+ TCM, CD4+ TEM, naive CD8+,
CD8+ TCM, and CD8+ TEM cells (subsets deﬁned in Table 3.1, gating strat-
egy shown in Figure 3.5). Henceforth we drop the term “thymocyte” for DP
and SP thymocytes unless it is needed for clarity.
The cells counts and Ki67hi fractions for the iSP4/mSP4 compartments,
the iSP8/mSP8 compartments, and the naive CD4+ T cell compartment are
shown in Figure 3.1. In all compartments, the cell counts increase from birth
until its peak at the age of ~50 days and then slowly declines. In every com-
partment except for iSP4, the Ki67hi fractions start at its highest right after
birth and decline very rapidly, reaching a low steady state at the age of ~125
days. The Ki67hi fractions in the iSP4 compartment begins at a lower frac-
tion and increases to a higher steady state Ki67hi at age ~100 days. It should
be noted that since Ki67 is expressed approximately for 3.5 days after a cell
division event [79], Ki67 expression does not necessarily represent divisions
that occurred within the compartment but instead could be inherited Ki67
expression from cell divisions in upstream compartments.
Figure 3.2 shows a schematic of the developmental trajectories within
the thymus. We assumed that thymocytes committed to the CD4 lineage
differentiate fromDP2 directly to iSP4 and that thymocytes committed to the
CD8 lineage pass through the DP3 stage before differentiating to iSP8 [38].
The structure of this chapter is as follows. We begin by modeling CD4+
T cell development from DP2 to mSP4 in Section 3.3 and study CD8 devel-
opment from DP3 to mSP8 in Section 3.4. We then connect the dynamics of
mSP4 cells with those of peripheral naive CD4 T cells in Section 3.5.
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Figure 3.2: Schematic of the developmental trajectory of CD4 and CD8 T cell lin-
eages.We assume a linear differentiation pattern of DP1→ DP2→ DP3. Thymocytes
committed to the CD4 lineage differentiate from DP2 → iSP4 → mSP4, and thymo-
cytes committed to the CD8 lineage differentiate from DP3 → iSP8 → mSP8. Naive
CD4+ T cells are formed from the export of mSP4→ naive CD4. We also highlighted
how these compartments are split up for the modeling effort: the SP4 model consid-
ered DP2, iSP4, and mSP4 at the same time, the SP8 model considered DP3, iSP8, and
mSP8, and the naive CD4+ model considered mSP4 and naive CD4+ T cells.
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Figure 3.3: Gating of lymphocytes/thymocytes, singlet events, and live cells.
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Subset Markers
DP1 CD4+CD8+TCRβloCD5lo
DP2 CD4+CD8+TCRβintCD5hi
DP3 CD4+CD8+TCRβhiCD5int
iSP4 CD4+CD8–TCRβhiNK1.1–CD25–Foxp3–CD62LloHSAhi
mSP4 CD4+CD8–TCRβhiNK1.1–CD25–Foxp3–CD62LhiHSAlo
iSP8 CD4–CD8+TCRβhiCD44–CD62LloHSAhi
mSP8 CD4–CD8+TCRβhiCD44–CD62LhiHSAlo
naive CD4+ TCRβ+CD4+CD8–NK1.1–CD25–Foxp3–CD44–CD62L+
CD4+ TCM TCRβ+CD4+CD8–NK1.1–CD25–Foxp3–CD44+CD62L+
CD4+ TEM TCRβ+CD4+CD8–NK1.1–CD25–Foxp3–CD44+CD62L–
naive CD8+ TCRβ+CD4–CD8+CD44–
CD8+ TCM TCRβ+CD4–CD8+CD122+CD44+CD62L+
CD8+ TEM TCRβ+CD4–CD8+CD122+CD44+CD62L–
Table 3.1: Markers used to deﬁne thymocyte and peripheral T cell subsets.
51
3.3 cd4+ t cell development in the thymus
3.3.1 Modeling CD4+ T cell development in the thymus
We explored an array of mathematical models to explain the division, loss
and (time-varying) ﬂows between the DP → iSP4 → mSP4 compartments,
and the subsequent loss or export of mSP4 thymocytes into the periphery.
To do this, we took advantage of the breakdown of each stage into Ki67hi/lo
cells and used ordinary differential equation (ODE) models to describe the
ﬂows between them.
We assumed that DP2 Ki67hi/lo thymocytes differentiate to iSP4hi/lo re-
spectively. In addition, data from TetZap70 mice in which single cohorts of
thymocytes were tracked through development in the thymus clearly show
that iSP4 become Ki67lo before mSP4 thymocytes begin to appear (unpub-
lished data from Louise Webb and Benedict Seddon).1 Thus, we assumed
that there is no direct ﬂow from Ki67hi iSP4→ mSP4. However, the follow-
ing two points are unclear:
1. Do iSP4 thymocytes lose Ki67 expression before differentiating into
mSP4? Or can they differentiate into the mSP4 compartment while
losing Ki67 expression?
2. Must iSP4 thymocytes divide before differentiating into mSP4?
We proposed three mathematical models to test these possible differentiation
patterns (shown in Figure 3.6).
3.3.2 Modeling the DP2 thymocyte compartment
In all three models, we modeled the DP2 compartment by ﬁtting empirical
descriptor functions to timecourses of cell counts and Ki67 proﬁles (Equa-
tions 3.1–3.2, Section 3.7.1). Every model assumes that DP2→ iSP4 occurs
at a constant per capita rate γDP2.
1TetZap70mice areZap70–/– micewith a tetracycline-inducible Zap70 transgene [41, 38].
In these mice, thymocytes are arrested at the early DP1 stage since they cannot receive positive
selection signals from TCR-pMHC interactions without Zap70 expression. Doxycycline can
be fed to these mice to induce Zap70 and allow thymocyte development to progress.
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3.3.3 Model #1: Immature SP4 thymocytes must lose Ki67 expression be-
fore differentiating to mature SP4 cells
The ﬁrst model (M1 in Figure 3.6A) assumes differentiation from only Ki67lo
iSP4→ Ki67lo mSP4 at a constant rate. Ki67hi iSP4/mSP4 become Ki67lo at
a per capita rate βSP4, meaning that the mean time spent as Ki67
lo is 1/βSP4.
iSP4 and mSP4 are assumed to have constant turnover rates, but we allowed
the turnover rates of Ki67hi/Ki67lo cells within these compartments to differ
(discussed in Section 3.3.7). No proliferation occurs in iSP4 thymocytes, and
mSP4 thymocytes proliferate at a declining rate; a constant proliferation rate
does not explain the data (discussed in Section 3.3.7). Equations 3.4–3.7 are
the ODEs for modelM1.
3.3.4 Model #2: Immature SP4 thymocytes can differentiate to mature SP4
thymocytes as they lose Ki67 expression
The second model (M2 in Figure 3.6B) extends model M1 by letting Ki67hi
iSP4→Ki67lo mSP4, which allows for the possibility of iSP4 maturing while
they lose Ki67 expression. This model uses the same form of Ki67 expres-
sion lifetimes, turnover rates, and proliferation used by model M1. Equa-
tions 3.8–3.11 are the ODEs for modelM2.
3.3.5 Model #3: Differentiation from immature SP4 to mature SP4 requires
division after loss of Ki67 expression
The last model (M3 in Figure 3.6C) requires division in the transition iSP4
to mSP4. Thus, the cells dividing from Ki67lo iSP4 → Ki67hi mSP4 is the
only way iSP4 mature to mSP4. This model again uses the same form of
Ki67 expression lifetimes, turnover rates, and proliferation used in models
M1 andM2. Equations 3.12–3.15 are the ODEs for modelM3.
3.3.6 Differentiation from immature SP4 to mature SP4 requires division
We assessed the abilities of these models to describe the kinetics of the sizes
and the Ki67hi fractions of the iSP4 and mSP4 compartments. We used a
Bayesian approach to ﬁt these models to the data and determine posterior
distributions for the parameters of each model using the Stan programming
language. The statistical models are described in Section 3.7.2. We took a
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Figure 3.6: (facing page) Three models for SP4 thymocyte development. This ﬁg-
ure depicts three models that describe in different ways how immature SP4 thymo-
cytes differentiate to mature SP4 thymocytes. Model M1 requires immature SP4 thy-
mocytes to lose Ki67 expression before they differentiate to mature SP4 thymocytes.
Model M2 extends the previous model by allowing Ki67hi immature SP4 thymocytes
to differentiate to Ki67lo mature SP4 thymocytes as well. Model M3 requires imma-
ture SP4 thymocytes to lose Ki67 expression and then divide in order to differentiate
to mature SP4 thymocytes.
Bayesian approach in part because we wanted to describe the ﬂows between
Ki67hi/lo populations within DP2→ iSP4→ mSP4 simultaneously, and the
large number of parameters involved complicated the use of standard fre-
quentist techniques that employ parameter-space search algorithms; but pri-
marily, a Bayesian approach allowed us to more carefully characterize the
uncertainty in parameters and support for different models.
We show the ﬁts of the models to the data as the mean of the posterior
distribution of predicted values at every time point. These “posterior mean
ﬁts” for modelM3 are shown in Figure 3.7 with 97% credible intervals for
the model ﬁt and 97% prediction intervals. The posterior mean ﬁts for mod-
elsM1 andM2 are shown in Figure 3.8 with 97% credible intervals for the
model ﬁt. These ﬁts are shown with two uncertainty envelopes. The smaller
bands (‘credible intervals’) indicate the uncertainty in how well the model
ﬁts the observed data (i.e. they reﬂect the posterior distributions of the dy-
namic model parameters). The wider envelopes indicate the degree of our
uncertainty in predicting new data with the model; this uncertainty reﬂects
both the posterior distributions of the dynamic parameters and posterior
distributions of the scatter in the observations in each dataset due to biolog-
ical variability and measurement error. The latter are also parameters that
are estimated in the ﬁts.
ModelM3 had the strongest statistical support (ΔLOOIC = 10.2, Akaike
weight = 0.99; see Section 2.7.4 for a description of these metrics) and ex-
plains the early kinetics of Ki67 expression in iSP4 thymocytes and the cell
counts in mSP4 thymocytes more accurately than the other two models. The
ﬁts of models M1 and M2 to cell counts and Ki67hi fractions were visually
and statistically similar (ΔLOOIC = 0.07, Figure 3.8).
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Figure 3.7: Posterior distribution of the ﬁt for model M3. In this model, immature
SP4 thymocytes differentiate into the mature SP4 compartment only by losing Ki67
expression ﬁrst and then dividing. The black curve shown is the posterior mean ﬁt to
the data, the darker envelope indicates the 97% credible interval for the model ﬁt,
and the lighter envelope indicates the 97% prediction intervals.
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Figure 3.8: Posterior distributions of the ﬁts for models M1 and M2. The posterior
mean ﬁts and the 97% credible intervals for model M1 (in blue) and model M2 (in
red) are shown. Both models have similar ﬁts, and the posterior distributions overlap,
resulting in the light purple envelopes around the mean ﬁts seen here. Both models
fail to capture the dynamics of the Ki67 proﬁle in the immature SP4 thymocytes in the
early time points and overestimate the number of mature SP4 thymocytes in the early
time points.
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We found that modelM3 of SP4 thymocyte maturation was strongly fa-
vored, as indicated by the 99% Akaike weight for the model. The estimated
parameter values are shown in Table 3.2. Turnover rates are the rates at
which cells are lost to death in the immature compartments or to death and
thymic export in the mature compartments, and the mean interdivision time
is the average time time it takes for a cell in the compartment to divide and
is given by inverse of the division rate. The mean residence time is the aver-
age time a cell spends in an compartment, which is calculated by taking the
inverse of all of the efflux rates from the compartment, and the Ki67 lifetime
is calculated by taking the inverse of the Ki67 loss rate and represents the
mean number of days a recently divide cell will express Ki67. This model
suggests that Ki67hi iSP4 thymocytes are required to lose Ki67 expression
and then divide again in order to differentiate to mSP4 thymocytes. In ad-
dition, the model requires the division of mSP4 thymocytes to occur more
rapidly in early life. The fastest mean interdivision time is 2.5 days at the
age of 5 days (which is the earliest time point in the data), the slowest is 105
days in adulthood, and the interdivision time decreases with a half-life of 22
days. This increased division rate early in life may increase the size of naive
αβ TCR clones exported early in life. The model also indicates that Ki67hi
mSP4 thymocytes are lost 14 times faster than Ki67lo mSP4, suggesting that
cell division predisposes mature thymocytes for egress, and/or division is
associated only with the ﬁnal stages of egress.
Model M3 has the clearest statistical support and seems to provide the
clearest explanation of SP4 thymocyte dynamics. Both models M1 and M2
do not have capture the Ki67 expression proﬁle of the immature SP4 thy-
mocytes and the mature SP4 cell counts. The failure of model M1 points to
the conclusion that immature SP4 cells need to divide in order to enter the
mature SP4 compartment, and the failure of modelM2 indicates that imma-
ture SP4 thymocytes must lost Ki67 expression before they can make these
divisions to transition into the mature SP4 compartment. Since mature SP4
Ki67hi fractions are high in the ﬁrst 50 days in life, this division require-
ment for the transition from immature to mature SP4 is consistent with the
observed data.
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3.3.7 Exploration of alternative models supports the conclusion that SP4
thymocytes show different turnover rates based on Ki67 expression,
and proliferation rates decrease with time
We also explored simpler versions of model M3 in which (i) Ki67hi/Ki67lo
thymocytes have the same turnover rates within the iSP4 and mSP4 com-
partments and (ii) the turnover rates are different for the Ki67hi/Ki67lo iSP4
thymocytes but the same for Ki67hi/Ki67lo mSP4 thymocytes. Both mod-
els yielded poorer ﬁts to the data (ΔLOOIC > 35 in favor of model M3,
with an Akaike weight of 1). The ﬁrst model failed to capture the dynamics
of Ki67 expression in iSP4 by overestimating the Ki67hi fractions early in
life and in mSP4 thymocytes by overestimating Ki67hi fractions later in life
(Figure 3.9, green curve). The second model failed to explain the dynam-
ics of Ki67hi mSP4 thymocytes at late times (results not shown). We tested
analogous versions of modelsM1 andM2, which also yielded very poor ﬁts
(results not shown).
We examined whether mSP4 kinetics could be explained with a constant
division rate. This model also yielded a poorer ﬁt (ΔLOOIC = 52.3 in favor
of model M3 with an Akaike weight of 1) by failing to explain the Ki67hi
fractions in mSP4 thymocytes after day 100 (Figure 3.9, orange curve).
3.4 cd8+ t cell development in the thymus
3.4.1 Modeling CD8+ T cell development in the thymus
We aimed to describe the kinetics of the SP8 compartment by exploring dif-
ferent mathematical models to describe the ﬂow from DP3→ iSP8→mSP8.
We assume that Ki67hi/lo DP3→ Ki67hi/lo iSP8 respectively. In contrast with
the SP4 compartments, data from TetZap70 mice do not clearly rule out
the differentiation of iSP8 to mSP8 before the loss of Ki67 expression (un-
published data from Louise Webb and Benedict Seddon). Thus, the models
allow Ki67hi/Ki67lo iSP8→ Ki67hi/lo mSP8 respectively. Ki67 lifetimes and
turnover rates were modeled similarly to the SP4 models, and proliferation
occurs in both iSP8 and mSP8.
We assessed the abilities of the models to explain the kinetics of cell num-
bers and Ki67hi fractions of the iSP8/mSP8 compartments. We ﬁrst tested
a model where all turnover and division rates are constant (Figure 3.10A,
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Figure 3.9: Posterior distributions of the ﬁts formore simple SP4 thymocytemod-
els. The posterior mean ﬁts and the 97% credible intervals for a model with same
turnover rates for Ki67hi and Ki67lo thymocytes within the immature and mature SP4
thymocyte compartments (in green) and for a model where proliferation of mature
SP4 thymocytes occurs with a constant rate (in orange).
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Compartment
Turnover Rates (day-1) Mean interdivision time (days) Ki67 Lifetime (days)
Mean 97% CI Mean 97% CI Mean 97% CI
Immature 
SP4
Ki67hi 1.8 (0.94, 2.8)
NA NA
4.0
(3.0, 
5.6)
Ki67lo 0.32 (0.20, 0.45)
Mature 
SP4
Ki67hi 0.50 (0.34, 0.68) Fastest: 2.2 
Slowest: 101 
t1/2: 22
Fastest: (1.6, 4.1) 
Slowest: (49, 1321) 
t1/2: (16, 31)Ki67lo 0.032 (0.015, 0.053)
Immature 
SP8
Ki67hi 4.2 (2.3, 6.1) Fastest: 0.3 
Slowest: 101 
t1/2: 9.2
Fastest: (0.2, 0.6) 
Slowest: (62, 317) 
t1/2: (5.7, 17.6)
6.1
(3.7,13.
4)
Ki67lo 0.54 (0.26, 1.0)
Mature 
SP8
Ki67hi
Fastest: 2.0 
Slowest: .50 
t1/2: 6.4
Fastest: (0.97, 3.5) 
Slowest: (0.19, 1.1) 
t1/2: (4.8, 9.2) Fastest: 1.2 
Slowest: 53 
t1/2: 19
Fastest: (0.8, 2.0) 
Slowest: (14, 4818) 
t1/2: (12, 30)
Ki67lo
Fastest: 4.2 
Slowest: .21 
t1/2: 6.4
Fastest: (0.17, 6.0) 
Slowest: (.055, .53) 
t1/2: (4.8, 9.2)
Naive 
CD4 0.019 NC 236 NC 3.2 NC
Table 3.2: Estimated parameter values for SP4 thymocytes, SP8 thymocytes, and
naive CD+ T cells. Abbreviations: NA, not applicable; NC, not calculated; CI, credible
interval.
61
Immature SP8DP3
Ki67+
Ki67–
Mature SP8
γDP3
βSP8 βSP8
μ–SP8
μ+SP8
δ+iSP8
δ–iSP8
γDP3
αmSP8αiSP8
αiSP8
δ+mSP8
δ–mSP8
M–mSP8
M+mSP8I
+
iSP8
αmSP8
αiSP8(t) αmSP8(t)
αiSP8(t) αmSP8(t)
I–iSP8
Immature SP8DP3
Ki67+
Ki67–
Mature SP8
γDP3
βSP8 βSP8
μ–SP8
μ+SP8
δ+iSP8
δ–iSP8
γDP3
αmSP8(t)αiSP8(t)
δ+mSP8
δ–mSP8
M–mSP8
M+mSP8I
+
iSP8
I–iSP8
Immature SP8DP3
Ki67+
Ki67–
Mature SP8
γDP3
βSP8 βSP8
μ–SP8
μ+SP8
δ+iSP8
δ–iSP8
γDP3
αmSP8(t)αiSP8(t)
δ+mSP8(t)
δ–mSP8(t)
M–mSP8
M+mSP8I
+
iSP8
I–iSP8
A
B
C
Figure 3.10: (facing page) Three models for SP8 thymocyte development. This
ﬁgure depicts three different models for the SP8 thymocyte compartments. (A) This
model depicts constant turnover, differentiation, and proliferation rates. (B) This
model allows the proliferation rates of the immature and mature SP8 compartments
to change with time. (C) This model extends the previous models by also allowing the
turnover rates of the mature SP8 compartments to change with time.
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Equations 3.18–3.21). The model ﬁts explained the cells counts in both iSP8
and mSP8 compartments but completely failed to capture the dynamics of
Ki67 expression levels (Figure 3.11, red curves). We extended this model by
allowing division rates to decline with age for iSP8 and mSP8 thymocytes
(Figure 3.10B, Equations 3.24–3.27) These division rates were modeled sim-
ilarly to the mSP4 proliferation rate of model M3 (Equations 3.22–3.23).
This model was able to explain the Ki67hi proﬁle of iSP8 thymocytes, but it
still did not completely explain the Ki67hi proﬁle of mSP8 thymocytes and
had worse ﬁts for cell counts (Figure 3.11, blue curves).
We extended the model further by allowing turnover rates in the mature
SP8 compartments to decline with age (Figure 3.10C, Equations 3.30–3.33,
turnover rates in Equations 3.28–3.29). This model was able to explain the
cell counts and Ki67 expression data from both immature and mature SP8
thymocytes (Figure 3.12) and had the most statistical support out of all three
models (ΔLOOIC > 70, Akaike weight = 1).
The estimated parameters values for this model are shown in Table 3.2.
Immature SP8 thymocytes start with a mean interdivision time of 0.3 days in
early life that exponentially increases to a interdivision time of 101 days in
adulthood with a half-life of 9.2 days. Mature SP8 thymocytes start with a
mean interdivision time of 1.2 days in early life that exponentially increases
to a interdivision time of 53 days in adulthood with a half-life of 19 days.
The model suggests that both immature and mature SP8 thymocytes are
dividing much more rapidly in early life than in adulthood. This conclusion
is similar to how division differs in early life for mature SP4 thymocytes.
In both SP4 and SP8 thymocyte populations, fast division rates are needed
to explain the high Ki67hi proﬁles found in early life. These patterns are
not surprising since the thymus is rapidly growing and expanding early in
life; the initial abundant proliferation in thymocytes reﬂects rapid thymic
growth.
The model invokes changing turnover rates for mature SP8 thymocytes
as well. Thus, these thymocytes have very short residence times early in life
(0.49 days for Ki67hi and 0.24 days for Ki67lo SP8 thymocytes) that increase
to longer residence times in adulthood (2.0 days for Ki67hi and 4.9 days
for Ki67lo SP8 thymocytes). These turnover rates are a combination of cell
death and thymic egress, so we cannot quantify how thymic output differs
between neonates and adults. However, the very short residence times in
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Figure 3.12: Posterior distribution of the ﬁts for the best-ﬁtting SP8 thymocyte
model. The posterior mean ﬁts, the 97% credible intervals for the ﬁts, and 97% pre-
diction intervals are shown for the SP8 thymocyte model with changing proliferation
rates and changing turnover rates for mature SP8 thymocytes.
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early life do suggest that both cell death is faster in early life (e.g. due to more
thymocytes dying from negative selection) and thymic output is greater in
early life. This contrasts with the mSP4 thymocyte compartment, in which
we saw no evidence of changing turnover rates.
SP8 thymocytes have a qualitatively different maturation pattern than
SP4 thymocytes since both iSP8 and mSP8 thymocytes divide with rates that
decrease into adulthood and since mSP8 thymocytes have turnover rates that
decrease with age as well. The models predict fundamentally different dif-
ferentiation patterns for SP4 and SP8 thymocytes such that SP8 thymocytes
do not have to lose Ki67 expression before transitioning from the immature
to mature stages whereas SP4 thymocytes do. This conclusion is reﬂective
of the idea that DP2 thymocytes directly mature into the SP4 compartment
whereas DP2 thymocytes must pass through the DP3 compartment before
differentiating into the SP8 compartment. SP8 thymocytes have a longer his-
tory in the DP compartment, and thus DP2 thymocytes entering the SP4
compartment and DP3 thymocytes entering the SP8 compartment are in fun-
damentally different states of differentiation. The different model structures
supported by the data demonstrate the different developmental histories of
the two SP compartments.
3.5 naive cd4+ t cells
3.5.1 No evidence for lymphopenia-induced proliferation of naive CD4+ T
cells in neonates
With a working model for the dynamics in the SP4 compartment, our next
aim was to ﬁnd the most parsimonious description of the dynamics of naive
CD4+ T cell numbers in lymph nodes. We aimed to estimate the proliferation
rate of naive CD4+ T cells in order to assess if LIP occurs within the naive
CD4+ compartment.
We considered the simplest model in which the Ki67hi/lo naive CD4+ T
cells are fed by Ki67hi/lo mSP4 cells respectively (Figure 3.13). This assumes
that the timecourses of mSP4 cells were proportional to their rates of export
from the thymus The subcompartments have the same constant turnover
rate δn, which encompasses both cell death and differentiation from the
naive CD4+ compartment. Ki67hi naive CD4+ T cells lose their Ki67 expres-
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Naive CD4+Mature SP4
Ki67hi
Ki67lo
N+CD4
N–CD4
φ+
βn
φ–
δn
δn
αn
αn
Figure 3.13: Model for naive CD4+ T cell counts and Ki67hi proportions. In this
model, naive CD4 T cells have different inﬂux rates from Ki67hi and Ki67lo mature SP4
thymocytes. Ki67hi andKi67lo naiveCD4T cells have the same turnover rates anddivide
with a constant proliferation rate.
sion with a mean lifetime of 1/βn. Naive CD4
+ T cells divide with a constant
rate αn. The respective ﬂows from Ki67hi/lo mSP4 → Ki67hi/lo naive CD4+
compartments have different per capita rates φ+ and φ−. The ODEs for this
model are Equations 3.36–3.37.
We determined the maximum-likelihood estimates of these parameters
by ﬁtting the model to the naive CD4+ T cell counts and Ki67 expression
proﬁles in the lymph nodes (Table 3.2) (ﬁtting procedure described in Ref-
erence [78]. The model ﬁt to the naive CD4+ T cell data is shown in Fig-
ure 3.14. We estimate a per capita rates of inﬂux to the naive pool from
the Ki67hi/lo mature SP4 thymocyte compartments of φ+ = 0.55 and φ− =
0.036 respectively. These values are in general agreement with the turnover
rates of the Ki67hi/Ki67lo mature SP4 compartments, which we estimated
to be 0.49 (97% credible interval: 0.35–0.65) and 0.03 (97% credible in-
terval: 0.01–0.05). The mean residence time for naive CD4+ T cells is 53
days, which is in agreement with estimates of ~10-60 days from previous
studies [78, 80].
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Figure 3.14: Model ﬁt to naive CD4+ T cell counts and Ki67hi proportions.
The estimated mean interdivision time of naive CD4+ T cells is 236 days
(αn = 0.00423 days-1). We next evaluated how sensitive this estimate is
to different inﬂux rates from the thymus by scanning through different ra-
tios of φ+ to φ−. The inﬂux into the naive CD4+ compartment from the
Ki67hi/Ki67lo mSP4 compartments are different since the turnover rates in
these compartments are different. Because of the uncertainty of the ratio
of the turnover rates of the Ki67hi/lo mSP4 compartments (posterior mean
16.6; 97% credible interval 9.2–31.2), there is uncertainty on the ratio of
the inﬂuxes into the naive CD4+ compartment. We scanned through differ-
ent values of φ+/φ− and ﬁtted the model to the naive CD4+ T cell data with
these ﬁxed ratios (Figure 3.15). We found that within a reasonable range
of ratios (shown in dark gray in Figure 3.15A), the mean interdivision time
for naive CD4+ T cells remained greater than 200 days, which is too slow
to be explained by LIP. Thus, we conclude that our inferences regarding the
interdivision time of naive CD4 T cells in lymph nodes is robust, despite any
uncertainty on thymic output rates.
Our estimate of 236 days is within the range of estimated interdivision
times of 127–530 days for naive CD4+ T cells in adult mice from Hogan
et al. [78]. In addition, since Ki67 expression has a mean lifetime of ~3.5
days [79], we would expect 0.00423 × 3.5 = 1.5% of naive CD4+ T cells
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Figure 3.15: Sensitivity of interdivision and residence times to the ratio of in-
ﬂuxes. In order to test the sensitivity of the estimated (A) mean interdivision times
and (B) mean residence times of naive CD4 T cells to the ratio of inﬂux of Ki67hi and
Ki67lo mature SP4 thymocytes, we scanned through different values of the ratio f and
ﬁt the model to the data. The darker gray intervals highlight the possible values of f
based on the 97% credible intervals of the ratio of the turnover rates of Ki67hi and
Ki67lo mature SP4 thymocytes. We ﬁnd robust estimates that are not sensitive to dif-
ferent values of f until f becomes very small. However, within the most likely ratio
values (shown in the darker gray intervals), we ﬁnd that the estimated interdivision
time for naive CD4+ T cells remains above 200 days.
to be Ki67hi in adult mice, which agrees with the Ki67hi proportions found
in the latest time points in the oldest mice. These agreements, and the visual
quality of the ﬁt, lend support to the conclusion that naive CD4+ T cells
in neonatal mice do not undergo substantial levels of LIP, at least at the
high levels of one division every 3–5 days observed in highly lymphopenic
mice [111] and that the elevated level of Ki67 in the periphery during the
ﬁrst ~75 days of life (Figure 3.14, right panel) is inherited, short-lived expres-
sion on cells recently exported from the highly proliferative young thymus.
A caveat is that any putative lymphopenia would likely span only a small
portion of the early part of the timecourse we are ﬁtting to, and so any LIP
might have a relatively small effect on the peripheral division rate averaged
across the ﬁrst 9 months of life.
In order to further explore the source of elevated Ki67 expression of
naive CD4+ T cells seen in early life, we compared the Ki67hi proportions
in mature SP4 thymocytes to Ki67hi proportions in naive CD4+ T cells (Fig-
ure 3.16). Every data point except for one is below the diagonal, indicating
that Ki67hi proportions are greater in mSP4 thymocytes than in naive CD4+
T cells up to age 296 days. This observation suggests that recent thymic
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emigrants in mice express higher levels of Ki67 than mature cells, which is
largely residual expression from recent proliferation in the thymus. To il-
lustrate this point further, we performed linear regression on the ratio of
the Ki67hi proportion in mSP4 to that in naive CD4+ T cells against time,
and found no evidence for a non-zero slope (for days 5–296, slope = 0.003,
p = 0.25 for all data, Figure 3.16B, left panel; for days 5–100, slope =
0.006, p = 0.56, Figure 3.16B, right panel). This ‘lockstep’ of the two pro-
portions is consistent with either (i) LIP occurring in equal measure in the
thymus and periphery; or (ii) our model of low levels of peripheral division
and Ki67 being largely inherited from the thymus early in life.
The model describes only the dynamics within the naive CD4+ compart-
ment and makes no predictions about the dynamics of the CD4+ memory
compartments. We conclude from the model that in early life there is no
signiﬁcant degree of divisions by naive CD4+ T cells that form more naive
CD4+ T cells. However, the model does not provide any insight if LIP oc-
curs in which naive T cells take on a memory phenotype. Future modeling
work will attempt to elucidate how naive CD4+ T cells differentiate into the
effector and central memory pools, which may include signiﬁcant degree of
LIP. High levels of LIP early in life could possibly explain the presence of
“virtual memory” T cells found in mice, which are antigen-inexperienced T
cells that express the same markers as typical memory cells (such as CD44)
but display a functionally naive phenotype [112]. These cells have been
thought to arise from T cell responses against gut bacteria or low-level ex-
posure to pathogens, but many of these virtual memory T cells have not
been stimulated by antigen but arise from cytokine signaling [113]. T cells
with memory-like phenotypes that are speciﬁc for non-encountered antigens
in mice have been shown to have the same phenotype as T cells that have
undergone LIP [113, 114]. Although naive CD4+ T cells do not exhibit in-
creased proliferation within the naive pool, some maybe undergoing LIP
events that result in the development of these virtual memory T cells.
70
02
4
6
8
0
2
4
6
8
0 100 200 300
Age (days)
25 50 75 100
Age (days)
0.00
0.25
0.50
0.75
1.00
0.00 0.25 0.50 0.75 1.00
Proportion Ki67hi in
mature SP4 thymocytes
Pr
op
or
tio
n 
K
i6
7h
i  in
na
iv
e 
CD
4 
T 
ce
lls
K
i6
7h
i m
at
ur
e 
SP
4
Ki
67
hi
  n
ai
ve
 C
D
4
0
100
200
300
Age (days)
Ki67 expression in mature SP4
thymocytes vs naive CD4+ T cells
Ratios of Ki67hi proportions in
mature SP4 thymocytes to naive CD4+ T cells
A
B
95% CI of linear regression ﬁtLinear regression ﬁt
Ki
67
hi
 m
at
ur
e 
SP
4
Ki
67
hi
  n
ai
ve
 C
D
4
Figure 3.16: Exploring Ki67 expression levels inmature SP4 thymocytes and naive
CD4+ T cells. (A) Theproportions of Ki67hi cells in naive CD4+ T cells are plotted against
the Ki67hi proportions in mature SP4 thymocytes. (B) The ratios of Ki67hi proportions
in naive CD4+ T cells to those in mature SP4 T cells are plotted against the age of the
mouse. Linear regressionwas performedon all data points (left plot) andondata from
mouse younger than 101 days (right plot).
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3.6 summary
Understanding the ontogeny of T cells provides a framework for studying the
characteristics of a robust and healthy T cell immunity. Using mathematical
models, we dissected the developmental dynamics of murine single-positive
CD4 and CD8 thymocytes and naive CD4+ T cells from day 5 to day 296
of life. Our key conclusions were:
• Our models are consistent with previously reported differentiation
patterns of DP2 → SP4 and DP2 → DP3 → SP8, and constant per
capita differentiation rates explain the inﬂux from the DP compart-
ments to the SP compartments.
• Increased proliferation rates in mSP4s and both iSP8 and mSP8 early
in life are needed to explain the high Ki67 levels found in neonatal
mice; models that invoked constant division rates failed to explain the
Ki67 data (Figure 3.8; Figure 3.11, red curve).
• Our estimates of the lifetime of Ki67 expression both in the thymus
and periphery are consistent with previous estimates of a few days [79].
• The ability of the neonatal environment to support LIP and the high
Ki67 expression levels found in T cells of neonatal mice have led to
the conclusion that signiﬁcant peripheral expansion of T cells occurs
in neonatal mice [46, 115]. However, we ﬁnd (i) Ki67 levels in naive
CD4 T cells track (and are consistently lower than) Ki67 levels in
mSP4 thymocytes; (ii) a model with constant and low levels of pe-
ripheral homeostatic division gives good ﬁts to the data; and (iii) the
estimated interdivision time is consistent with a previous study. Our
results therefore support the conclusion that early in life, the elevated
Ki67 expression in naive CD4 T cells is not due to LIP but is residual
expression from a highly proliferative young thymus.
More questions must be answered to obtain a fuller picture of the on-
togeny of peripheral T cells. First, the dynamics of naive CD8+ T cells will
be studied with mathematical models to determine if LIP occurs in the CD8+
compartment. We saw that SP4 and SP8 thymocytes have different differ-
entiation and development patterns; in particular, mature SP8 thymocytes
exhibit turnover rates that change with time (Figure 3.10C). Second, using
counts and Ki67 proﬁles we will develop mathematical models to describe
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Function Parameter Value Units
nDP2(t)
a1 0.068 Days–1
a2 0.0029 Days–1
b1 -1730000 Number of cells
b2 2280000 Number of cells
kDP2(t)
c1 0.018 Days–1
d1 0.20 Number of cells
nDP3(t)
a3 0.025 Days–1
a4 0.0041 Days–1
b3 18000 Number of cells/day
b4 180000 Number of cells
g1 6.8 Days
g2 1.4 Days
g3 256 Days
kDP3(t)
c2 0.0094 Days
d2 0.33 Number of cells
d3 0.63 Number of cells
nmSP4(t)
a5 0.05 Days–1
a6 0.005 Days–1
b5 1440000 Number of cells
b6 1500000 Number of cells
kmSP4(t)
c4 2.93 Days–1
d4 0.033 Number of cells
d5 0.14 Number of cells
Table 3.3: Parameter values for empirical descriptor functions for DP2, DP3, and
mature SP4 thymocytes.
the developmental pathways and dynamics of CD4+ and CD8+ effector and
central memory compartments in neonatal mice. Finally, we would like to
quantify the size of exported clones during development. Since mid- and
post-selection thymocyte proliferation rates are falling with time, we would
expect exported clone sizes to fall with age. We could quantify this by im-
plementing a stochastic version of our ODE models (using for example the
Gillespie algorithm) to generate the distribution of exported clone sizes.
3.7 mathematical models
3.7.1 DP2 thymocytes
In all three models, we describe the DP2 compartment by ﬁtting DP2 cell
counts and Ki67 proﬁles with empirical descriptor functions. These forms
of these functions were chosen to describe the patterns observed in the data
and does not explicitly model the dynamics in these compartments. For the
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Figure 3.17: Empirical descriptor functions ﬁtted to DP2 cell counts and Ki67hi
proportions.
DP2 counts, we used a function nDP2(t) in the form
nDP2(t) = b1e
−a1t + b2e−a2t (3.1)
where t is in days, a1 > 0, and a2 > 0. For the DP2 Ki67hi fractions, we
used a function kDP2(t) in the form
kDP2(t) = −d1e−c1t + 1 (3.2)
where t is in days, c1 > 0, and d1 > 0. Values for the parameters are shown
in Table 3.3. Every model assumes that DP2 thymocytes differentiate to im-
mature SP4 thymocytes with a constant rate γDP2, which estimated to be
0.424 days– (0.237, 0.635; 95% credible interval).
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3.7.2 SP4 thymocytes
Model #1: Immature SP4 thymocytes differentiate to mature SP4 cells at a
constant rate after losing Ki67 expression
The ﬁrst model (M1 in Figure 3.6A) is described by the following processes:
• Differentiation: only Ki67lo iSP4→ mSP4 with a constant rate μSP4.
• Ki67 lifetimes: Ki67hi iSP4/mSP4 thymocytes lose Ki67 expression at
a constant rate βSP4.
• Turnover of iSP4: Ki67hi/Ki67lo iSP4 thymocytes are lost with turnover
rates δ+iSP4 and δ
−
iSP4 respectively.
• Turnover of mSP4: Ki67hi/Ki67lo mSP4 thymocytes are lost by either
thymic egress or death with one-parameter turnover rates δ+mSP4 and
δ−mSP4 respectively.
• Proliferation: iSP4 thymocytes do not undergo cell proliferation, and
mSP4 thymocytes proliferate with a time-dependent rate αmSP4(t).
The proliferation rate αmSP4(t) begins at a maximum rate αmSP4max , de-
cays exponentially to a minimum rate αmSP4min , and is given by
αmSP4(t) =
(
αmSP4max − αmSP4min
)
e−λmSP4t + αmSP4min (3.3)
The ODEs for modelM1 are
dI+SP4
dt
= γDP2kDP2(t)dDP2(t)−
(
βSP4 + δ
+
iSP4
)
I+SP4 (3.4)
dI−SP4
dt
= γDP2
(
1− kDP2(t)
)
dDP2(t) + βSP4I
+
SP4 −
(
δ−iSP4 + μSP4
)
I−SP4 (3.5)
dM+SP4
dt
= 2αSP4(t)M
−
SP4 +
(
αSP4(t)− δ+mSP4 − βSP4
)
M+SP4 (3.6)
dM−SP4
dt
= μSP4I
−
SP4 + βSP4M
+
SP4 −
(
αSP4(t) + δ
−
mSP4
)
M−SP4 (3.7)
with initial conditions (I+
o
SP4, I
−o
SP4,M
+o
SP4,M
−o
SP4).
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For the Bayesian model, let DSP4i =
(
ti,xiSP4i ,k
iSP4
i ,x
mSP4
i ,k
mSP4
i
)
denote
data from mouse i at age ti days, with xiSP4i iSP4 cells in the thymus that
have a proportion kiSP4i that are Ki67
hi and xmSP4i mSP4 cells in the thymus
that have a proportion kmSP4i that are Ki67
hi. We then deﬁne the following
variables from the solutions to Equations 3.4–3.7:
XiSP4(t) = I
+
SP4(t) + I
−
SP4(t)
KiSP4(t) =
I+SP4(t)
I+SP4(t) + I
−
SP4(t)
XmSP4(t) = M
+
SP4(t) +M
−
SP4(t)
KmSP4(t) =
M+SP4(t)
M+SP4(t) +M
−
SP4(t)
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ModelM1 is then:
log
(
xiSP4i
)
logit
(
kiSP4i
)
log
(
xmSP4i
)
logit
(
kmSP4i
)
 ∼MVNormal


log
(
XiSP4(ti)
)
logit
(
KiSP4(ti)
)
log
(
XmSP4(ti)
)
logit
(
KmSP4(ti)
)
 , S

S =

σXiSP4 0 0 0
0 σKiSP4 0 0
0 0 σXmSP4 0
0 0 0 σKmSP4

βSP4 ∼ PNormal(0.2857,0.02)
γDP2 ∼ PNormal(0.8,0.4)
δ+iSP4 ∼ PNormal(0.1,0.2)
δ−iSP4 ∼ PNormal(0.1,0.2)
μSP4 ∼ PNormal(0.1,0.1)
δ+mSP4 ∼ PNormal(0,0.09)
δ−mSP4 ∼ PNormal(0,0.4)
αmSP4max ∼ PNormal(1,0.1)
αmSP4min ∼ PNormal(0.01,0.05)
λmSP4 ∼ PNormal(0.01,0.01)
I−
o
SP4 ∼ PNormal(473482,100000)
I+
o
SP4 ∼ PNormal(580857,100000)
M+
o
SP4 ∼ PNormal(20000,2000)
M−
o
SP4 ∼ PNormal(250000,30000)
σXiSP4 ∼ HalfCauchy(0,2)
σKiSP4 ∼ HalfCauchy(0,2)
σXmSP4 ∼ HalfCauchy(0,2)
σKmSP4 ∼ HalfCauchy(0,2)
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Here PNormal(μ, σ) indicates a normal distribution with mean μ and
standard deviation σ that is greater than or equal to 0.2 MVNormal(μ⃗, S)
denotes a multivariate normal distribution with mean vector μ⃗ and convari-
ance matrix S. Note that the covariances in the matrix S have been set to 0
since we are assuming that the counts and Ki67 proportions in the mature
and immature SP4 compartments are independent from each other.
Model #2: Immature SP4 thymocytes differentiate to mature SP4 cells at a
constant rate during or after losing Ki67 expression
The second model (M2 in Figure 3.6B) extends model M1 also allowing
Ki67hi iSP4 thymocytes to differentiate into the Ki67lo mSP4 compartment
This is modeled by pooling all iSP4 thymocytes together and letting them
differentiate into the Ki67lo mature SP4 compartment with a constant per
capita rate μSP4. The loss of Ki67 expression, turnover rates, and prolifera-
tion is modeled identically to modelM1. In particular, the proliferation rate
αmSP4(t) is the same as Equation 3.3.
The ODEs for modelM2 are
dI+SP4
dt
= γDP2kDP2(t)dDP2(t)−
(
βSP4 + δ
+
iSP4
)
I+SP4 (3.8)
dI−SP4
dt
= γDP2
(
1− kDP2(t)
)
dDP2(t) + βSP4I
+
SP4 − δ−iSP4I−SP4 (3.9)
dM+SP4
dt
= 2αSP4(t)M
−
SP4 +
(
αSP4(t)− δ+mSP4 − βSP4
)
M+SP4 (3.10)
dM−SP4
dt
= μSP4
(
I−SP4 + I
+
SP4
)
+ βSP4M
+
SP4 −
(
αSP4(t) + δ
−
mSP4
)
M−SP4 (3.11)
with initial conditions (I+
o
SP4, I
−o
SP4,M
+o
SP4,M
−o
SP4).
2To be precise, the prior
x ∼ PNormal(μ, σ)
has a distribution of
Normal(x|μ, σ)
1−NormalCDF(0|μ, σ)
where x ≥ 0 and NormalCDF(0|μ, σ) is the normal cumulative distribution function at 0 to
normalize the density to 1.
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For the Bayesian model, let DSP4i =
(
ti,xiSP4i ,k
iSP4
i ,x
mSP4
i ,k
mSP4
i
)
denote
data from mouse i at age ti days, with xiSP4i iSP4 cells in the thymus that
have a proportion kiSP4i that are Ki67
hi and xmSP4i mSP4 cells in the thymus
that have a proportion kmSP4i that are Ki67
hi. We then deﬁne the following
variables from the solutions to Equations 3.8–3.11:
XiSP4(t) = I
+
SP4(t) + I
−
SP4(t)
KiSP4(t) =
I+SP4(t)
I+SP4(t) + I
−
SP4(t)
XmSP4(t) = M
+
SP4(t) +M
−
SP4(t)
KmSP4(t) =
M+SP4(t)
M+SP4(t) +M
−
SP4(t)
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ModelM2 is then:
log
(
xiSP4i
)
logit
(
kiSP4i
)
log
(
xmSP4i
)
logit
(
kmSP4i
)
 ∼MVNormal


log
(
XiSP4(ti)
)
logit
(
KiSP4(ti)
)
log
(
XmSP4(ti)
)
logit
(
KmSP4(ti)
)
 , S

S =

σXiSP4 0 0 0
0 σKiSP4 0 0
0 0 σXmSP4 0
0 0 0 σKmSP4

βSP4 ∼ PNormal(0.2857,0.02)
γDP2 ∼ PNormal(0.8,0.4)
δ+iSP4 ∼ PNormal(0.1,0.2)
δ−iSP4 ∼ PNormal(0.1,0.2)
μSP4 ∼ PNormal(0.1,0.1)
δ+mSP4 ∼ PNormal(0,0.09)
δ−mSP4 ∼ PNormal(0,0.4)
αmSP4max ∼ PNormal(1,0.1)
αmSP4min ∼ PNormal(0.01,0.05)
λmSP4 ∼ PNormal(0.01,0.01)
I−
o
SP4 ∼ PNormal(473482,100000)
I+
o
SP4 ∼ PNormal(580857,100000)
M+
o
SP4 ∼ PNormal(20000,2000)
M−
o
SP4 ∼ PNormal(250000,30000)
σXiSP4 ∼ HalfCauchy(0,2)
σKiSP4 ∼ HalfCauchy(0,2)
σXmSP4 ∼ HalfCauchy(0,2)
σKmSP4 ∼ HalfCauchy(0,2)
The covariances in the matrix S again have been set to 0.
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Model #3: Differentiation from immature SP4 to mature SP4 requires divi-
sion to occur
The third and best ﬁtting model (M3 in Figure 3.6C) describe differentia-
tion by allowing immature SP4 thymocytes to differentiate to mature SP4
only by dividing at a constant rate μSP4 after losing Ki67 expression. Thus,
differentiation occurs with a ﬂow from Ki67lo iSP4→ Ki67hi mSP4 only by
dividing at a constant rate μSP4. The loss of Ki67 expression, turnover rates,
and proliferation is modeled identically to modelM1 andM2.
The ODE equations for model M3 is
dI+SP4
dt
= γDP2kDP2(t)dDP2(t)−
(
βSP4 + δ
+
iSP4
)
I+SP4 (3.12)
dI−SP4
dt
= γDP2
(
1− kDP2(t)
)
dDP2(t) + βSP4I
+
SP4 −
(
δ−iSP4 + μSP4
)
I−SP4 (3.13)
dM+SP4
dt
= 2μSP4I
−
SP4 + 2αSP4(t)M
−
SP4 +
(
αSP4(t)− δ+mSP4 − βSP4
)
M+SP4
(3.14)
dM−SP4
dt
= βSP4M
+
SP4 −
(
αSP4(t) + δ
−
mSP4
)
M−SP4 (3.15)
with initial conditions (I+
o
SP4, I
−o
SP4,M
+o
SP4,M
−o
SP4).
For the Bayesian model, let DSP4i =
(
ti,xiSP4i ,k
iSP4
i ,x
mSP4
i ,k
mSP4
i
)
denote
data from mouse i at age ti days, with xiSP4i iSP4 cells in the thymus that
have a proportion kiSP4i that are Ki67
hi and xmSP4i mSP4 cells in the thymus
that have a proportion kmSP4i that are Ki67
hi. We then deﬁne the following
variables from the solutions to Equations 3.12–3.15:
XiSP4(t) = I
+
SP4(t) + I
−
SP4(t)
KiSP4(t) =
I+SP4(t)
I+SP4(t) + I
−
SP4(t)
XmSP4(t) = M
+
SP4(t) +M
−
SP4(t)
KmSP4(t) =
M+SP4(t)
M+SP4(t) +M
−
SP4(t)
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ModelM3 is then:
log
(
xiSP4i
)
logit
(
kiSP4i
)
log
(
xmSP4i
)
logit
(
kmSP4i
)
 ∼MVNormal


log
(
XiSP4(ti)
)
logit
(
KiSP4(ti)
)
log
(
XmSP4(ti)
)
logit
(
KmSP4(ti)
)
 , S

S =

σXiSP4 0 0 0
0 σKiSP4 0 0
0 0 σXmSP4 0
0 0 0 σKmSP4

βSP4 ∼ PNormal(0.2857,0.05)
γDP2 ∼ PNormal(0.8,0.4)
δ+iSP4 ∼ PNormal(0.6,1)
δ−iSP4 ∼ PNormal(0.26,0.2)
μSP4 ∼ PNormal(0.1,0.5)
δ+mSP4 ∼ PNormal(0.3,0.3)
δ−mSP4 ∼ PNormal(0.3,0.2)
αmSP4max ∼ PNormal(6,3)
αmSP4min ∼ PNormal(0.01,0.005)
λmSP4 ∼ PNormal(0.01,0.01)
I−
o
SP4 ∼ PNormal(473482,100000)
I+
o
SP4 ∼ PNormal(580857,100000)
M+
o
SP4 ∼ PNormal(30000,5000)
M−
o
SP4 ∼ PNormal(250000,30000)
σXiSP4 ∼ HalfCauchy(0,2)
σKiSP4 ∼ HalfCauchy(0,2)
σXmSP4 ∼ HalfCauchy(0,2)
σKmSP4 ∼ HalfCauchy(0,2)
The covariances in the matrix S again have been set to 0.
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3.7.3 DP3 thymocytes
We describe the DP3 compartment by ﬁtting DP3 cell counts and Ki67 pro-
ﬁles with empirical descriptor functions. For the DP3 counts, we used a func-
tion dDP3(t) in the form
dDP3(t) = b3(t− g2)ea3(t+g3) + b4(1− e−a4(t+g4)) (3.16)
and for Ki67hi fractions,
kDP3(t) = −d2e−c2t + d3 (3.17)
where t is in days, a3, a4,b3,b4, g2, g3, g4, c2,d2,d3 > 0. Values for the pa-
rameters are shown in Table 3.3. Every model assumes that Ki67hi/Ki67lo
DP3 thymocytes differentiate to Ki67hi/Ki67lo iSP8 thymocytes respectively
with a constant rate γDP3.
3.7.4 SP8 thymocytes
The ﬁrst model shown in Figure 3.10A is the simplest model considered and
describes the following processes:
• Differentiation: Ki67hi/lo iSP8 → Ki67hi/lo mSP4 with a constant rate
μSP4 with constant per capita rates μ
+
SP8 and μ
−
SP8 respectively.
• Ki67 lifetimes: Ki67hi iSP8/mSP8 thymocytes lose Ki67 expression at
a constant rate βSP8.
• Turnover of iSP8: Ki67hi/Ki67lo iSP8 thymocytes are lost with turnover
rates δ+iSP8 and δ
−
iSP8 respectively.
• Turnover of mSP8: Ki67hi/Ki67lo mSP8 thymocytes are lost by either
thymic egress or death with one-parameter turnover rates δ+mSP8 and
δ−mSP8 respectively.
• Proliferation: iSP8 thymocytes proliferation with a constant rate αciSP8,
and mSP8 thymocytes proliferate with a time-dependent rate αcmSP8.
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The ODEs for this model are
dI−SP8
dt
= γDP3
(
1− kDP3(t)
)
dDP3(t) + βSP8I
+
SP8
− (αciSP8 + μ−iSP8 + δ−iSP8) I−SP8 (3.18)
dI+SP8
dt
= γDP3kDP3(t)dDP3(t) + 2α
c
iSP8I
−
SP8
+
(
αciSP8 − μ+SP8 − βSP8 − δ+iSP8
)
I+SP8
(3.19)
dM−SP8
dt
= μ−SP8I
−
SP8 + βSP8M
+
SP8 −
(
αcmSP8 + δ
−
mSP8
)
M−SP8 (3.20)
dM+SP8
dt
= μ+SP8I
+
SP8 + 2α
c
mSP8M
−
SP8 +
(
αcmSP8 − βSP8 − δ+mSP8
)
M+SP8 (3.21)
with initial conditions
(
I−
o
SP8, I
+o
SP8,M
+o
SP8,M
−o
SP8
)
.
For the Bayesian model, let DSP8i =
(
ti,xiSP8i ,k
iSP8
i ,x
mSP8
i ,k
mSP8
i
)
denote
data from mouse i at age ti days, with xiSP8i iSP8 cells in the thymus that
have a proportion kiSP8i that are Ki67
hi and xmSP8i mSP8 cells in the thymus
that have a proportion kiSP8i that are Ki67
hi. We then deﬁne the following
variables from the solutions to Equations 3.18–3.21:
XiSP8(t) = I
+
SP8(t) + I
−
SP8(t)
KiSP8(t) =
I+SP8(t)
I+SP8(t) + I
−
SP8(t)
XmSP8(t) = M
+
SP8(t) +M
−
SP8(t)
KmSP8(t) =
M+SP8(t)
M+SP8(t) +M
−
SP8(t)
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
log
(
xiSP8i
)
logit
(
kiSP8i
)
log
(
xmSP8i
)
logit
(
kmSP8i
)
 ∼MVNormal


log
(
XiSP8(ti)
)
logit
(
KiSP8(ti)
)
log
(
XmSP8(ti)
)
logit
(
KmSP8(ti)
)
 , S

S =

σXiSP8 0 0 0
0 σKiSP8 0 0
0 0 σXmSP8 0
0 0 0 σKmSP8

βSP8 ∼ PNormal(0.2857,0.05)
γDP3 ∼ PNormal(2.6,0.7)
δ+iSP8 ∼ PNormal(3,1)
δ−iSP8 ∼ PNormal(3.5,1)
μ+SP8 ∼ PNormal(5,5)
μ−SP8 ∼ PNormal(0.5,0.2)
δ+mSP8 ∼ PNormal(3,1)
δ−mSP8 ∼ PNormal(3,1)
αciSP8 ∼ PNormal(1,1)
αcmSP8 ∼ PNormal(0.5,0.2)
I−
o
SP8 ∼ PNormal(10000,2000)
I+
o
SP8 ∼ PNormal(15000,2000)
M+
o
SP8 ∼ PNormal(10000,3000)
M−
o
SP8 ∼ PNormal(120000,30000)
σXiSP8 ∼ HalfCauchy(0,2)
σKiSP8 ∼ HalfCauchy(0,2)
σXmSP8 ∼ HalfCauchy(0,2)
σKmSP8 ∼ HalfCauchy(0,2)
The covariances in the matrix S have been set to 0.
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The secondmodel in Figure 3.10B extends the ﬁrst model by allowing for
proliferation rates that change with time in both iSP8 and mSP8 compart-
ments. These proliferation rates start at a maximum rate and exponentially
decay to a minimum rate. They are given by the following equations:
αiSP8(t) =
(
αiSP8max − αiSP8min
)
e−ηiSP8t + αiSP8min (3.22)
αmSP8(t) =
(
αmSP8max − αmSP8min
)
e−ηmSP8t + αmSP8min (3.23)
The ODEs for this model are
dI−SP8
dt
= γDP3
(
1− kDP3(t)
)
dDP3(t) + βiSP8I
+
SP8
− (αiSP8(t) + μ−iSP8 + δ−SP8) I−SP8 (3.24)
dI+SP8
dt
= γDP3kDP3(t)dDP3(t) + 2αiSP8(t)I
−
SP8
+
(
αiSP8(t)− μ+SP8 − βSP8 − δ+iSP8
)
I+SP8
(3.25)
dM−SP8
dt
= μ−SP8I
−
SP8 + βSP8M
+
SP8 −
(
αmSP8(t) + δ
−
mSP8
)
M−SP8 (3.26)
dM+SP8
dt
= μ+SP8I
+
SP8 + 2αmSP8(t)M
−
SP8
+
(
αmSP8(t)− βSP8 − δ+mSP8
)
M+SP8
(3.27)
For the Bayesian model, let DSP8i =
(
ti,xiSP8i ,k
iSP8
i ,x
mSP8
i ,k
mSP8
i
)
denote
data from mouse i at age ti days, with xiSP8i iSP8 cells in the thymus that
have a proportion kiSP8i that are Ki67
hi and xmSP8i mSP8 cells in the thymus
that have a proportion kiSP8i that are Ki67
hi. We then deﬁne the following
variables from the solutions to Equations 3.24–3.27:
XiSP8(t) = I
+
SP8(t) + I
−
SP8(t)
KiSP8(t) =
I+SP8(t)
I+SP8(t) + I
−
SP8(t)
XmSP8(t) = M
+
SP8(t) +M
−
SP8(t)
KmSP8(t) =
M+SP8(t)
M+SP8(t) +M
−
SP8(t)
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
log
(
xiSP8i
)
logit
(
kiSP8i
)
log
(
xmSP8i
)
logit
(
kmSP8i
)
 ∼MVNormal


log
(
XiSP8(ti)
)
logit
(
KiSP8(ti)
)
log
(
XmSP8(ti)
)
logit
(
KmSP8(ti)
)
 , S

S =

σXiSP8 0 0 0
0 σKiSP8 0 0
0 0 σXmSP8 0
0 0 0 σKmSP8

βSP8 ∼ PNormal(0.2857, 0.05)
γDP3 ∼ PNormal(2.6, 0.7)
δ+iSP8 ∼ PNormal(3, 1)
δ−iSP8 ∼ PNormal(3.5, 1)
μ+SP8 ∼ PNormal(5, 5)
μ−SP8 ∼ PNormal(0.5, 0.2)
δ+mSP8 ∼ PNormal(3, 1)
δ−mSP8 ∼ PNormal(3, 1)
αiSP8max ∼ PNormal(3.1, 1)
αiSP8min ∼ PNormal(0.01, 0.003)
ηiSP8 ∼ PNormal(0.1, 0.03)
αmSP8max ∼ PNormal(0.5, 0.2)
αmSP8min ∼ PNormal(0.1, 0.3)
ηmSP8 ∼ PNormal(0.1, 0.03)
I−
o
SP8 ∼ PNormal(10000, 2000)
I+
o
SP8 ∼ PNormal(15000, 2000)
M+
o
SP8 ∼ PNormal(10000, 3000)
M−
o
SP8 ∼ PNormal(120000, 30000)
σXiSP8 ∼ HalfCauchy(0, 2)
σKiSP8 ∼ HalfCauchy(0, 2)
σXmSP8 ∼ HalfCauchy(0, 2)
σKmSP8 ∼ HalfCauchy(0, 2)
The covariances in the matrix S have been set to 0.
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The third model in Figure 3.10C extends the previous model by allowing
turnover rates of mSP8 thymocytes to change with time. The turnover rates
start at a maximum and exponentially decay to a minimum rate. They are
given by the following equations:
δ+mSP8(t) =
(
δ+mSP8max − δ+mSP8min
)
e−νt + δ+mSP8min (3.28)
δ−mSP8(t) =
(
δ−mSP8max − δ−mSP8min
)
e−νt + δ−mSP8min (3.29)
The ODEs for this model are
dI−SP8
dt
= γDP3
(
1− kDP3(t)
)
dDP3(t) + βSP8I
+
SP8
− (αiSP8(t) + μ−iSP8 + δ−SP8) I−SP8 (3.30)
dI+SP8
dt
= γDP3kDP3(t)dDP3(t) + 2αiSP8(t)I
−
SP8
+
(
αiSP8(t)− μ+SP8 − βiSP8 − δ+iSP8
)
I+SP8
(3.31)
dM−SP8
dt
= μ−SP8I
−
SP8 + βSP8M
+
SP8 −
(
αmSP8(t) + δ
−
mSP8(t)
)
M−SP8 (3.32)
dM+SP8
dt
= μ+SP8I
+
SP8 + 2αmSP8(t)M
−
SP8
+
(
αmSP8(t)− βSP8 − δ+mSP8(t)
)
M+SP8
(3.33)
For the Bayesian model, let DSP8i =
(
ti,xiSP8i ,k
iSP8
i ,x
mSP8
i ,k
mSP8
i
)
denote
data from mouse i at age ti days, with xiSP8i iSP8 cells in the thymus that
have a proportion kiSP8i that are Ki67
hi and xmSP8i mSP8 cells in the thymus
that have a proportion kiSP8i that are Ki67
hi. We then deﬁne the following
variables from the solutions to Equations 3.30–3.33:
XiSP8(t) = I
+
SP8(t) + I
−
SP8(t)
KiSP8(t) =
I+SP8(t)
I+SP8(t) + I
−
SP8(t)
XmSP8(t) = M
+
SP8(t) +M
−
SP8(t)
KmSP8(t) =
M+SP8(t)
M+SP8(t) +M
−
SP8(t)
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 ∼MVNormal
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log
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XiSP8(ti)
)
logit
(
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log
(
XmSP8(ti)
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logit
(
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 , S

S =

σXiSP8 0 0 0
0 σKiSP8 0 0
0 0 σXmSP8 0
0 0 0 σKmSP8

βSP8 ∼ PNormal(0.2857, 0.05)
γDP3 ∼ PNormal(2.6, 0.7)
δ+iSP8 ∼ PNormal(3, 1)
δ−iSP8 ∼ PNormal(3.5, 1)
μ+SP8 ∼ PNormal(3, 3)
μ−SP8 ∼ PNormal(0.5, 0.2)
δ+mSP8max ∼ PNormal(2, 1)
δ+mSP8min ∼ PNormal(0.1, 0.5)
δ−mSP8max ∼ PNormal(1, 1)
δ−mSP8min ∼ PNormal(0.1, 0.5)
ν ∼ PNormal(0.1, 0.025)
αiSP8max ∼ PNormal(3.1, 1)
αiSP8min ∼ PNormal(0.01, 0.003)
ηiSP8 ∼ PNormal(0.1, 0.03)
αmSP8max ∼ PNormal(0.5, 0.2)
αmSP8min ∼ PNormal(0.1, 0.3)
ηmSP8 ∼ PNormal(0.1, 0.03)
I−
o
SP8 ∼ PNormal(10000, 2000)
I+
o
SP8 ∼ PNormal(15000, 2000)
M+
o
SP8 ∼ PNormal(10000, 3000)
M−
o
SP8 ∼ PNormal(120000, 30000)
σXiSP8 ∼ HalfCauchy(0, 2)
σKiSP8 ∼ HalfCauchy(0, 2)
σXmSP8 ∼ HalfCauchy(0, 2)
σKmSP8 ∼ HalfCauchy(0, 2)
The covariances in the matrix S have been set to 0.
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3.7.5 Naive CD4+ T cells
The model for naive CD4+ T cells is shown in Figure 3.13. The counts
and Ki67hi proportions were described with empirical descriptor functions
dmSP4(t) and kmSP4(t) respectively:
dmSP4(t) = −b5e−a5t + b6e−a6t (3.34)
kmSP4(t) = d4e
−c4t + d5 (3.35)
Ki67hi/Ki67lo mSP4 thymocytes differentiate to the Ki67hi/Ki67lo naive
CD4+ compartment with constant per capita rates φ+/φ− respectively. Naive
CD4+ lose Ki67 expression with a rate βn and divide with rate αn. Both
compartments have a common turnover rate δn. The ODEs for this model
are
dN−CD4
dt
= φ−
(
1− kmSP4(t)
)
dmSP4(t) + βnN
+
CD4 −
(
α + δn
)
N−CD4 (3.36)
dN+CD4
dt
= φ+kmSP4(t)dmSP4(t) + 2αN
−
CD4 +
(
α − βn − δn
)
N+CD4 (3.37)
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C H A P T E R  4

Counting Lymphocytes Using Thoracic Duct
Cannulations
4.1 introduction
4.1.1 Aim of the chapter
Accurately quantifying the number of T cells and B cells in the secondary
lymphoid organs (SLOs) of a mouse has eluded the ﬁeld since obtaining all
SLOs from a mouse is not possible. Counting lymphocytes by dissecting the
spleen and every visible lymph node provides only a lower bound on these
numbers because some SLOs might be missed. In particular, we would be
counting recirculating T cells such as TCM and TEM cells, in contrast with
TRM cells which reside in peripheral sites like the gut. Knowing the number
of T cells and B cells and their subsets would provide a basis for understand-
ing the characteristics of a mature adaptive immune system. For example,
CD4+ T cells were once thought to primarily reside in the gut rather than the
SLOs, leading to inaccurate conclusions about T cell biology; quantiﬁcation
of the lymphocyte population sizes in individual organs is needed for a pre-
cise understanding of the immune system [116]. In particular, these numbers
would help us quantify the diversity of the T cell receptor and B cell receptor
repertoires; for example, we could estimate clonal sizes by knowing the num-
ber of unique receptors in the repertoire and the number of lymphocytes. In
addition, quantifying exact number of T cell subsets would characterize how
many naive and memory T cells are needed for physiologically healthy im-
mune system. Carefully quantifying the numbers of T cells and their subsets
in the SLOs will help us elucidate the properties needed for healthy immune
responses.
We can do a back-of-the-envelope calculation to roughly estimate the
number of T cells and B cells in the mouse. Consider that a mouse spleen
has about 100× 106 white blood cells. Approximately 30% of these are αβ
T cells, of which 70% are CD4+ and 30% are CD8+ T cells [117]. Thus,
• CD4+: 21× 106 cells in the spleen
• CD8+: 9× 106 cells in the spleen
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For B cells, they approximately comprise 50% of splenic white blood
cells, giving us an estimate of
• B cells: 50× 106 cells in the spleen
For lymph nodes, we can roughly estimate another 100×106 white cells by
estimating about 30 lymph nodes in the mouse [118], each with 3×106 cells.
Assuming 70% of lymph nodes are αβ T cells (with the same 70%/30% split
for CD4+ and CD8+ T cells) and 30% are B cells, we get estimates of
• CD4+: 49× 106 cells in the LNs
• CD8+: 21× 106 cells in the LNs
• B cells: 30× 106 cells in the LNs
By combining spleen and LN estimates together, we get rough estimates of
• CD4+: 60× 106 cells
• CD8+: 30× 106 cells
• B cells: 80× 106 cells
In this chapter, we aim to determine accurate estimates of the number of
T cells and B cells found in the lymph nodes and spleens of the mouse. We
attempted to do so by utilizing a thoracic duct (TD) cannulation technique.
4.1.2 Overview of the experimental approach
We performed TD cannulation on male wild-type C57Bl6 mice of ages 10–
12 weeks to collect circulating T cells and B cells and then used these counts
to estimate the total number of T cells and B cells in the mouse. Figure 4.1
shows a schematic of how we aimed to estimate lymphocyte numbers with
this approach. We cannulated the thoracic ducts of wild-type mice in order
to collect circulating T cells and B cells (Figure 4.1A). A proportion of these
circulating lymphocytes are directed to the collection vessel instead of recir-
culating back into the lymph nodes and spleens, and this results in a decrease
in lymphocyte numbers in these organs (Figure 4.1B–C). Thus, the number
of lymphocytes collected during the cannulation should be proportional to
the drop in lymphocyte numbers in the spleen and lymph nodes. We col-
lected counts from spleens and lymph nodes from non-cannulated mice and
from mice that undergone sham surgeries as well. These data served as the
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baseline for lymphocyte numbers in order measure the effect on cell numbers
in the cannulated mice.
We also performed sham surgeries in which every step was performed
except the actual cannulation of the thoracic duct so that we could observe
if the surgery procedure itself had an effect on cell counts. In these sham
surgery experiments, we found that the surgery itself causes a drop in lym-
phocyte numbers in the lymph nodes and spleens of mice. As we will discuss
in Section 4.3.2, the loss of cells in the lymph nodes and spleens could be
a response to many effects due to the surgery, including the induction of
glucocorticoids from the stress of surgery and the use of general anesthesia.
Thus, the drop in cell numbers in the cannulated mice is a combination of
lymphocytes collected from the cannulation, a loss of cells due to the surgical
procedure itself, and potentially the redistribution of cells to tissues.
In order to minimize the loss of cells due to sample preparation, the
number of times that samples were ﬁltered and centrifuged were kept at
a minimum. Lymph samples were ﬁltered once before being counted, and
lymph node and spleen samples were ﬁltered and centrifuged once before
being counted. Each ﬁltering step and centrifugation would cause some ex-
perimental loss of cells, but these were kept to a minimum and should cancel
each other out in the calculations done in this chapter. The sample sizes are
6 mice for cannulations, 7 mice for sham surgeries, and 7 mice as controls.
We illustrate how we calculate total cell numbers in Figure 4.2. The can-
nulation causes some fractional drop in the cell counts in the SLOs (Fig-
ure 4.2A–B), with the cells being collected by the cannula in the collecting
vessels (Figure 4.2C). Since the fractional drop in cell numbers in the SLOs is
proportional to the number collected, we can back-calculate the total num-
ber of lymphocytes in the mouse. If f is the fractional drop in the cell counts
in the lymphoid tissue due to the cannulation and X is the number of cells
collected from the cannulation, then the total number of cells N is
fN = X
N =
X
f
(4.1)
where f is estimated by dividing the spleen/LN counts in cannulated mice
by the spleen/LN counts in non-cannulated mice (Figure 4.2C).
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AB
C
X
Control Sham surgery Cannulation
Control Sham surgery Cannulation
Figure 4.1: Overview of how lymphocyte numberswere estimated using thoracic
duct cannulation. (A) We studied three groups of mice: control mice, mice that un-
derwent sham surgeries, and mice that had their thoracic ducts cannulated. (B) We
collected the lymph nodes, spleens, and lymph (for the cannulated mice) from these
mice. (C) We obtained cell counts and quantiﬁed the proportions of different T cell
and B cell subsets. We determined the drop in counts due to cells being lost to surgi-
cal stress by comparing the counts in control mice to the counts in the sham surgery
mice.We also determined the drop in counts due to the cannulation by comparing the
counts in sham surgery mice to cannulated mice. In the cannulated mice, the drop in
the SLOs due to the cannulation after correcting for cell loss from the surgery should
be represented by the number of cells collected.
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N
X
f
The mouse has
N lymphocytes
in all of its LNs
and spleen
A TD cannulation
causes a fractional
drop f in cell counts
B The fractional drop
is caused by X cells
collected by the
cannulation
The total 
number of
lymphocytes
N can be 
calculated
N = X
f
C
D
Figure 4.2: Schematic of calculate total lymphocyte numbers (A) Suppose that a
mouse has N lymphocytes in all of its lymph nodes and spleen. (B) The thoracic duct
cannulation drains recirculating lymphocytes away from the body, causing a fractional
decrease f in the cell counts in the secondary lymphoid organs. (C) The fractional drop
is caused by the cells collected during the cannulation. The number of cells collected
is denoted as X. (D) The total number N can be determined with X and f using Equa-
tion 4.1.
4.2 results
4.2.1 Stress from the surgical procedure has differential effects on cell num-
bers in secondary lymphoid organs
We wanted to see how cell counts in SLOs change due to the stress from
surgical procedures. We performed sham surgeries in which every step of
the TD cannulation procedure except for the insertion of the cannula into
the thoracic duct. The lymph nodes (mesenteric, cervical, inguinal, and ax-
illary) and spleens were collected from control mice and sham surgery mice.
The mesenteric lymph nodes (MLNs) were analyzed by themselves, and the
cervical, inguinal, and axillary lymph nodes were pooled together in these
experiments since these lymph nodes are not directly drained by the thoracic
duct (henceforth referred to as OLNs for the other lymph nodes). Lympho-
cytes were counted and stained for T cell and B cell subsets (gating strategies
shown in Figures 4.3–4.4).
The following T cell subsets were identiﬁed: naive CD4 (live TCRβ+CD4+
CD25– CD44– CD62L+), CD4 effector memory (live TCRβ+ CD4+ CD25–
CD44+ CD62L–), CD4 central memory (live TCRβ+ CD4+ CD25– CD44+
CD62L+), total CD4 (live TCRβ+ CD4+), naive CD8 (live TCRβ+ CD8+
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Figure 4.3: Gating strategy for CD4 and CD8 T cells. Gating strategy shown already
have lymphocytes, singlets and live cells gated (Figure 3.3).
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CD122–), CD8 effector memory (live TCRβ+ CD8+ CD122+ CD62L–), CD8
central memory (live TCRβ+ CD8+ CD122+ CD62L+ CD44+), and total
CD8 (live TCRβ+ CD8+). The B cell subsets identiﬁed were mature B cells
(live IgM+ IgD+ AA4.1–) and transitional B cells (live IgM+ IgD+ AA4.1+).
In Figure 4.5, we calculated the ratios of cell counts of T cell subsets
from control mice to cell counts from mice that underwent sham surgeries.
We calculated 99% conﬁdence intervals by performing bootstrapping with
2000 replicates. We see consistently that the OLNs show the largest decrease
in cells counts in the sham surgery mice. In all T cell subsets except for CD4+
effector memory and CD8+ effector memory T cells, we observed decreases
in counts in the MLNs in the sham surgery group. The spleen showed no
discernible effects on cell counts from the surgery, which is clearly shown by
the fact that all conﬁdence intervals overlap with the ratio of 1.
We repeated the same calculations in transitional and mature B cells in
Figure 4.6 by performing bootstrapping with 2000 replicates. We again see
that OLNs exhibit the largest decrease in cell numbers in both transitional
and mature B cells. MLNs show decreases in cell counts as well, except the
conﬁdence interval for transitional B cells in the MLNs contain the ratio
value of 1. Unlike the T cells subsets, both transitional and mature B cell
numbers decrease in the spleens due to the sham surgery.
The data clearly show that T cells and B cells in the different SLOs
are reduced in numbers to different extents by surgery-induced stress. Since
MLNs, OLNs, and spleens show differential changes from the stress of the
surgical process itself, we could not pool all SLOs together and treat them as
one homogenous group. This prevented us from using the approach used to
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Figure 4.5: Loss of T cells due to surgical stress. The ratio of the mean number of
cells in mice that underwent sham surgery to that of control mice are shown for all T
cell subsets. The mean ratios are plotted as circles, and the bars represent bootstrap
99% conﬁdence intervals. OLNs consistently showed the largest decrease due to sur-
gical stress whereas MLNs showed decreases in all compartments except the CD4 ef-
fector memory and CD8 effector memory compartments. Spleens appeared to not be
affected by the stress from surgery. (7 sham surgery mice, 7 control mice).
derive Equation 4.1, and so we will discuss in Section 4.3.3 how the model
was extended to include these differential effects.
4.2.2 Cannulating the thoracic duct causes different secondary lymphoid
organs to lose proportionally different numbers of cells
We cannulated the thoracic ducts of mice and collected lymph for 18–24
hours. After collecting the lymph, we collected the lymph nodes (mesenteric,
cervical, inguinal, and axillary) and spleens of the mice. We counted the
number of cells in the lymph, lymph nodes, and spleens and stained for T cell
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Figure 4.6: Loss of B cells due to surgical stress. The ratio of the mean number of
cells in mice that underwent sham surgery to that of control mice are shown for tran-
sitional B cells and mature B cells. The mean ratios are plotted as circles, and the bars
represent bootstrap 99% conﬁdence intervals. As observed in the T cell subsets, OLNs
consistently showed the largest decrease in cell counts due to surgical stress. MLNs
showed decreases in cell counts as well, but the 99% conﬁdence intervals includes a
ratio of 1 for transitional B cells. Unlike T cell subsets, spleens appeared to have de-
creases in B cell counts due to the stress from surgery. (7 sham surgery mice, 7 control
mice).
and B cell subsets described in Section 4.2.1. As before, the cervical, inguinal,
and axillary LNs (OLNs) were pooled together in these experiments.
In Figure 4.7, we show the ratios of cell counts of T cell subsets from
cannulated mice to the mean of the counts of mice that underwent sham
surgery mice. Bootstrapping with 2000 replicates was performed to create
99% conﬁdence intervals. The ratios for each cannulated mouse are shown
as gray circles, and mean ratios are shown in black circles. The mean ratios
of the MLNs were less than 1 in all T cell compartments, with statistical sig-
niﬁcance found in the CD4+ naive, CD4+ TCM, CD4+ TEM, total CD4+, and
total CD8+ compartments (one-tailed 1-sample t-test, p < 0.01). The mean
ratios in the spleens showed less consistent decreases in the cannulated mice,
with only the CD4+ naive, CD8+ naive, total CD4+, and total CD8+ com-
partments showing statistically signiﬁcance means less than 1 (one-tailed
1-sample t-test, p < 0.01). The OLNs had no compartment where the mean
ratio was less than 1, and all compartments showed no statistical difference
from mean ratios of 1 (two-tailed 1-sample t-test, p < 0.01).
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Figure 4.7: The decrease in T cell counts due to thoracic duct cannulations. The
ratio of the number of cells in cannulated mice to the mean number of cells in mice
that underwent sham surgery are shown for all T cell subsets. The mean ratios are
plotted as black circles, and the bars represent bootstrap 99% conﬁdence intervals.
Ratios from the counts of individual cannulatedmice are shown in lighter gray circles.
(7 sham surgery mice, 6 cannulated mice).
In Figure 4.8, we performed similar calculations for transitional and ma-
ture B cells. The 99% conﬁdence intervals were calculated with bootstrap-
ping with 2000 replicates, ratios for each cannulated mouse are shown as
gray circles, and mean ratios are shown in black circles. Unlike the T cell
subsets, neither the transitional B cells or mature B cells show statistically
signiﬁcant decreases in counts in the cannulated mice compared to the mice
that underwent sham surgeries (one-tailed 1-sample t-test, p < 0.01).
The data exhibit heterogeneity in the changes caused by TD cannula-
tion across the lymphocyte subsets and the different SLOs. Because of these
differential changes, these data suggest again that SLOs cannot be pooled.
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Figure 4.8: The effect of thoracic duct cannulations on B cell counts. The ratio of
cell numbers in cannulated mice to the mean number of cells in surgery mice for B
cells. None of the SLOs in either transitional B cells and mature B cells show any statis-
tical differences between cannulated and sham surgery mice. (7 sham surgery mice, 6
cannulated mice).
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Figure 4.9: (facing page) Proportions of CD8 naive, central memory, and effector
memory T cells in the cannulated, sham surgery, and control mice. (A) Proportions
of naive CD8 T cells out of CD8+ cells in all three treatment groups. (B) Proportions of
CD8 central memory T cells out of CD8+ cells in all three treatment groups. (C) Propor-
tions of CD8 effectormemory T cells out of CD8+ cells in all three treatment groups. No
statistically signiﬁcant differences were found in any groups. (7 sham surgery mice, 6
cannulated mice)
4.2.3 Surgical stress and thoracic duct cannulations do not change the rel-
ative frequencies of major T and B cell subsets within SLOs
We were curious if certain T cell and B cell subsets were more suscepti-
ble to the effect of surgical stress. Figures 4.9–4.10 show the proportions
of the CD4+ and CD8+ T cell subsets within all three treatment groups. In
the CD8+ T cell compartments, no statistically signiﬁcant differences can be
seen among the control, sham surgery, and cannulated mice in CD8+ naive,
central memory, and effector memory T cells in all SLOs (Mann-Whitney
U Test, p < 0.01). In the CD4+ T cell compartments, no statistically signif-
icant differences can be seen among the control, sham surgery, and cannu-
lated mice in the CD4 central memory and effector memory T cells (Mann-
Whitney U Test, p < 0.01). There was a statistically signiﬁcant difference in
the naive CD4+ T cells in the OLNs between cannulated and control mice
(Mann-Whitney U Test, p < 0.01), but the effect size was small as the dif-
ference between the mean proportions of the two groups is 0.069. Similarly,
Figure 4.11 show that proportions of transitional and mature B cells were
not statistically different among the three treatment groups in any of the
SLOs (Mann-Whitney U Test, p < 0.01).
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Figure 4.10: Proportions of CD4+ naive, central memory, and effector memory T
cells in the cannulated, sham surgery, and control mice. (A) Proportions of naive
CD4+ T cells out of total CD4+ cells in all three treatment groups. (B) Proportions of
CD4+ central memory T cells out of total CD4+ cells in all three treatment groups. (C)
Proportions of CD4+ effector memory T cells out of total CD4+ cells in all three treat-
ment groups. No statistically signiﬁcant differences were found in any groups except
for naive CD4+ T cells in the OLNs between cannulated and control mice. (7 control
mice, 7 sham surgery mice, 6 cannulated mice).
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Figure 4.11: Proportions of transitional and mature B cells in the cannulated,
sham surgery, and control mice. (7 control mice, 7 sham surgery mice, 6 cannulated
mice).
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4.3 extending the model
4.3.1 Extending The Model To Account For Differential Effects On Dif-
ferent Secondary Lymphoid Organs
The different effects on cell numbers by the sham surgeries and the tho-
racic duct cannulations challenged the assumption that all SLOs are affected
identically by these procedures. This heterogeneity prevented us from using
Equation 4.1 and required a more complex model that captures these effects.
The different changes in cell numbers due to the thoracic duct cannulation
may reﬂect the anatomy of lymphatic drainage, which we will discuss in the
next section.
4.3.2 The anatomy of the lymphatics in the mouse inﬂuences how thoracic
duct cannulation effects cell numbers in the spleen and in different
lymph nodes
Carefully understanding the anatomy of the lymphatic drainage of the lymph
nodes studied here helps us predict the effect of draining circulating lym-
phocytes with the cannulation of the thoracic duct (Figure 4.12). Since the
cannulation drains the thoracic duct, the outﬂow from the mesenteric lymph
nodes is being drained directly. The spleen has no direct lymphatic inputs
or outputs; instead, recirculating lymphocytes enter and leave the spleen
through the blood. The TD cannulation reduces the number of lympho-
cytes that recirculate back into the blood, which in turn reduces the number
of cells that to return the spleen. The cervical, inguinal, and axillary lymph
nodes are indirectly affected by the cannulation since the afferent lymphat-
ics will bring fewer cells into these lymph nodes due to recirculating lym-
phocytes being shunted away by the cannulation. Because these SLOs are
affected by the TD cannulation differently, we expect different fractional
changes in counts in TD cannulation experiments in short time scales, as we
observed in Section 4.2.2.
Although we might intuitively expect counts in the OLNs to decrease as
well, the data show no difference in counts between cannulated mice and
mice that underwent sham surgeries for T cells. The relatively short time
scales of the cannulation might be not long enough to cause decreases in
cell counts in these lymph nodes. Since the lymphatic ducts that ultimately
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Figure 4.12: Schematic of the lymphatic drainage of different lymph nodes. The
mesenteric lymph nodes are drained by the thoracic duct, from which the TD can-
nulation directly shunts lymph away. The other lymph nodes are drained by other
lymphatic vessels, and thus the cannulation does not directly shunt lymph away from
these lymph nodes. Lymphocytes recirculate through the spleen via blood.
return lymph from these lymph nodes to the systemic circulation are not
cannulated, their drainage rates are mostly likely not increased in the short
term. So despite the fact that the inﬂow of lymphocytes is decreased due
to the TD cannulation, the outﬂow of these lymph nodes likely are not af-
fected, and the short period of time that the cannulation collects in these
experiments lymph might not show a discernible effect in counts.
4.3.3 Estimating total lymphocyte counts from thoracic duct cannulation
data
The data clearly showed that the TD-drained lymph nodes, the non-TD-
drained lymph nodes, and the spleen must be considered separately. Equa-
tion 4.1 needs to be expanded to account for cell loss from the surgical pro-
cedure while considering the differential effects on cell counts from the TD
cannulation. We sketch out the details of the extended model in Figure 4.13.
Figure 4.13A–C shows how we account for the fact that TD cannula-
tion causes different fractional drops in cell counts in the lymph nodes di-
rectly drained by the TD, the non-TD drained lymph nodes, and the spleen.
The lymphocyte subset of interest have a total count of N cells in all of the
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SLOs. A proportion fm of these cells is in the TD-drained lymph nodes (rep-
resented by the mesenteric lymph nodes), a proportion fo of these cells is in
the non-TD-drained lymph nodes (represented the other lymph nodes), and
the remaining fspl = (1− fm− fo) proportion is in the spleen (Figure 4.13A).
After cannulating the mouse and collecting cells for a period of time, drained
recirculating cells do not return to the SLOs, resulting in a drop in counts.
We denote the proportional decrease in the counts of each compartment
as p, q, and r for the TD-drained LNs, the non-TD-drained LNs, and the
spleen respectively (Figure 4.13B). Multiplying the proportion of the counts
represented by the compartment, the proportional drop due to cannulation,
and the total number of lymphocytes N gives us the number of cells of that
compartment that were collected by the cannulation (Figure 4.13C). For ex-
ample, the number of cells collected from the spleen is given by
p(1− fm − fo)N .
This does not account for the cells that die or disappear due to the stress
of the surgical procedure. To account for these cells, we denote ps as the
proportion of the compartment that is lost due to the stress of the surgery
itself (Figure 4.13, lightest colored portion). Then, after the mouse is cannu-
lated, we denote pc as the proportion of the remaining (1 − ps) proportion
of the compartment that is drained by the cannulation (Figure 4.13, middle
colored portion). pc is deﬁned relative to the remaining compartment after
cells lost to the surgical stress and not to the full compartment. The middle
colored portion in Figure 4.13 represents the number of cells that should be
collected by the cannulation.
Combining the approaches in Figures 4.13C and 4.13D together, we get
the full model in Figure 4.13E. Thus, the total number of lymphocytes col-
lected from the cannulation from all three compartments after accounting
for cell loss due to the surgical stress is
(1− ps)pc(1− fm − fo)N+ (1− qs)qcfmN+ (1− rs)rcfoN (4.2)
where ps, qs, and rs are the fractional losses due to surgical stress, pc, qc,
and rc are the fractional losses due to the cannulation after correcting for
the loss due to surgical stress, and N is the total number of lymphocytes in
all SLOs. If X is the number of cells collected by the cannulation, then we
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can set Equation 4.2 equal to X and solve for N, yielding
N =
X
(1− ps)pc(1− fm − fo) + (1− qs)qcfm + (1− rs)rcfo . (4.3)
We estimated ps, qs and rs by comparing cell counts in mice that received
sham-surgeries to control mice. We estimated pc, qc and rc by comparing cell
counts in cannulated mice to mice that received sham-surgeries.
4.3.4 The differential changes in the secondary lymphoid organs by the can-
nulations and surgical stress prevent the calculation of total lympho-
cyte numbers
Since we cannot pool cell counts from the different, Equation 4.2 was used
to estimate total numbers of the T cell and B cell subsets. This equation has
three unknown parameters that we cannot estimate, namely fm, fo, and fspl =
(1 - fm - fo). These fractions represent what fraction of the total lymphocytes
in the SLOs is represented by the TD-drained lymph nodes, the non-TD-
drained lymph nodes, and the spleen respectively. Since these fractions are
unknown, we scanned across all possible combination of values for fm and
fo and used these in Equation 4.2 to calculate total numbers. We constrained
the fractions for each compartment to be between 0.1 and 0.9 since values
outside of this range seem to be physiologically unrealistic values.
We estimated ps, qs, and rs by dividing the mean sham surgery counts
by the mean control count of the spleens, MLNs, and OLNs respectively.
For every cannulated mouse, we then estimated pc, qc, and rc by dividing
the cell count of the lymphocyte subset by the mean sham surgery counts
of the spleens, MLNs, and OLNs respectively. We also bootstrapped the
cannulation and sham surgery data to create 95% conﬁdence intervals for
all values of fm and fo.
In Figures 4.14–4.15, the calculated total cell counts for the total CD4
and total CD8 T cell compartments. In Figure 4.14A and Figure 4.15A,
we show heatmaps that represent the estimated numbers of total CD4 and
CD8 T cells respectively by assuming different values for fm, fo, and fs. The
estimated CD4 T cell numbers ranged from 11 × 106 to 46 × 106, and
the estimated CD8 T cell numbers ranged from to 35 × 106 to 100 × 106,
which do not agree with our rough estimates derived in Section 4.1.1. In
111
fm 
q r
p
fo(1 – fm – fo ) 
f1 f2(1 – f1 – f2 ) 
fm fo(1 – fm – fo ) 
cann.
qfmN 
rfoN
(1 – q)fmN 
(1 – r)foN 
p (1 – fm – fo ) N 
(1 – p )  
(1 – fm – fo ) N 
qsfmN r sfoN
ps (1 – fm – fo ) N 
(1 – ps) pc 
(1 – fm – fo ) N 
(1 – qs)  
qcfmN 
(1 – r s)
r cfoN 
A B
C
D E
Fraction of lymphocytes in LNs
drained by the thoracic duct
Fraction of lymphocytes in LNs
not drained by the thoracic duct
Fraction of lymphocytes
drained by the spleen
ps fpsN
f
pc
f(1 – ps) 
(1 – pc)N (1 – p
s)(1 – pc) 
(1 – fm – fo )N
fm(1 – q
s)  
(1 – qc)N
fo(1 – r
s)  
(1 – r c)N
(1 – ps) 
(1 – pc)
 fpc(1 – ps)N
112
Figure 4.13: (Facing page) Extending the total number of lymphocytes calcula-
tion to account for differential effects from the cannulation. The spleen and dif-
ferent lymph nodes are affected by the TD cannulation differently, and thus we need
to extend Equation 4.1 to account for these differences. (A) Let N be the number of
lymphocytes in all spleens and lymph nodes. We split these lymphocytes into three
groups, indicated by the three colors: a proportion fm of them are found in lymph
nodes drained by the thoracic duct (red), a proportion fo of them are found in lymph
nodes drained by other lymphatic ducts (green), and the remaining (1 – fm – fo) are
found in the spleen (blue). (B) After the mouse is cannulated, a fractional drop occurs
in each compartment due to recirculating lymphocytes being drained by the cannula-
tion andnot returning to the SLOs.Wedenotep,q, and r as the fractional drops for the
TD-drained LNs, the non-TD-drained LNs, and the spleen respectively. The portion of
these compartments that are drained by the cannulation are shown in the light colors.
(C) The ﬁgure is split into the compartments and the drained and non-drained parts
of each compartment. The equations that relate the total number of lymphocytes N
to the number of cells in each part is shown. The sum of the three light-colored parts
should equal the number of cells collected in the cannulation (assumingno loss of cells
due to surgical stress). (D) Cells die or are lost due to the stress from the surgery itself,
and wemust account for this loss. We use ps to denote the proportion of lymphocytes
that are lost due to the surgery. We then use pc to denote denote the proportion of
the remaining lymphocytes that are drained by the cannulation after accounting for
loss due to surgical stress. (E) This is the generalization of (C) by accounting for the loss
of cells due to the surgery itself in all compartments. We show how to calculate the
number of cells in each compartment in relation to the total number of lymphocytes
N. The boxes labeledwith a gray outline represent the number of cells collected by the
cannulation.
Figure 4.14B–D and Figure 4.15B–D, we show respectively the estimated
CD4 and CD8 T cell numbers with 95% conﬁdence intervals for ﬁxed values
of fspl. The estimated total T cell numbers are very sensitive to the values of
fm, fo, and fspl. In Figures 4.16–4.17, we show the estimated total numbers
for the CD4 and CD8 T cell subsets and 95% conﬁdence intervals for ﬁxed
values of fspl. These numbers are also very sensitive to the chosen values
of fm, fspl, and fo. We performed the same calculations for transitional and
mature B cells (Figures 4.18–4.19).
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Making inferences about total numbers for the T cell and B cell subsets
is difficult since we do not know how the three different types of SLOs con-
tribute to the lymphocyte pool. Because we cannot pool all the SLOs and
use the simple approach employed for Equation 4.1, we need to know the
values of fm, fspl, and fo. Since these data show that the estimated total num-
bers using Equation 4.2 is dependent on accurate values of fm, fspl, and fo,
we are unable to make accurate estimates for the sizes of any of these T cell
and B cell subsets.
In addition, the large conﬁdence intervals indicate uncertainty about
these estimates; there is uncertainty both in the effect on cell counts by the
sham surgeries and in the effect on cell counts by the cannulations. These cal-
culations incorporate uncertainty on both processes when calculating these
estimates, so these large conﬁdence intervals are not surprising.
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Figure 4.14: Estimated number of total CD4 T cell. (A) The estimates of the total
number of CD4 T cells for different combinations of fm, fo, and fspl. (B)–(D) Estimates
of the total number of CD4 T cells and bootstrap 95% conﬁdence intervals for ﬁxed
values of fspl (0.25, 0.5, and 0.75)
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Figure 4.15: Estimated number of total CD8 T cell. (A) The estimates of the total
number of CD8 T cells for different combinations of fm, fo, and fspl. (B)–(D) Estimates
of the total number of CD4 T cells and bootstrap 95% conﬁdence intervals for ﬁxed
values of fspl (0.25, 0.5, and 0.75)
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Figure 4.16: Estimated numbers of CD4+ T cell subsets for different values of fspl.
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Figure 4.17: Estimated numbers of CD8+ T cell subsets for different values of fspl.
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Figure 4.18: Estimated number of transitional B cells.
(A) The estimates of the total number of transitional B cells for different combina-
tions of fm, fo, and fspl. (B)–(D) Estimates of the total number of transitional B cells and
bootstrap 95% conﬁdence intervals for ﬁxed values of fspl (0.25, 0.5, and 0.75)
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Figure 4.19: EstimatednumberofmatureB cells. (A)Theestimates of the total num-
ber of mature B cells for different combinations of fm, fo, and fs. (B)–(D) Estimates of
the total number of mature B cells and bootstrap 95% conﬁdence intervals for ﬁxed
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4.4 discussion
We sought to accurately estimate the number of T cells and B cells and their
subsets in the SLOs of the mouse using thoracic duct cannulations. Our idea
centered on using TD cannulations to perturb the SLOs by draining away
recirculating lymphocytes. We expected the fold reduction of cell numbers
in all SLOs to be directly proportional to the number of lymphocytes col-
lected by the cannulation. However, heterogenous effects on the different
lymphocyte subsets and on the different SLOs complicated the mathemati-
cal model for estimating the size of the lymphocyte compartments. T cells
and B cells in the SLOs were lost due to effects of the surgeries that were
independent of the cannulation itself. These observations prevented us from
reliably estimating total T cell and B cell numbers but illustrated important
consequences of surgical procedures on the immune system.
Surgical procedures have been shown to have signiﬁcant effects on the
immune system in humans and in mice. These effects include decreases in
T cell counts [119], shifts in TH1/TH2 ratios [120], and increases in serum
cytokine levels [121]. These changes in the immune system are mediated
by at least two factors: the anesthetics used in surgeries and the release of
steroids and hormones in response to surgical stress. Isoﬂurane (the anes-
thetic used in our experiments) has been shown to decrease TH1/TH2 ratios
and changes in CD3+, CD4+, and CD8+ counts [120, 122]. The stress on the
body induced by surgical procedures has been shown to cause an increase
in levels of glucocorticoids, catecholamines, and ACTH in humans [119].
One study showed that human patients undergoing distal gastrectomies or
colectomies had decreases in CD3+ cell counts in blood samples with a shift
in more CD8+ cells and less CD4+ cells [119]. Increases in glucocorticoid
levels in mice have also been shown to cause cell death in most T cell thy-
mocyte subsets as well [123]. Although the study byMajumdar et al. studied
the effects of glucocorticoids in the context of Salmonella typhimurium in-
fections, they showed that blocking the glucocorticoid receptor rescues the
thymocyte subsets, indicating that glucocorticoids have a important role in
the death of these cells [123].
121
The procedure performed for the sham surgeries included every step of
the cannulation procedure except for the insertion of the cannula into the
thoracic duct. This included the incisions through the skin and muscle lay-
ers, the manipulation of the spleen and other tissues in order to visualize
the thoracic duct, the placement and securing of the cannula near the tho-
racic duct, and the placement of the mouse in a harness for recovery. The
sham surgery placed an exceptional amount of stress on the body that is
comparable to the stress from any other major surgical procedure.
The large changes in cell numbers in the SLOs observed in Section 4.2.1
due to the sham surgeries represent a real effect of surgeries that must con-
sidered in the design of experiments. We showed that cell numbers of many
T cell subsets decrease in the lymph nodes—with no apparent changes in the
spleen—and that B cell numbers decrease in lymph nodes and spleens. Re-
sults from experiments that involve surgeries can potentially be affected by
these quantitative changes in the number of T cells in lymph nodes and B cells
in lymph nodes and the spleen. For example, surgical experiments studying
T cell responses may ﬁnd responses that are quantitatively different due to
the shrinkage in T cell numbers. In addition, we did not study the changes
in cell numbers in the thymus. It is plausible that thymic population sizes
might shrink and have changes in phenotype due to the increased corticos-
teroid levels induced by the surgery [123]. Further experiments measuring
cell counts of thymocyte subsets in the thymii of mice that have undergone
sham surgeries would characterize the degree of shrinkage in response to
surgeries.
Our study does not untangle the roles of anesthesia and the surgery it-
self in the loss of lymphocytes. Previous studies have shown contrasting ef-
fects on the immune system by different anesthetics, which indicates that
anesthetics have some role in these changes [121, 120, 122]. This could be
studied by giving mice general anesthesia with isoﬂurane and counting lym-
phocytes in their SLOs. This experiment would help us to characterize how
much of the decrease in cell numbers is due to the stress of the anesthetic and
to the stress of the surgery. Detailed understanding of how anesthetics affect
the immune system can have clinical applications in trying to minimize these
effects; for example, general anesthesia has been associated with increased
rates of surgical site infections, which corroborates with anesthesia affecting
the immune system [124, 125].
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In summary, knowing the total number of T cells and B cells would help
us quantify the characteristics of a mature adaptive immune system, partic-
ularly in quantifying the diversity of the TCR and BCR repertoire. We were
unable to determine accurate estimates of these numbers, but our results
point towards heterogeneous effects from surgical procedures on lympho-
cytes in SLOs that may have implications in experimental design and have
clinical consequences in regards to surgeries affecting the immune systems
of patients.
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C H A P T E R  5

Obtaining paired αβ TCR sequences
5.1 introduction
5.1.1 Identifying TCR sequences can answer many important questions in
immunology
The set of antigens that a T cell clonotype can respond to is deﬁned by its T
cell receptor. Recombination of the V(D)J segments and the addition of nu-
cleotides in the junctions of these segments results in an enormous diversity
of receptors in the TCR repertoire.
Many fundamental questions about T cell biology can be answered by
sequencing TCRs. How many T cell clonotypes does the body maintain?
How does the TCR repertoire differ among a group of people, and how
does it change with age? Are there speciﬁc TCRs that consistently result
in large, expanded clonotypes against a speciﬁc antigen or is this process
inherently stochastic? TCR sequencing is an important tool in attempting to
characterize these fundamental physiologically properties of T cell biology.
In clinical immunology, identifying clonotypes that are important to the
pathogenesis of diseases and disorders could have immense value in our un-
derstanding of disease mechanisms and in developing treatments. For ex-
ample, identifying T cell clonotypes that respond well to a patient’s tumor
could have profound inﬂuence in the design of personalized immunother-
apy for the patient. Similarly, sequencing the dominant clones involved in
autoimmune conditions can help the design of therapies for controlling or
eliminating autoreactive T cells.
The number of questions that can be answered and the potential for clin-
ical applications with TCR sequencing demands for efficient, high-through-
put, and economical methods for determining TCR sequences of T cells.
The ﬁeld of lymphocyte-receptor sequencing is rapidly changing with con-
tinual advances that allow us to probe TCR repertoires in greater detail and
with greater efficiency. In this chapter, we will discuss a method that we de-
veloped called alphabetr that efficiently and accurately determines paired
TCR sequences of epitope-speciﬁc T cell populations.
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5.1.2 Detailed descriptions of statistical multi-cell sequencing approaches
Approaches like alphabetr belong to a class of TCR sequencing methods
called frequency-based pairing. The other two approaches that have been
described in the literature are a preliminary attempt used to pair B cell recep-
tors [76] and a commercial product called pairSEQ developed by Adaptive
Biotechnologies [1].
Reddy et al. [76] attempted a preliminary version of frequency-based
pairing in B cells by matching the relative frequencies of the most abundant
VL and VH CDR3 sequences. In this study, the VL and VH CDR3s were se-
quenced in bonemarrow plasma cells frommice inoculatedwith puriﬁed C1,
with chicken egg ovalbumin, or with recombinant bacterially expressed hu-
man B-cell regulator of IgH transcription. VL and VH CDR3 sequences rep-
resented with approximately equal frequencies and has frequencies greater
than 0.5% of the repertoire were assumed to derive from the same B cell.
A methodology called pairSEQ by Howie et al. [1] attempts to iden-
tify TCRα/TCRβ pairs by sampling T cells (typically thousands) from the
PBMCs of a subject into the wells of 96-wells plates and sequencing the
CDR3α and CDR3β chains sampled in these wells. RNA is extracted from
the cells and reverse transcribed into cDNA. The CDR3α and CDR3β se-
quences are ampliﬁed using primers speciﬁc for the V regions and C re-
gions, and DNA barcodes were added as well-identiﬁers. These ampliﬁed
products are pooled together and then sequenced, and the resulting data
are CDR3α and CDR3β sequences and their barcodes that correspond to
the well from which they originate. Due to various sources of experimen-
tal error, a sampled T cell will not necessarily have its CDR3α and/or its
CDR3β sequenced, so pairSEQ accounts for this “dropping” of chains. The
algorithm then produces a list CDR3α/CDR3β pairs and an estimated false
discovery rate (FDR) for each pair for a user-speciﬁed rejection threshold.
The pairSEQ approach assumes that the CDR3α and CDR3β sequences
are practically unique for every clone in a T cell population—an assump-
tion not necessarily incorrect when taking samples from the naive repertoire
pool (see Section 6.3.3) but highly inaccurate for antigen-speciﬁc T cell pop-
ulation (discussed below in Section 5.1.4). By sampling a T cell population
into multiple subsets as done in a pairSEQ experiment, the chains of a clone
should be found in an unique pattern of subsets since any given clone is
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found with a relatively low frequency in the general T cell repertoire. With a
procedure to optimize the number subsets taken and the number of cells sam-
pled in each subset, pairSEQ uses the pattern of co-appearances of CDR3α
and CDR3β sequences to determine TCR pairs. The statistical procedure
used by pairSEQ calculates the p-value of the number of co-appearances of
every pair of CDR3α and CDR3β sequences under the null hypothesis that
these sequences are not from the same clone and then estimates an cutoff
p-value for rejecting the null hypothesis.
pairSEQ begins by computing the probability (i.e. the p-value) of seeing
the pattern of shared wells from chain αi and chain βj given the numbers of
wells in the experiment by chance, wells containing chain αi, and wells con-
taining chain βj for all pairs i and j.
1 Let the pair {r, s} denote an occupancy
pattern in the data where an α chain occupies r wells and a β chain occu-
pies s wells. Then, for every possible occupancy pattern, a cutoff p-value δrs
is calculated by performing multiple simulations of how two independent
α and β chains would be sampled in the pairSEQ experiment and ﬁnding
the smallest p-value calculated from these simulations. Thus, if the p-value
for αi and βj given its co-appearance pattern in the data {r, s} is less than
δrs, then αi and βj is a TCR pair. An approach based on one developed by
Bandcroft et al. [126] is then used to estimate the FDR for these pairs.
Howie et al. [1] attempted to demonstrate the accuracy and throughput
of their algorithm by applying pairSEQ on two categories of samples: mix-
ing T cells from whole PBMCs from two patients into the same 96-well plate
and combining tumor-inﬁltrating lymphocytes (TILs) from nine tumor sam-
ples into one 96-well plate. The former was designed to test the accuracy of
pairSEQ by showing that TCR pairs derived from both patients—namely,
pairs such that one chain is from the 1st patient and the other chain is from
the 2nd patient—were identiﬁed at a rate estimated by the FDR. In “Ex-
periment 1” of their paper, the percentage of cross-subject TCR pairs was
0.98% and was in agreement with the estimated 1% FDR. In addition, Ju-
rkat T cells were added to the samples, and the Jurkat CDR3α/CDR3β pair
was successfully identiﬁed as well. It should be noted that these two points
of analysis provide circumstantial evidence for the accuracy of pairSEQ. The
cross-subject experiment indirectly shows agreement in the predicated FDR
1We denote the ith unique CDR3α sequence as αi and the jth CDR3β sequence as βj. If a
clone has a TCR made up of the pair αi and βj, we simply denote the clone as αiβj.
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and the cross-subject pairing rate, but their analysis does not test if the TCR
pairs themselves identiﬁed in each subjects are correct (except for the one
TCR from the Jurkat cells). The TIL experiment is discussed in Section 5.2.2,
and these data were used to test alphabetr in Section 5.3.2.
5.1.3 Features of TCR repertoires
T cell repertoires have a signiﬁcant number of dual-TCRα clones and a small
number of dual-TCRβ clones
Studies have demonstrated that 10–30% of T cells possess two productive
TCRα chains, deﬁned as a T cell that contains mRNA transcripts of two
different CDR3α sequences that do not contain stop codons or shortened
sequences [127, 65, 70]. A rough calculation predicts a dual-TCRα clone
prevalence of 20% in the naive pool.2 The presence of dual-TCRα clones is
a consequence of how thymocyte development occurs. In the DP thymocyte
stage, thymocytes make repeated attempts at α-chain rearrangement on both
chromosomes. Rearrangement continues until a thymocyte receives a pos-
itive selection signal from a self-pMHC molecule; simply expressing a full
TCR molecule is not sufficient for stopping α-rearrangement. As a result, a
thymocyte can potentially rearrange two in-frame TCRα chains before α-
rearrangement is shut off. It is unclear if the presence of two different TCRα
chains at the mRNA level always results in the expression of two TCRα
proteins, but expression of two TCRα chains has been shown by labeling
Vα segments with antibodies [127]. The functional signiﬁcance is not fully
2We can make a very rough estimate for the proportion of developing DN4 thymocytes
that will rearrange two productive α chains. The probability of a T cell having two produc-
tively rearranged TCRα chains is dependent on the T cell forming in-frame joins between the
V and J segments, which we assume to be simply 1/3. Thus,
P(no productive chains) =
(
1− 1
3
)2
=
4
9
P(exactly one productive chain) = P(ﬁrst chain productive) + P(second chain productive)
=
2
3
· 1
3
+
1
3
· 2
3
=
4
9
P(two productive chains) =
(
1
3
)2
=
1
9
Since T cells that have no productive chains would fail positive selection, we would expect
1/9
4/9 = 25% of thymocytes to be dual-TCRα clones.
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understood, but dual-TCRα T cells have been postulated to mediate au-
toimmunity by allowing the second ‘hitchhiker’ TCRα to enter the periph-
eral repertoire without necessarily undergoing negative selection [127, 128].
Other studies have proposed physiological purposes of these dual TCRs, in-
cluding a mechanism to facilitate thymocyte commitment to the regulatory
T cell lineage [129] and the “rescue” of non-selected TCRs through suc-
cessful selection of the one of the two TCRs, effectively expanding the TCR
repertoire [130]. The signiﬁcant prevalence of dual-TCRα clones necessi-
tates special considerations for frequency-based pairing techniques.
The presence of dual-TCRβ clones has been shown in a limited number
of themost recent single-cell sequencing studies [131, 70]. These studies have
found the expression of two CDRβ sequences of 6%–7% of their sampled
T cells that contain at least one productive CDR3β. The low prevalence of
dual-TCRβ clones can be ignored with little consequence, which we will
discuss in the end of Section 5.3.1.
Epitope-speciﬁc T cell populations can exhibit a signiﬁcant degree of sharing
of CDR3 sequences
Epitope-speciﬁc T cell populations contain many clones that share CDR3 se-
quences, which we deﬁne as two or more clones that have the same CDR3α
sequence but have different CDR3β sequences (or vice versa). This is a signif-
icant feature of epitope-speciﬁc T cell repertoires, which we discuss in detail
here. Frequency-based pairing approaches for epitope-speciﬁc populations
must be speciﬁcally tailored to deal with the sharing of CDR3 sequences.
5.1.4 Epitope-speciﬁc T cell populations display a signiﬁcant degree of CDR3α
and CDR3β sharing
Previous single-cell TCR sequencing studies of epitope-speciﬁc T cell popu-
lations and TIL populations have not fully appreciated the degree of CDR3α
and CDR3β sharing that can be found in populations of limited clonality.
We analyzed the data from past single-cell analyses of epitope-speciﬁc T cell
populations in mice and humans and discovered notable levels of sharing of
both CDR3α and CDR3β sequences at the amino acid level across clones
within individuals (Table 5.1). In the study by Cukalac et al., the antigen-
experienced epitope-speciﬁc T cell populations exhibit more sharing than
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Figure 5.1: (Facing page) Analysis of TCRα usage in human, YFV-speciﬁc
peripheral-blood CD8+ T cells. (A)Observed distribution of relative clone sizeswithin
the population speciﬁc for the HLA-A02:01/LLWNGPMAV epitope. Clones expressing
a unique CDR3α are shown in grey; clones that share a CDR3α are colored, and the
numbers in the coloured boxes represent the number of clones sharing each CDR3α.
(B) The distributions of CDR3α nucleotide insertion lengths in clones with shared
CDR3α (left hand panel) and unique CDR3α (right hand panel).
naive populations [67]. This potentially indicates that recruitment of T cells
in an immune responses has a bias for TCRs with speciﬁc CDR3β and/or
CDR3α sequences, whichwould result in increased sharing in epitope-speciﬁc
populations. The small sizes of the sampled repertoires obscures any gener-
alizations about the magnitude of sharing exhibited in antigen-speciﬁc pop-
ulations, but the consistent ﬁndings across many studies demonstrate this
common characteristic of these repertoires.
The phenomenon of CDR3β sharing can be demonstrated by tracking
the sequence of events that are involved in generating TCRs in the thymus.
In mice, thymocytes undergo 6–9 divisions following TCRβ rearrangement
at the DN3 stage [34, 35, 36, 37], generating 64–512 cells with the same
TCRβ chain that then undergo independent TCRα rearrangement. If we as-
sume that 5% of these precursors survive selection [132, 133, 134, 38],
then selection results in TCRβ clone sizes of 3–25 cells [24]. Thymocytes
may undergo 1 or 2 divisions at the single-positive CD4 or CD8 stage be-
fore leaving the thymus [38]. Assuming 2-fold expansion here on average,
each αβ T cell precursor at DN3 generates 6–50 new naive cells with iden-
tical TCRβ chains, comprising of 3–25 unique TCRαβ clones of typically 2
cells. Comparable estimates of TCRβ clone sizes have been obtained else-
where [37, 24]. There is also evidence that TCRβ-clone sizes can be aug-
mented by convergent recombination of the same TCRβ chain [18, 135]. If
a particular CDR3β contributes strongly to the affinity of binding to a given
peptide-MHC as described in the previous paragraph, our rough quantiﬁca-
tion of TCRαβ clonality in thymopoesis is consistent with the observation
that TCRβ-sharing is commonly found within epitope-speciﬁc populations
(Table 5.1).
Because TCRα rearrangement occurs after TCRβ rearrangement, any
sharing of CDR3α sequences across clones presumably arises from conver-
gent recombination, where the same CDR3α is formed from independent
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Citation Peptide/System Status # of
clones
# of
distinct
α chains
# of
distinct
β chains
# of
shared
α chains
# of
shared
β chains
% of α
chains
that are
shared
% of β
chains
that are
shared
[65] KbPB1703 Immune 35 16 24 3 2 18.8 8.3
[69] Human CD4+
TILs
Colon cancer 216 226 216 7 0 3.1 0.0
CD4+ T cells
from adjacent
colon
305 239 237 15 0 6.3 0.0
[67] DbNP366 Naive 1 17 17 15 0 2 0.0 13.3
Naive 2 11 11 11 0 0 0.0 0.0
Naive 3 7 7 7 0 0 0.0 0.0
Naive 4 10 7 9 3 1 42.9 11.1
Naive 5 13 13 12 0 1 0.0 8.3
Naive 6 9 9 9 0 0 0.0 0.0
Immune 1 12 10 8 2 3 20.0 37.5
Immune 2 15 9 8 4 3 44.4 37.5
Immune 3 12 11 8 1 1 9.1 12.5
Immune 4 10 10 8 0 1 0.0 12.5
DbPA244 Naive 1 11 11 11 0 0 0.0 0.0
Naive 2 10 10 10 0 0 0.0 0.0
Naive 3 8 8 8 0 0 0.0 0.0
Naive 4 25 25 25 0 0 0.0 0.0
Naive 5 43 40 43 2 0 5.0 0.0
Immune 1 17 15 15 2 1 13.3 6.7
Immune 2 27 21 20 5 6 23.8 30.0
Immune 3 14 14 12 0 2 0.0 16.7
Immune 4 20 14 20 3 0 21.4 0.0
DbPB1-F262 Naive 1 13 13 13 0 0 0.0 0.0
Naive 2 13 12 13 1 0 8.3 0.0
Naive 3 9 9 9 0 0 0.0 0.0
Naive 4 41 41 41 0 0 0.0 0.0
Naive 5 21 21 21 0 0 0.0 0.0
Naive 6 24 22 23 2 1 9.1 4.4
Naive 7 16 16 16 0 0 0.0 0.0
Immune 1 9 9 8 0 1 0.0 12.5
Immune 3 11 11 11 0 0 0.0 0.0
Immune 4 20 15 17 1 2 6.7 11.8
Immune 5 16 15 16 1 0 6.7 0.0
This
study
Human CD8+
YFV
Immune 184 169 179 15 3 8.9 1.7
Table 5.1: A summary of the degrees of sharing of CDR3α and CDR3β at the amino
acid level across clones within epitope-speciﬁc T cell populations, found in pub-
lished single-cell TCR sequencing data and our own. Unless indicated otherwise, the
samples were obtained from inﬂuenza-infected mice. The data clearly demonstrate
that sharing of both α and β chains within an individual occurs in different infec-
tion/inoculation settings.
rearrangement events. In this hypothesis is true, then sharing is expected
to arise most frequently for sequences that are similar to germline VJ se-
quences and thus contain relatively few random N-nucleotide insertions.
To examine this possibility, we immunized an HLA-A2 human volunteer
with the live attenuated yellow fever vaccine YFV-17D, took a peripheral
blood sample 15 days post-vaccination, and used dextramer staining and
single-cell RNAseq to recover paired TCRαβ sequences from CD8+ T cells
speciﬁc for the immunodominant epitope HLA-A02:01/LLWNGPMAV (de-
scribed in Section 2.5). Out of 256 cells, we observed 169 unique CDR3α
sequences, with 15 (8.9%) of them shared between two or more clones (Fig-
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ure 5.1A, colored bars represent clones with shared CDR3α sequences, and
the numbers in the boxes indicate the number of clones sharing each CDR3α
sequence). We examined the numbers of nucleotide insertions at the V-J
junction of the CDR3α and indeed saw signiﬁcantly fewer in CDR3α se-
quences that were shared between two or more clones (mean of 2.04 inser-
tions, n = 23) than in sequences that were unique to a single clone (mean of
3.62 insertions, n = 154; p < 0.005, Wilcoxon rank sum test; Figure 5.1B).
It appears that convergent TCRα recombination may derive at least in part
from the reduced junctional diversity of clones possessing CDR3 regions
that are closer to germline.
Despite our incomplete understanding of the mechanisms and processes
that cause CDR3α and CDR3β sharing, single-cell sequencing data clearly
suggest that any method for sequencing epitope-speciﬁc populations and
other populations of limited clonality will need to explicitly handle these
features in the repertoire.
5.1.5 Aim of the chapter
The aim of this chapter is to describe a frequency-based pairing methodol-
ogy called alphabetr to efficiently and accurately identify paired TCR se-
quences. alphabetr is designed to identify TCR pairs from epitope-speciﬁc
T cell populations that contain dual-TCRα clones and the sharing of CDR3α
and CDRβ sequences; it also estimates the frequencies of the identiﬁed clones
within their parent populations. The chapter will also discuss the extensive
testing performed on the algorithm through simulated and real sequencing
data sets to demonstrate its accuracy and its advantages and limitations over
single-cell sequencing technologies.
5.2 description of alphabetr and how it was tested
5.2.1 An overview of the alphabetr algorithm
We developed a procedure named alphabetr (algorithm for pairing alpha
and beta T cell Receptors) that recovers TCRαβ pairs from high-throughput
sequencing data, shown schematically in Figure 5.2. The experimental pro-
cedure is to sequence the CDR3α and CDR3β regions from multiple sam-
ples of T cells from the same parent population (Figure 5.2A–B). In contrast
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with single-cell sequencing, multiple samples of many cells are sorted into
wells of 96-well plates (Figure 5.2A). The number of cells in each well can
be freely varied, and as described in Section 5.3.1, varying the sample size
across the plate(s) helps to increase both the number and accuracy of pair-
ings. The CDR3α and CDR3β sequences found in each well are sequenced
(Figure 5.2B), and a list of the set of unpaired sequences from each sam-
ple are inputs for the alphabetr algorithm. Although Figure 5.2B depicts
amino acid sequences as inputs, the inputted data can comprise of the CDR3
nucleotide sequences and/or the addition of V(D)J segment information.
With these data, alphabetr chooses a random subsample of wells and
then calculates association scores between every α and every β chain (Fig-
ure 5.2C(i)-(ii)). The score is the sum of the number of co-occurrences of the
chains weighted inversely by the number of unique CDR3α sequences in the
well and the number of co-occurrences in each well weighted inversely by the
number of unique CDR3α sequences in the well (Figure 5.2C(ii)). Weight-
ing the number of co-occurrences in this way reﬂects the intuitive idea that
our conﬁdence that a co-occurring CDR3α and CDR3β pair derive from the
same clone decreases as the number of unique CDR3 sequences recovered
from that well increases. The algorithm then solves a linear sum assignment
problem within each well based on these plate-wide association scores to
generate a list of candidate pairs of CDR3α and CDR3β sequences within
each well (Figure 5.2C(iii)). Each well yields a list of αβ pairs—where each
CDRα is paired with only one CDR3β and vice versa—that maximizes the
sum of the association scores. After repeating this assignment problem for
every well in the random subset, the algorithm generates a list of the num-
ber times every CDR3α and CDR3β pair was associated with each other.
This list then allows for sharing of chains across clones. Those αβ pairs that
appear in a number of wells greater than a calculated ﬁlter level then form
a reﬁned list of candidate pairs; this ﬁlter is calculated as the mean of the
number of associations of every αβ pair that had at least one association.
This pairing and ﬁltering process is repeated on many different randomly
chosen subsets of the data (Figure 5.2C), and a consensus list of putative
paired CDR3 sequences comprises those appearing in more than a consensus
threshold of these lists (Fig 5.2D). This resampling procedure of repeatedly
using different subsets of the data acts to reduce the effect of very common
clones pushing up the consensus threshold for inclusion in the ﬁltered list
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and increases the efficiency of pairing of rarer clones while minimizing the
inclusion of incorrect αβ pairs (discussed more fully in Section 5.5.2). The
consensus threshold is chosen by the user, and a higher threshold will de-
crease the number of incorrectly paired CDR3 sequences while decreasing
the number of correctly identiﬁed pairs. Steps shown in Figure 5.2A–C are
described in more detail in Section 5.5.2.
The algorithm then uses a maximum likelihood approach to estimate the
relative frequencies of the clones associated with each candidate αβ pair (Fig-
ure 5.2D). The probability of all chains associated with a clone co-appearing
in a given number of wells can be calculated from the binomial distribution,
and thus the number of wells that contain the chains of a clone in the data
provides information about the frequency of that clone. We calculate the
maximum likelihood estimates for this distribution given the data to esti-
mate clonal frequencies within the parent population (mathematical details
in Section 5.5.3).
These estimated frequencies are then used with the patterns of co-occur-
rences of chains to distinguish between β-sharing and dual-TCRα clones.
The algorithm decide whether each candidate pair of clones that share a β
chain (e.g. αiβ and αjβ) are indeed two clones or derive from one dual-TCRα
clone (e.g. αiαjβ). This is done by exploiting the fact that the pattern of co-
occurrences of all three chains will be different under the two hypotheses,
and two methods are used to determine with which hypothesis the observed
data is consistent.
The ﬁrst method—dubbed the k-means approach—ﬁnds rare dual-TCRα
clones by using the estimated frequencies of a putative β-sharing clone pair
αiβ and αjβ to calculate the expected number of wells in which all three
chains should co-occur. The three chains will tend to co-occur more often if
they derive from a dual-TCRα clone than if they derive from two CDR3β-
sharing clones. For each candidate clone, we take the ratio of the number
of co-occurrences of their clones in the data to the expected number of co-
occurrences assuming that the chains derive from a CDR3β-sharing clone.
We cluster these candidate clones using k-means clustering into two sets
based on these ratios, and the set with higher ratios are chosen as dual-TCRα
clones (a representative example is shown in Figure 5.6).
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Figure 5.2: (Facing page) An overview of the implementation of alphabetr. (A)
From the population of interest, multiple samples of 20-300 T cells are sorted into 96-
well plates. This design allows for a given clone to be sampled in multiple wells. (B)
High-throughput sequencing is used to recover the unpaired CDR3αand CDR3β se-
quences of the clones sampled in each well. No quantitative information regarding
the number of times each clone was sampled in a given well; (C) (i) A random sub-
set of the wells is chosen, (ii) association scores between every unique α and β found
across the wells within this sample are calculated, and (iii) the set of one-to-one αβ
pairs thatmaximizes the sumof association scores is identiﬁed using theHungarian al-
gorithm [136]. Step (iii) is illustrated for a particular set of CDR3α and CDR3β recovered
fromonewell as amatrix of association scores calculated across allwells in the subsam-
ple. (D) Steps C(i)–(iii) are repeated to generate a consensus list of pairs, ﬁltering out
candidates that appear rarely across replicates. (E) The frequencies of each remain-
ing candidate αβ pair within the parent population are estimated using a maximum-
likelihood approach assuming only sharing and nodual-TCRα clones. Dual-TCRα clones
(e.g. αiαjβk) are then distinguished from clones apparently sharing a TCRβ chain (e.g.
αiβk and αjβk) with two methods—one using k-means and the other using full likeli-
hood calculations based on the patterns of co-occurrences—and the frequencies of
these clones are re-calculated. (F) The output of the algorithm is a list of single and
dual-TCRα clones, each with their estimated frequency within the parent population.
The second method—dubbed the full-likelihood approach—ﬁnds more
common dual-TCRα clones by using a more sophisticated approach that
calculates the likelihoods of all three-way, two-way, and individual concur-
rences of αi, αj, and β under both hypotheses. Unlike the k-means approach,
the full-likelihood approach incorporates additional information from the
partial appearances of the chains of the candidate clone, which occurs due
to the dropping of chains. These likelihoods are computationally expensive
and in practice can be used for wells with ≤50 cells, which are conveniently
thewells that containmaximal information regarding common clones. Thus,
this approach designed to identify more abundant dual-TCRα clones. Can-
didate clones with larger likelihoods under the dual-TCRα hypothesis than
the CDR3β-sharing hypothesis are then chosen as dual-TCRα clones—we
empirically found that a difference of 10 in the log likelihoods identiﬁes
many correct dual-TCRα clones with a low rate of mistakes.
The output of the algorithm is a list of single or dual-TCRα clones to-
gether with estimates of their frequencies within the parent population (Fig-
ure 5.2F). alphabetr does not attempt to identify dual TCRβ expressing
cells because dealing with this relatively infrequent phenomenon together
with dual-TCRα chains and sharing of both TCRα and TCRβ chains across
clones is extremely challenging algorithmically. However, we will demon-
139
strate that the presence of dual TCRβ clones at rates shown in previous
studies has little effect on its performance (see the end of Section 5.3.1).
5.2.2 Evaluating the algorithm with simulated and experimental data
We evaluated the accuracy and precision of alphabetr by testing the algo-
rithm with simulated data and with a tumor-inﬁltrating lymphocyte dataset
from the Howie et al. study [1]. Simulating data allowed us to test how
well the algorithm performed with data from T cell populations with differ-
ent degrees of clonality, different degrees of CDR3α and CDR3β-sharing,
and many different experimental conditions. In addition to testing a wide
breadth of different immunological and experimental conditions, simula-
tions have the advantage of knowing the “right answers,” giving us the
option to directly assess the accuracy and efficiency of the algorithm in a
way that cannot be done with experimental data.3 However, to demonstrate
a real-world application of alphabetr, we successfully identiﬁed CDR3α/
CDR3β pairs from T cells in the pairSEQ TIL sequencing dataset by com-
paring them to the pairs identiﬁed by pairSEQ [1].
Simulations of sequencing of epitope-speciﬁc T cell populations
To extensively test alphabetr, we created an comprehensive set of differ-
ent synthetic datasets by simulating T cell populations with different num-
bers of clones, different immunodominance hierarchies, different degrees of
CDR3α- and CDR3β-sharing, and different proportions of clones express-
ing dual-TCRα chains. In addition, we added experimental noise to simulate
realistic errors in sequencing experiments, including sequencing errors and
the failure to amplify and sequence a chain at all. We then simulated the se-
quencing experiments by sampling T cells from these populations into wells
of virtual plates and then “sequenced” the CDR3s from sampled cells, al-
lowing for the errors to occur.
3One could imagine an experiment where a T cell population is split into two samples,
one sequenced with single-cell sequencing and one with the alphabetr approach. Although
single-cell sequencing would provide us with some of the “right answers,” current single-
cell approaches cannot be scaled to sequence the thousands of clonotypes that would be
identiﬁed by alphabetr. In addition, single-cell sequencing is itself prone to errors. It would
be akin to trying to mark an exam with a partial answer sheet except the answer sheet was
printed smudgy ink.
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Percentage of CDR3α
and CDR3β sequences
shared
Level of sharing
Low Medium High
α β α β α β
Not shared 90% 90% 81.6% 85.9% 60% 60%
2 clones 5% 5% 8.5% 7.6% 20% 20%
3 clones 5% 5% 2.1% 3.7% 10% 10%
4 clones 0% 0% 0.7% 1.9% 10% 10%
5 clones 0% 0% 3.3% 0.9% 0% 0%
6 clones 0% 0% 0.5% 0% 0% 0%
7 clones 0% 0% 3.3% 0% 0% 0%
Table 5.2: The three different levels of sharing used in the simulations. Three dif-
ferent levels of sharing were used to test the robustness of alphabetr to T cell popula-
tionswith different degrees of sharing. Themedium sharing level is the average of the
rates of sharing found in all of the studies showing in Table 5.1. The low sharing level
was chosen to have much fewer shared chains than the medium sharing level, and
the high sharing level was chosen to havemuchmore shared chains than themedium
sharing level.
We simulated different degrees of CDR3α- and CDR3β-sharing at ranges
of frequencies consistent with published single-cell TCR sequencing studies
(Table 5.1) and our own data (Fig 5.1A). We also allowed between 10% and
30% of clones to express two productive TCRα chains and 6% of clones to
express two productive TCRβ chains, both of which are at the upper limit of
rates observed in T cell populations. The sequences in each ‘well’ were then
generated by sampling between 10 and 300 T cells from the parent popu-
lation with replacement. The choice in the pattern of sample sizes has huge
implications in the accuracy and efficiency of the algorithm (Figure 5.3).
The breadth of the characteristics varied in our simulations reﬂect a
range of plausible immunodominance hierarchies found in T cell responses,
motivated by an analysis of epitope-speciﬁc cells recovered from human sub-
jects immunized with live attenuated yellow fever virus vaccine based on
analysis in Section 5.1.4 and from DeWitt et al. [62]). The following range
of parameters were varied:
• Number of distinct clones. We tested populations with 500, 2100, and
3000 unique clonotypes. These numbers seem to cover a wide range of
possible numbers of clonotypes found in antigen-speciﬁc populations
that have been found based on β-only sequencing studies [62].
• Different levels of skew in the immunodominance hierarchies. We as-
sumed skewed distributions of clone sizes, with between 5 and 50
clones comprising the most abundant 50% of the population and the
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Sampling
Strategy
Number
of plates
Number of wells × number of cells per well
High-Mixed
1 26 × 20 13 × 50 19 × 100 19 × 200 19 × 300
5 128 × 20 64 × 50 96 × 100 96 × 200 96 × 300
Low-Mixed
1 26 × 15 6 × 20 13 × 30 19 × 50 19 × 100 19 × 150
5 96 × 15 32 × 20 64 × 30 96 × 50 96 × 100 96 × 150
Table 5.3: The mixed sampling strategies used in the simulations. The bold text
numbers indicate the number of cells sampled in the wells, and the associated normal
text numbers indicate the number of wells with that sample size.
remainder forming a ﬂat tail at low frequency (described mathemat-
ically in Section 5.5.5). These distributions test populations with dif-
ferent levels of skew in the clonal frequencies.
• Different levels of sharing. We simulated different degrees of CDR3α-
and CDR3β-sharing at ranges of frequencies consistent with published
single-cell TCR sequencing studies (Table 5.1) and our own data (Fig-
ure 5.1A). We tested populations that display low, medium, and high
levels of sharing (deﬁned in Table 5.2). The medium level of sharing is
the average of the sharing levels of all studies shown in Table 5.2.
• Proportion of clones expressing two productive TCRα chains.We tested
populations with 10% of its clones and 30% of its clones expressing
two distinct CDR3α sequences. A level of 30% is used since it is an
upper limit of estimates from the literature [127].
• Different sampling strategies. We explored different sampling strate-
gies, i.e. the number of plates used and the number of cells sampled in
each well of the plates. The different sampling strategies are described
in Table 5.3.
To assess the robustness of alphabetr to experimental noise, we sim-
ulated the properties of two forms of sequencing error: dropping of chains
and productive in-frame sequencing errors. Dropping of chains represents
the failure to amplify or detect CDR3α and/or CDR3β sequences, a process
which likely has both purely random and clone-speciﬁc elements [1]. In order
to capture the dropping of chains in the simulations, every clone was ran-
domly assigned a drop rate from a lognormal distribution with mean 0.15
and standard deviation of 0.01 with the rate capped at 0.9. Each instance
of the CDR3α and CDR3β sequences from that clone (namely, the num-
ber of times that clone was sampled) was then removed from the well with
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probability equal to the randomly assigned drop rate. In-frame sequencing
errors occur when a sequencer mislabels a base or a series of bases in a
read, potentially incorrectly identifying the CDR3 sequence with an erro-
neous nucleotide and/or amino acid sequence. To model these productive
in-frame sequencing errors, every unique CDR3α and CDR3β sequence was
assigned an error rate randomly drawn from a lognormal distribution with
mean 0.02 and standard deviation 0.005. Each instance of a sequence at the
per-cell level was replaced at random by one of three erroneous ‘daughter’
sequences—each set of three unique and speciﬁc to the parent sequence—
with probability equal to the sequence-speciﬁc in-frame error rate. Thus, on
average each CDR3α and CDR3β generated mutant daughter sequences at
the rate of 2% per instance in each cell in the plate.
Testing with the pairSEQ TIL sequencing data
The TIL sequencing data described by Howie et al. provided an opportunity
to test alphabetr with a real human TCR sequencing dataset of restricted
clonal diversity [1]. The data were obtained by sampling T cells from nine
different tumor samples from nine different patients into one 96-well plate
and sequencing the CDR3α and CDR3β chains of the T cells sampled in each
well using the pairSEQ platform. In addition, deep sequencing of the CDR3α
and CDR3β sequences was performed on PMBCs from each patient using
the immunoSEQ platform [18]. These sets of sequences from the patients
served as libraries to resolve the sequences found in the mixed pairSEQ 96-
well plate to their tumor sources.
Because the mixed plate contained 561452 unique CDR3α nucleotide se-
quences and 955987 unique CDR3β nucleotide sequences, these data are too
diverse for direct input into alphabetr. 4 We therefore made tumor-sample-
speciﬁc virtual plates by matching CDR3 regions in the pairSEQ wells to the
immunoSEQ libraries of CDR3 sequences obtained from PMBCs sampled
from each patient. This was done by exactly matching the ﬁrst 76 bases of
4There are at least two reasons for this. First, is designed to handle the more restricted
clonality found in epitope-speciﬁc populations and thus the hundreds of thousands of se-
quences represented in these data are too diverse for its design. Second, in the alphabetr
R package, all of the possible αβ pairs are stored in an n × m matrix, where n is the num-
ber of unique CDR3α sequences and m is the number of unique CDR3β sequences. The
536740813124 possible αβ pairs are about 250 times greater than the largest positive inte-
ger that can be represented in R.
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the nucleotide sequences of CDR3α pairSEQ sequences to the last 76 bases
of the nucleotide sequences of the CDR3α libraries of each tumor sample.
For the CDR3βsequences, matching regions were 81 bases in length. These
choices reﬂect the different reads utilized by pairSEQ and immunoSEQ se-
quencing. Each of the nine plate of tumor-speciﬁc chains was then analyzed
using alphabetr to obtain αβ pairs, and the pairs identiﬁed by alphabetr
were compared to the pairs identiﬁed by pairSEQ. Since single-cell sequenc-
ing was not performed to validate the identiﬁed pairs, we can analyze only if
the two methods agree; the possibility of both methods being wrong exists,
which motivated the need to perform extensive simulations.
Metrics used to evaluated the algorithm
For the simulations, the αβ pairs identiﬁed by alphabetr were compared
with the correct list of αβ pairs, and the following metrics were calculated:
1. Overall depth, the number of αβ pairs that were correctly identiﬁed,
as a proportion of the total number in the parent population (in this
calculation, a dual-TCRα clone αjαkβ is treated as two clones αjβ and
αkβ)
2. Depth of top clones, the proportion of the clones that comprise the top
50% of the population after ranking by frequency that were correctly
identiﬁed
3. False pairing rate, the proportion of identiﬁed αβ pairs that were in-
correct
4. Adjusted dual depth, a measure of how well dual-TCRα clones were
be identiﬁed from candidate pairs, namely
# correctly identiﬁed dual-TCRα clones
# true dual-TCRα clones whose two α
chains are in the list of candidate αβ pairs
5. False dual rate, the proportion of candidate dual-TCRα clones that are
incorrectly identiﬁed.
These ﬁve metrics evaluate different aspects of the accuracy and effec-
tiveness of alphabetr. Overall depth measures how many correct CDR3α/
CDR3β pairings that alphabetr can identify out of all possible pairs found
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in the target populations, regardless of whether the CDR3α/CDR3β pair
derive from a single TCR or a dual-α TCR clone. Depth of top clones in-
dicates how well alphabetr identify the immunodominant clones of a T
cell population. False pairing rate captures how often alphabetr identi-
ﬁes spurious CDRα/CDRβ pairs. Adjusted dual depth evaluates how well
alphabetr distinguishes dual-TCRα clones from two clones sharing the
same CDR3α sequence. Instead of using an absolute dual depth, we ad-
justed the dual depth for the fact alphabetr cannot identify a dual clone if
both CDR3α sequences from a dual clone are not paired with the CDR3β
of that clone. This measures when alphabetr makes a mistake of failing to
identify a dual clone αiαjβ after it pairs αiβ and αjβ. Finally, the false dual
rate measures how many of the dual-TCRα clones identiﬁed by alphabetr
are incorrect.
5.3 results
5.3.1 Testing alphabetr with simulated datasets
Mixed sampling strategies with stringent consensus threshold strikes a bal-
ance of depth and accuracy of pairing
We began testing alphabetr with simulations of populations with 2100
clones, medium levels of sharing (as deﬁned in Table 5.2), 30% of clones ex-
pressing dual-TCRα chains, and experimental lognormal errors as described
in Section 5.3.1. We evaluated howwell the algorithm performs as measured
by overall depth of the population, depth of top clones, depth of clones in
the tail of the population, and the false pairing rate. The simulations also ex-
plored how different sampling strategies affect the performance measured by
these metrics since the number of cells sampled in the wells of the sequencing
plates can be varied. We also show results for different consensus thresholds
uses for the pairings (described schematically in Section 5.2.1 and described
mathematically in Section 5.5.1).
Figure 5.3 shows the results from these simulations. Figure 5.3A shows
the depth of the clones in the top 50% of the population only, and Fig-
ure 5.3B shows the depth of the clones in the other 50% tail of the popula-
tion only. Figure 5.3C shows the depth for the whole population, and Fig-
ure 5.3D shows the false pairing rates. The different number of top clones
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Figure 5.3: (Facing page) Depth and accuracy of αβ pairings generated by alpha-
betr, for a range of overall sample sizes, sampling strategies and underlying dis-
tributions of clone sizes. Simulations were performed using simulated data sets of
one or ﬁve plates using six different sampling strategies (Table 5.3) and different de-
grees of skew in clonal frequencies, as indicated by the number of clones comprising
50%of the populationwhen ranked by frequency. ‘Threshold’ refers to the stringency
of pair association, T (Section 5.5.1). (A) The proportion of themost abundant 50% of
clones that were identiﬁed. (B) The proportion of the least abundant 50% of clones
that were identiﬁed. (C) The overall depth is inﬂuenced strongly by the tail depth, in-
dicating that data from one plate may be sufficient for recovering the most common
clones. (D) The rate at which CDR3α and CDR3β sequences were incorrectly paired.
changes on the x-axis (populations become less skewed moving from left to
right), and the different sampling strategies are represented on the y-axis.
The rows of the facetted panels show the application of different consensus
thresholds, and the columns of the facetted panels represent the use of either
one 96-well plate or ﬁve 96-well plates. For each set of conditions, metrics
were computed by averaging the results of 100 simulated experiments.
With only a single plate, the most abundant 50% of clones were recov-
ered with depths between 62% and 89% with a moderate threshold of 0.6
and the mixed sampling strategies, improving with less skewed distributions
(Figure 5.3A, left panels). Coverage of rare clones (Figure 5.3B, left panels)
is much more limited, particularly for sparse sampling strategies, but im-
proves with a more lenient consensus threshold of 0.3. The use of ﬁve plates
considerably boosts the recovery of rare clones (Figure 5.3B, right panels),
providing up to 61% depth with a threshold of 0.6 and 70% with a thresh-
old of 0.3. As a result, for all sampling strategies, increasing the number of
plates—and hence total sample size—increases overall depth (Figure 5.3C),
almost entirely through greater recovery of rarer clones.
Increasing the number of plates also signiﬁcantly reduces the false pair-
ing rate (Figure 5.3D), which can be as low as 3.1% for 5 plates and a
stringent threshold of 0.9 (Figure 5.3D, lower right panel). In general, in-
creasing the stringency threshold reduces false pairing rates. The stringency
of the threshold can be relaxed if there is no signiﬁcant presence of dual-
TCRβ clones in the T cell population, which will be discussed in the end of
this section.
Increasing the consensus threshold of the resampling procedure—that is,
requiring a high frequency of occurrence of candidate pairs across subsets
of the data—results in a lower false pairing rate at the cost of lower depth,
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largely for rarer clones (Figures 5.3C–D). This is because rarer clones will
be excluded from the replicates more often than common ones; as the strin-
gency of pair selection is increased, rare clones will tend to be ﬁltered out.
In summary, mixed sampling strategies with moderate to high accep-
tance thresholds yield the lowest false pairing rates (Figure 5.3D) while
maintaining good depth of recovery of rare clones (Figure 5.3B). The high-
mixed strategy obtains a larger overall sample size than the other sampling
strategies and thus achieves greater depths, particularly of rare clones.
In practice, the availability of cells may place constraints on the sampling
strategy. For example, with ﬁve plates the high- and low-mixed strategies re-
quire a total of 64,000 and 33,000 cells respectively. A typical sample of four
tubes (approximately a total of 30mL) of human blood yields roughly 3×107
PBMCs, of which roughly half are αβT cells.With such a sample, numbers of
T cells speciﬁc for immunodominant epitopes of highly immunogenic infec-
tions such as Epstein-Barr virus and cytomegalovirus [137, 138, 139, 140],
the number of antigen-speciﬁc T cells is unlikely to be limiting. A conser-
vative estimate is that to acquire ~100,000 cells needed for the high-mixed
sampling strategy on ﬁve 96-well plates requires epitope-speciﬁc frequencies
in excess of 1% of αβ T cells, or 0.5% of PBMC. Frequencies below this may
dictate fewer plates and/or a sparser sampling strategy.
Precise estimation of frequencies of common clones beneﬁts from sparse or
mixed sampling strategies
We assessed the ability of alphabetr to estimate clonal frequencies over a
range of clonal size distributions and sampling strategies (Figure 5.4). We
show results only for the most abundant clones making up 50% of the pop-
ulation. The left and right panels of Figure 5.4A show typical sets of abun-
dance estimates for populations with moderately and highly skewed clonal
distributions, with 25 and 5 clones respectively making up the top 50% of
clones by size. We tested the method of construction of point estimates and
conﬁdence intervals using simulated data and conﬁrmed that close to 95%
of such intervals contained the true frequency (results not shown).
Figure 5.4B summarizes the precision of the abundance estimation for
a variety of sampling strategies and levels of skew. We also calculate the
coefficient of variation σˆ/fˆ, where σˆ is estimated by using a quadratic ap-
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proximation to the 95% conﬁdence interval 3.92σˆ, and fˆ is the estimated
frequency. The procedure yielded CVs in the range 0.13–0.41 for one plate
and 0.07–0.20 for ﬁve plates (Figure 5.4B), indicating very precise estimates.
Intuitively, the inﬂuence of skew arises because the data provides the
most information about the frequency of a given clone when sample sizes
causes the clone to appear in an intermediate proportion of wells. For in-
stance, as an extreme example, if a clone appears in 0 wells of the plates,
then the data have no information about the frequency of the clone. At the
other extreme, if a clone appears in all of the wells of the plate, then the
data indicate only that the clone is very abundant but fails to be informative
about the magnitude of the frequency (namely, a large range of frequencies
can explain the data). Sampling low numbers of cells is therefore optimal for
determining the abundance of highly immunodominant clones to ensure that
they are not sampled in too many wells, and larger numbers are optimal for
determining the abundance of rare clones so that they are sampled at all. For
the clone distributions considered here, the sparsest sampling strategy (i.e.
uniformly 10 cells/well in our simulations) gives the greatest precision for
the common clones. In general, however a mixed sampling strategy strikes
a balance between precision over a wide range of abundances (Figure 5.4B,
bottom row in each panel), false pairing rates, and depth.
The clonal frequencies shown in Figure 5.4A depend on prior knowl-
edge or estimation of the mean drop rate, or the mean probability that any
CDR3α or CDR3β of a clone will fail to be sequenced. Although this drop
rate is most likely speciﬁc to experimental protocol and equipment, our sim-
ulations used a mean of 15%, which appears to be an upper bound for these
drop rates, and this rate can be roughly estimated using a protocol performed
by Howie et al. [1].
Neglecting this error rate yields lower bounds on clonal abundances.
We performed simulations to determine the sensitivity of clonal frequency
estimation to inaccuracies in estimates of the average drop rate of CDR3α
and CDR3β sequences. These simulations involved creating data sets of 5
plates, the high-mixed sampling strategy, and a constant mean drop rate of
ε = 0.15. We then performed frequency estimation on these data sets using
mean drop rates of ε = 0.15, ε = 0.08, and ε = 0. We show the mean bias
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Figure 5.4: Assessment of the precision of clonal frequency estimation. (A) Point
estimates of clonal frequencies calculated by alphabetr, derived from representative
simulations usingﬁve plates anddistributionswith 25 and5 clones in the top 50% (left
and right panels respectively). (B) The CVs of frequency estimates for a range of skew
of clone sizes and sampling strategies. Results here are averages over 100 simulations.
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Dropping rate Number of
top clones
Percent of 95%-CI
containing true frequency
Mean bias
ε = 0.15 5 91.5% 3.8%
10 93.4% 2.4%
25 92.7% 2.1%
50 92.3% 3.0%
ε = 0.08 5 65.3% -12.1%
10 53.4% -12.7%
25 47.7% -12.8%
50 47.8% -12.7%
ε = 0 5 31.2% -25.2%
10 12.8% -26.4%
25 6.7% -26.3%
50 7.8% -26.2%
Table 5.4: Assessing the impact of underestimation of sequencing error on clonal
frequency estimation. Using accurate estimates of the drop rate (here, ε = 0.15) re-
sults in accurate frequency estimates. Underestimating the drop rate leads to biased
estimates that are lower bounds on the true frequencies.
in these frequency estimates, where
Bias =
Estimated frequency− True frequency
True frequency
Table 5.4 shows the results of 200 simulations for each combination of ε and
skewness of the clone size distribution indicated by the number of clones in
the top 50% of the population when ranked by clonal frequency. Assum-
ing no dropping of chains (ε = 0) leads to the underestimation of clonal
frequencies and inaccuracies in the construction of the 95% conﬁdence in-
tervals.
Efficient discrimination of dual-TCRα and CDR3β-sharing clones requires a
mixed sampling strategy and distinct methods for common and rare clones
The ﬁnal step in the algorithm is to decide whether each candidate pair of
clones that share a β chain (e.g. αiβ and αjβ) are indeed two clones or de-
rive from one dual-TCRα clone (e.g. αiαjβ). Two methods are used for this
discrimination, one which identiﬁes rare clones and another which identiﬁes
more common clones.
To do this, we exploit the fact that the pattern of co-occurrences of all
three chains will be different under these two hypotheses. Initially, we use
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the estimated frequencies of a putative β-sharing clone pair αiβ and αjβ to
calculate the expected number of wells in which all three chains should co-
occur. Essentially, the three chains will tend to co-occur more frequently if
they derive from a dual-TCRα clone than if they derive from two β-sharing
clones. We construct the ratio of the expected to the observed numbers of
three-way co-occurrences for each β-sharing pair and perform k-means clus-
tering on these ratios. The cluster of higher values forms the ﬁrst list of can-
didate dual-TCRα clones. A visual example of the clustering of clones into
two groups is shown in Figure 5.6.
However, performing k-means clustering on only the numbers of three-
way occurrences is inefficient at discriminating β-sharing and dual-TCRα
clones that are relatively abundant because the expected frequencies of co-
occurrences become indistinguishable, particularly for rich sampling strate-
gies in which the three chains co-occur in many wells. We therefore added
a second step which utilizes more information from the plates, calculating
the likelihoods of all three- and two-way concurrences of αi, αj, and β un-
der both hypotheses. Exact computation of these likelihoods is only practical
for the low-occupancy wells (less than 50 cells/well), which conveniently are
also the wells that contain maximal information regarding common clones.
As a result, this second approach can be performed only when using sparse
sampling strategies or the low-occupancy wells used in the mixed sampling
strategies. We determined empirically that differences in the log likelihoods
of more than 10 distinguish the β-sharing and dual-TCRα hypotheses.
Figure 5.5 summarizes the ability of the algorithm to distinguish TCRβ-
sharing and dual-TCRα clones. Common clones are identiﬁed through the
three-way likelihood approach, and mixed sampling strategies give the best
results in this case, with adjusted depths of up to 79% for less skewed dis-
tributions (Figure 5.5A). The likelihood approach still performs relatively
poorly with very highly skewed populations, distinguishing dual-TCRα from
β-sharers correctly at most 34% of the time for population with 5 clones
making up the top 50% of the population (Figure 5.5A). Under these cir-
cumstances, the statistics of co-incidence of the three chains are very similar
under the two hypotheses of dual-TCRα or TCRβ-sharing clones. In con-
trast, the k-means procedure achieves adjusted depths of 93–99% for rare
clones when using 5 plates and the high-mixed strategy (Figure 5.5B). Aver-
aging over all clones, this strategy gives false dual rates of between 10–13%
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Figure 5.5: Discriminating between dual-TCRα and β-sharing clones. We assess the
degree of recovery of dual-TCRα clones with the adjusted dual depth, which is the
proportion of dual-TCRα clones correctly assigned out of the list of candidate dual-
TCRα and TCRβ-sharing clones. (A) The adjusted dual depth of common clones. (B)
The adjusted dual depth of rare clones. For common clones, we used likelihood-based
discrimination; for rare clones we used a k-means clustering approach. (C) The false
dual rate averaged over all clones—the proportion of identiﬁed dual-TCRα that are
incorrect. All results are shown for a threshold of 0.3 with 30% prevalence of dual-
TCRα and are averages over 100 simulations.
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Figure 5.6: Discriminating between β-sharing and dual-TCRα clones. For each can-
didate β-sharing clone pair (αiβ, αjβ) we calculate the ratio of the observed number
of co-occurrences of the three chains to the number expected under the hypothesis
they are indeed distinct clones. The latter uses the estimated frequencies of the two
clones. These ratios typically partition into a lower set of values that represent CDR3β
sharers and a higher set of values that represent dual-TCRαclones. Note that the lower
cluster is not centered on one; this is because calculating the expected number of co-
occurrences of all three chains under the two hypotheses with a non-zero drop rate ε
is computationally intractable due to large multinomial coefficients. However, assum-
ing ε = 0 biases both estimates, and k-means still resolves the two clusters of ratios.
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(Figure 5.5C).
Exploring different degrees of CDR3α andCDR3β sharing, richness in clonal
structure, and prevalence of dual TCRβ
In order to evaluate the robustness of alphabetr, we performed simula-
tions to measure its ability to determine TCR pairs from a wide range of
antigen-speciﬁc T cell populations with different levels of sharing, with dif-
ferent numbers of distinct clones, and without the presence of dual-TCRβ
clones.
Different levels of sharing.We performed simulations with the high level
of sharing and low leves of sharing within populations comprised of 2100
clones (Table 5.1). The higher sharing level had a minimal effect on top and
tail depths while causing an absolute increase in false pairing rates of only
1%-2% (Figure 5.7). The lower level of sharing decreased the false pairing
rate by approximately 1% in absolute terms while having minimal effect on
top and tail depths (Figure 5.8). In both cases, the depths of recovery were
very similar to those presented in Figure 5.3 with very small differences in
the false pairing rate.
Different levels of clonal diversity.We simulated populations with higher
diversity by increasing the number of unique clones to 3000 clones and
populations with lower diversity by decreasing the number of clones to
500 clones (with error models and levels of sharing identical to those used
for simulations for Figure 5.3. For populations of 3000 clones, alphabetr
maintained the same top depth while obtaining slightly lower tail depths,
which is not surprising given that larger total sample sizes are needed to
achieve coverage of the larger tail of more diverse populations (Figure 5.10).
False pairing rates show no substantial difference. For populations of 500
clones, simulations show that alphabetr again have similar top depths and
higher tail depths (Figure 5.9). The higher false pairing rates seen here are
due to the fact that using both of the mixed sampling strategies described
in the main text (Table 5.3) involve sufficiently large numbers of cells per
well. For low-diversity populations, common clones will appear together in
wells very often with these sample sizes, creating ambiguity in pairing and
increasing the apparent degree of sharing of chains between clones. Popula-
tions comprising of fewer clones overall will by deﬁnition have higher rela-
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tive abundances, and in such situations, frequency-based pairing approaches
will beneﬁt from sparser sampling strategies.
The presence of dual TCRβ clones. Although alphabetr does not iden-
tify dual TCRβ clones, we performed simulations to see how the presence of
such clones in the parent population affects the ability of alphabetr to as-
sociate TCRα and TCRβ correctly (Figure 5.11). The presence of dual TCRβ
clones at a frequency of 6% increases the false pairing rate by approximately
3% in absolute terms (compare Figure 5.11D and Figure 5.3D) while not af-
fecting the top and tail depths (Figures 5.11A–B and Figures 5.3A–B). Since
signiﬁcant levels of dual-TCRβ clones have been shown in only a small num-
ber of studies sequencing antigen-speciﬁc T cell populations [131, 70], we
believe this represents an upper bound on the effect of dual TCRβ clones on
the performance of alphabetr.
5.3.2 Testing alphabetrwith tumor-inﬁltrating lymphocyte sequencing data
Using simulated data allowed us to assess the performance of alphabetr
directly using the gold standard of known TCRαβ sequences and under a
range of plausible experimental conditions. Despite the wide range of dif-
ferent plausible T cell populations used in the simulations, we wanted to
directly demonstrate the utility of alphabetr with T cell sequencing data
from human samples. So, we illustrate a real-world application by apply-
ing alphabetr to a published TIL sequencing dataset as described in Sec-
tion 5.2.2. This dataset had less than 106 unique CDR3α and CDR3β se-
quences and thus likely represents samples from clonally restricted T cell
populations since these numbers are far less than the estimated diversity of
the naive T cell repertoire. One tumor sampled (Breast 1) yielded only 7 pairs
by pairSEQ, and we excluded it from the analysis. We applied alphabetr to
the chains from each of the remaining 8 tumors in turn and then compared
the pairs determined by alphabetr to those identiﬁed explicitly by pairSEQ
(Table 5.5). The true TCR clonotypes are unknown and so our aim was to
measure degrees of concordance and conﬂict between the two methods. In
6 out of 8 tumors, alphabetr recovered fewer clones; however we found
average concordance rates of 77%, deﬁned as the proportion of the pairs
identiﬁed by alphabetr that were also identiﬁed by pairSEQ. Perhaps more
strikingly, we also found a very low incidence of conﬂicting pairs (mean 2%
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Figure 5.7: Simulations of populations with a high level of sharing. Performance
of alphabetr at the high level of chain sharing. The results shown are the averages of
100 simulations.
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Figure 5.8: Simulations of populations with a low level of sharing. Performance
of alphabetr at low level of chain sharing. The results shown are the averages of 100
simulations.
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Figure 5.9: Simulations of populations consisting of 500 unique clones. Perfor-
mance of alphabetr with 500 clones in the parent T cell population. The results shown
are the averages of 100 simulations.
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Figure 5.10: Simulations of populations consisting of 3000 unique clones. Perfor-
manceof alphabetrwith 3000 clones in theparent T cell population. The results shown
are the averages of 100 simulations.
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Figure 5.11: Simulations with no dual-TCRβ clones. Performance of alphabetr with-
out dual-CDR3β chains in populations of 2100 clones and medium levels of sharing.
The results shown are the averages of 100 simulations.
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Tumor
Sample
Number of
pairs
identiﬁed
by
alphabetr
Number of
pairs unam-
biguously
identiﬁed
by pairSEQ
Number of
identical
identiﬁed
pairs
Percentage of
alphabetr
pairs
agreeing with
pairSEQ
Number
of
conﬂicting
pairs
Number of
novel pairs
from
alphabetr
Breast 2 98 85 74 75.5% 0 24
Breast 3 109 129 94 86.2% 1 14
Breast 4 50 85 26 52.0% 1 23
Kidney 1 74 112 58 78.4% 3 13
Kidney 2 145 286 126 86.9% 5 5
Kidney 3 213 282 166 77.9% 8 39
Kidney 4 157 176 131 83.4% 1 25
Lung 1 173 163 124 71.7% 1 48
Table 5.5: Recovery of tumor-inﬁltrating lymphocyte TCR pairs using alphabetr
and data from Reference [1]. The data were processed by associating chains with
their tumor sources through exact matching of the CDR3 nucleotide sequences from
the mixed tumor samples to the CDR3 libraries obtained from blood samples from
each patient. The data were then simpliﬁed by selecting only those chains associated
with one tumor. We then used alphabetr to identify TCRαβ pairs. The numbers of
pairs unambiguously identiﬁed by pairSEQwere determined by directly matching nu-
cleotide sequences to the CDR3 libraries, and only those pairs for which both chains
could be directly associated with the corresponding tumor sample were included in
the analysis.
Figure 5.12: (Facing page) Comparison of well occupancy patterns of the clones
identiﬁed by alphabetr and by pairSEQ. For eachmethod, TCRαβ pairs identiﬁed for
all tumor samples were combined to estimate the distribution of the number of wells
inwhich the chains co-appeared. The differences between these distributions indicate
the relative efficiency with which the two algorithms identify clones, as a function of
their abundance.
across tumors, as a proportion of all pairs identiﬁed by alphabetr). Con-
ﬂicts were deﬁned as those determined by the two methods that have only
one chain in common. In addition, alphabetr identiﬁed 5–48 novel pairs
in the tumor samples. The high concordance rate and low conﬂicting rate is
particularly encouraging since the sampling strategy used in these data are
not ideal for alphabetr since it is optimized for pairSEQ. These results all
provide additional validation for the accuracy and efficiency of alphabetr
and indicate that alphabetr can be applied to T cell populations of lim-
ited clonality such as TIL populations and not just epitope-speciﬁc T cell
populations.
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To compare the abilities of the two algorithms to identify rare or com-
mon clones, we stratiﬁed the identiﬁed αβ chain pairs by the frequency with
which they co-appeared in wells. With stringency thresholds greater than
0.7, we ﬁnd that with a single 96-well plate and a sampling strategy opti-
mized for pairSEQ, alphabetr is less efficient at identifying rare clones but
identiﬁes clones with moderate to high abundances—for which the TCRα
and TCRβ chains co-appear in more than a quarter of the wells—more effi-
ciently, as shown in Figure 5.12A. Figure 5.12B shows similar patterns when
this analysis is broken down by each individual tumor sample. The clones
identiﬁed by alphabetr alone exhibit moderate levels of sharing (CDR3α
sharing, mean 16%, range 0-60%; CDR3β sharing, mean 13%, range 4-
31%). Of the sharers, an average of 76% share a chain with a clone that
was identiﬁed by both methods.
Extensive single-cell sequencing is required to achieve equivalent overall
depth to alphabetr
We wanted to determine if and how implementing alphabetr improves
upon single-cell methodologies. One approach to assessing this would in-
volving splitting a sample of antigen-speciﬁc T cells into two subsamples,
perform single-cell sequencing on one subsample, and apply alphabetr
to the remainder to compare their performance on the same set of parent
clones. An alternative approach that we employed is by simulating both sce-
narios. The advantages of the simulation approach are that it allows us to (i)
triangulate both methods with the gold-standard of knowing true sequences
with complete certainty, which is not possible in practical settings due to
dropping of chains and in-frame sequencing errors, and (ii) explore levels of
single-cell sequencing that are currently prohibitively costly.
We simulated the sequencing of 96 to 9600 single cells sampled from
the same synthetic T cell populations used for evaluating alphabetr, par-
ticularly with the same sequencing errors. Figure 5.13 compares the perfor-
mance of the two methods for a population of 2100 clones with 5, 10, 25,
and 50 clones making up the top 50% by frequency. alphabetr was imple-
mented with the ﬁve-plate high-mixed sampling strategy and with a strin-
gency threshold T = 0.6. Under the conditions used for Figure 5.13, almost
double the number of single-cell sequencing runs was required to achieve the
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same top depth yielded by alphabetr with ﬁve plates, and more than 100
plates of single cells are required to approach alphabetr’s level of recov-
ery of rare clones. With the same clone size distribution, even a single plate
analyzed with alphabetr yields top depths from 78% to 92%, depending
on the threshold parameter used (Figure 5.3A), whereas 96 single cells yield
a top depth of 60% (Figure 5.13, middle column of plots). Single-cell se-
quencing will exhibit a false positive rate that is approximately twice the
mean of the in-frame error rate, or 4% in our simulations, an accuracy that
is comparable to that of alphabetr at its most stringent.5
5.3.3 The alphabetr package
An open-source implementation of alphabetr is available freely on CRAN
as an R package, and the most updated development version is available on
github.com/edwardslee/alphabetr. The package includes a detailed vignette
that explains step-by-step usage of the package.
5.4 discussion
Although high throughput single-cell sequencing approaches are becom-
ing more inexpensive and technically feasible, smaller-scale solutions us-
ing frequency-based sampling potentially remain far more economical. Our
approach and the commercially available pairSEQ are currently the only
two frequency-based pairing technologies described in the literature that can
be scaled to identify thousands of TCR sequence pairs without sequencing
tens of thousands of single cells. The alphabetr approach is the ﬁrst to
our knowledge to directly address the promiscuous nature of CDR3α and
5Spurious TCR pairs occur in single-cell sequencing when one or both of the CDR3s are
incorrect identiﬁed with an in-frame sequencing error. In a single-cell sequencing experiment,
if one of the chains are dropped and is identiﬁed with a shorten CDR3 with an early stop
codon, then these errors are easy to detect and can simply removed from the ﬁnal list of
CDR3 pairs. If a spurious in-frame error occurs on average 2% of the time (as chosen in our
simulations), then probability of identifying an incorrect TCR pair is
P(CDR3α having an in-frame error)+
P(CDR3β having an in-frame error)+
P(both chains having in-frame errors) =
.02× .98+ .98× .02+ .02× .02 = 3.97%
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Figure 5.13: (Facing page) Comparison of single-cell approaches and alphabetr.
Single-cell sequencing was simulated by sampling from the same populations used to
evaluate alphabetr and including both the dropping errors and in-frame sequencing
errors. In these simulations, the parent population contains 2100 cloneswith 25 clones
representing the top 50% of the clones ranked by abundance. The results were evalu-
ated for (A) top depth, (B) tail depth, and (C) overall depth. The dashed lines show the
mean performance of alphabetr applied to ﬁve plates using the high-mixed sampling
strategy and a threshold of 0.6 (values taken from Figure 5.3). (D) The same simula-
tions were performed for populations with 5, 10, and 50 clones representing the top
50%of the clones ranked by frequency. The single-cell sequencing results are averages
of 200 simulations.
CDR3β usage within epitope-speciﬁc populations. The combination of al-
phabetr and relatively low-cost sequencing strategies addresses these issues
by being capable of handling a wide range of clonal structures—skewed
abundances, dual-TCRα clones, sharing of both CDR3α and CDR3β se-
quences among clones—as well as providing estimates of clonal frequencies.
Single-cell technologies clearly allow the identiﬁcation of highly-expand-
ed clones within populations. However, most of the currently available tech-
nologies cannot sample enough single cells to adequately sample the rare
clones of T cell populations. As we have demonstrated, our algorithm offers
the potential to both identify these common clones as well as achieve high
depths of rarer clones that far exceed those currently possible with reason-
able levels of single-cell sequencing. Although TCRβsequencing have been
used a proxy for measuring diversity in T cell populations, the presence of
a signiﬁcant number of CDR3α- and CDR3β-sharing clones would cause
TCRβ-only sequencing to underestimate TCR diversity. Thus, identifying
TCRαβ sequence pairs will be the gold-standard of identifying individual T
cell clones and characterizing clonal diversity of T cell populations. In ad-
dition, establishing the levels of CDR3α- and CDR3β-sharing within popu-
lations details more information about mechanisms of antigen recognition,
repertoire diversity, and the efficiency of recruitment into immune responses.
Our analysis shows that distinguishing betweenCDR3β-sharing and dual-
TCRα clones is a difficult challenge in frequency-based pairing schemes. This
is because the expected patterns of co-occurrences of the three chains un-
der the two situations are very similar when sequencing samples of a few
tens of cells per well since all three chains typically appear in nearly all the
wells. The difference in co-occurrence patterns can be made clearer to an
extent by sampling very few numbers of cells per well, but this approach
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reduces the total sample size of cells sampled, which would sacriﬁce the
depth of identifying rare clones. We might intuitively suppose that upper
limit of 30% prevalence of dual-TCRα clones in the naive T cell pool fa-
vors dual-TCRα over CDR3β-sharing clones. However, this intuition may
not be true in epitope-speciﬁc populations. The numbers of precursor naive
T cell clones may range 10–1000 cells in mice [52, 141, 117], which we
estimate is comparable to or larger than the size of CDR3β-sharing pop-
ulations exported from the thymus (see Section 6.3.3). If the sharing of a
CDR3β among clones confers overlap in their TCR speciﬁcities and recruit-
ment into immune responses is efficient, we might expect to see signiﬁcant
levels of CDR3β-sharing within expanded epitope-speciﬁc populations. In-
deed, as shown in Table 5.1, CDR3β-sharing has been seen to reach lev-
els of up to 25% in responses to inﬂuenza epitopes in naive mice [65, 67]
and almost 40% in secondary responses [67]. It also occurred at a level of
2% in our analysis of CDR3α and CDR3β usage among CD8+ cells speciﬁc
for a YFV epitope in a human volunteer. The CDR3βsharing/dual-TCRα
ambiguity is therefore a robust feature of epitope-speciﬁc responses and is
challenging to unravel fully with statistical approaches.
There are at least three ways to address this problem. One solution is
to pair alphabetr with a set of single-cell samples (e.g. one plate of sin-
gle cells and four plates of mixed sampling). Since the ambiguity is partic-
ularly unclear with abundant CDR3β-sharing and dual-TCRα clones, this
limited amount of extra information may serve to resolve the issue. A sec-
ond approach is to exploit the fact that 30–40% of clones will yield both
an in-frame and an out-of-frame CDR3α sequence [65]. Currently, alpha-
betr does not utilize out-of-frame sequences and could be extended to as-
sociate clones with their out-of-frame sequences. Clones possessing one in-
frame and one out-of-frame CDR3α could then be excluded from the list of
dual-TCRα candidates, which would assist in CDR3β-sharing/dual-TCRα
discrimination. A third possibility is to extend the algorithm to use the se-
quence information and make sequence consensus comparison to determine
a likeliness of two CDR3α pairing with the same CDR3β. If dealing with
epitope-speciﬁc populations, we might expect more sequence similarity in
the CDR3α in two CDR3β-sharing clones than in a dual-TCRα clone, which
have two unlikely related CDR3α sequences; the two TCRα chains rearrange
independently and presumably only one is involved in antigen recognition.
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Identifying dual-TCRβ clones with a frequency-based pairing approach
remains an open problem. Although the frequency of dual-TCRβ clones in
T cell populations has been not well characterized, two single-cell sequenc-
ing studies have clearly demonstrated that such clones have the potential of
existing in T cell populations, albeit in very low frequencies. Since allelic ex-
clusion of the TCRβ chains should be nearly complete, we would not expect
dual-TCRβ clones to be a common occurrence and thus alphabetr not be-
ing able to identify dual-TCRβ clones is not a considerable limitation. And
as we have shown in the simulations, the presence of dual-TCRβ clones does
not appear signiﬁcantly affect the accuracy and depth of pairing TCRs.
In practice, one needs a strategy for implementing alphabetr on a given
sample of T cells with no a priori knowledge of the number or size distribu-
tion of clones. Assuming the number of available T cells is not limiting, we
advocate a high-mixed sampling approach that involves sampling 20-300
cells per well and deals efficiently with a wide range of clonal abundances.
With the alphabetr package implemented in R, a standard desktop com-
puter with 16 Gb of RAM is able to handle samples from parent distribu-
tions of up to 4000 clones. When sampling populations with much fewer
clones, lower numbers of cells/well are needed to avoid high false pairing
rates. Assuming cell numbers are not limiting, bulk sequencing of the TCRβ
chain could be used to gain a rough estimate of the richness of the parent
distribution and so indicate when a sparse sampling strategy would be ben-
eﬁcial. In situations where cell numbers are limiting, one approach could be
to begin with a single plate of 10 cells/well to obtain a rough lower bound
on the richness of the distribution and apply a low or high mixed sampling
strategy with the remaining cells from the sample, as appropriate. The sin-
gle plate of 10 cells/well is then still usable for the pairing process and for
frequency estimation.
Finally, we stress the importance of obtaining paired TCR sequences and
identifying a representative sample of TCRs of the repertoire of interest.
For example, studies that employed TCRβ sequencing have come to erro-
neous conclusions because of the lack of TCRα information. Cukalac et al.
found that the sequences of clones responding to the inﬂuenza NP366 peptide
from different mice have identical CDR3β sequences that pair with differ-
ent CDR3α sequences [67]. If the study had been performed with TCRβ
sequencing, the results would suggest that these clones are identical, lead-
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ing to the false conclusion that there exists a dominant “public” TCR for
DbNP366-speciﬁc cells. Until single-cell sequencing can sample many thou-
sands of clones, alphabetr is an important way of obtaining a representa-
tive sample of paired TCR sequences of antigen-speciﬁc T cell populations.
It should be noted that the advantages of large sample sizes from frequency-
based pairing approaches come at the cost of identifying false pairs. pairSEQ
attempts to minimize false pairs by estimating a false determining rate while
alphabetr attempts to constrain the rate of identifying false pairs with the
threshold parameter. In research applications, the economical and biological
advantage of identifying many thousands of TCR pairs outweighs this disad-
vantage. However, in clinical applications, false pairs may not be tolerable
and perfectly correct pairs might be needed through single-cell sequencing.
Frequency-based pairing and single-cell sequencing technologies can com-
plement each other and should be used according to the research question
and the application.
While we have framed most of our analysis around the sequencing of
epitope-speciﬁc populations, alphabetr can equally well be applied more
generally to T cell populations of restricted and potentially skewed polyclon-
ality, such as tumor inﬁltrating lymphocytes or T cells extracted from sites
of autoimmune responses. It therefore has immediate applications in can-
cer immunotherapy and other personalized immunomodulatory treatments.
Until single cell sequencing becomes more affordable, frequency-based pair-
ing methods provide a rapid and economical means of characterizing the
clonal structure of T cell populations.
5.5 detailed description of the algorithm
We present a detailed description of the algorithm in Sections 5.5.1–5.5.4
and a description of the simulated immunodominance hierarchies in Sec-
tion 5.5.5. The equations presented in this chapter are derived in Section 5.5.6.
5.5.1 Determining αβ pairs
Our approach uses the fact that CDR3α and CDR3β sequences (referred to
as α and β chains) from the same clone will tend to appear together in wells.
Let Nα be the total number of unique α chains, Nβ be the total number of
unique β chains, and the α and β chains found in the data set be labeled from
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α1 to αNα and from β1 to βNβ respectively. Let W be the number of wells
used to collect the sequencing data. The association score between chains αi
and βj is measured by a score
Sij =
W∑
k=1
(
δkij
ckα
+
δkij
ckβ
)
, (5.1)
where the wells in the data are labelled from 1, 2, . . ., W, the numbers of
distinct α and β chains in well k are ckα and c
k
β respectively, and δ
k
ij is 1 if both
αi and βj are found in well k and 0 otherwise. Equation 5.1 adds the inverse
of the total number of α chains found in the well to the inverse of the total
number of β chains found in the well and then sums these for all wells where
αi and βj co-appear. The scaling accounts for the fact that a larger number of
unique chains recovered in a well lowers our conﬁdence that a co-occurring
α and β pair derive from the same clone.
The algorithm begins by sampling a proportion pJ of the wells in the data
without replacement. For all analyses presented here, we used pJ = 0.75,
which provided a good balance between depth and false pairing rate. The
algorithm computes the association scores between every unique α and β
chain using Equation 5.1 based on the sampled subset of wells. LetAk denote
the set of A distinct α chains found in well k, that is,
Ak =
{
αmk1
, αmk2
, . . . , αmkA
}
,
where the mki ∈ {1, . . . ,Nα} are integers that denote the labels of the A
TCRα chains found in well k. Similarly, let Bk denote the set of B distinct β
chains found in well k, that is,
Bk =
{
βnk1
, βnk2
, . . . , βnkB
}
,
where the nki ∈ {1, . . . ,Nβ} subscripts denotes the labels of the B TCRβ
chains found in well k. The algorithm solves the following linear assignment
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problem using the Hungarian algorithm [136]:
maximize
∑
αi∈Ak
∑
βj∈Bk
Sijxij
subject to
∑
αi∈Ak
xij = 1 for βj ∈ Bk∑
βj∈Bk
xij = 1 for αi ∈ Ak
xij ≥ 0, αi ∈ Bk, βj ∈ Ak,
(5.2)
where xij = 1 indicates that αi and βj are assigned as a candidate TCR pair
and xij = 0 otherwise.
A pair αi and βj is deﬁned as an assigned pair of well k if xij = 1 for the
solution of Equation 5.2 associated with well k. The number of assignments
made for every pair of α and β is recorded asXij, i.e.Xij equals the number of
times xij = 1 from the solutions of Equation 5.2 for each well in the subset.
We then calculate a ﬁlter level F that determines the minimum number of
assignments required for an assigned candidate pair of α and β chains to be
determined as a true TCR pair. This ﬁlter level is calculated as the mean of
the number of associations of every αβ pair that had at least one association,
namely F is the mean of the set{
N(i, j) : N(i, j) > 0, i ∈ 1,2, . . . , nα , j ∈ 1,2, . . . , nβ
}
,
where N(i, j) is the number of times αiβj are assigned to each other and nα
and nβ are the number of unique α and β sequences found across the wells
respectively. We then choose the pairs that had more associations than F,
i.e. pairs αiβj such that Xij > F. The output of this algorithm is then a list of
candidate αβ pairs that may be associated with a T cell clone. At this stage,
dual-TCRα cells are not identiﬁed; thus a dual-TCRα clone αiαjβ may be
represented in this list as one or both of αiβ and αjβ.
The procedure above is performed Nr times on random subsets of the
wells (all simulations in this paper use Nr = 100), and each replicate yields
a list of candidate αβ pairs. We then perform a ﬁltering or consensus step
in which only αβ pairings that appear in more than a threshold proportion
T of these lists are retained as candidates. This threshold T is chosen by the
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Number of top clones Overall Depth Top Depth Tail Depth False Pairing
5 25.3% 68.1% 25.2% 42.1%
10 25.5% 84.0% 25.3% 42.0%
25 17.6% 87.7% 16.9% 26.0%
50 18.2% 88.5% 88.5% 27.4%
Table 5.6: Simulations without the resampling procedure. Simulations were per-
formed by pairing CDR3α and CDR3β sequences using the information from all wells
at the same time instead of pairing using multiple resampled subsets of the wells as
described in Section 5.5.1. These simulations show the unsatisfactory results from not
using the resampling approach, particularly in the high false pairing rates and low tail
depths. 100 simulations were performed for each level of skew in the immunodomi-
nance hierarchies.
user of the algorithm. The simulations presented before explore thresholds
of T = 0.3, T = 0.6, and T = 0.9.
5.5.2 Justiﬁcation of the resampling procedure
The resampling procedure is performed in order to reduce the false pairing
rate and increase the depth of the rare clones. Applying the pairing procedure
to all of the wells all at once—namely, pair CDR3α and CDR3β sequences
using all of the wells—results in very high false pairing rates with low depth.
In order to demonstrate this, we performed simulations (Table 5.6) to show
how not resampling hurts the depth and false pairing rates.
Two intuitive reasons explain why resampling improves pairing perfor-
mance. First, false pairing rates dramatically fall because resampling al-
lows us to depend on consensus across many pairing attempts to ﬁnd true
TCR pairs. Since we are sampling many different subsets of the data, true
CDR3α/CDR3β pairs will be paired together many more times than than
spurious pairs. Second, resampling allows for the discovery of rare clones
by preventing common clones from masking the pairing relationships of the
CDR3α and CDR3β sequences of rare clones. Common clones will tend to
appear in many wells and thus appear together with rare clones; this can
mask the presence of any rare clones. By resampling different subsets of the
wells, we allow for the possibility of rare clones to be represented by ﬁnd-
ing conﬁgurations of wells that do not mask the rare clones. Resampling is
a standard technique used in many statistical learning algorithms, and we
found that it is the crux of the success of alphabetr.
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5.5.3 Maximum-likelihood estimation of clonal frequencies
We use maximum likelihood estimation to infer clonal frequencies based
on the number of wells in which a pair of α and β chains both appear. We
form a likelihood that models the process of sampling cells from a parent
population and the error processes that occur during sequencing.
Let N = {n1, n2, . . . , ns} be the set of s distinct sample sizes (ni cells
per well) in all of the wells and W = {w1, w2, . . . , ws} be a set where wi
represents the number of wells with samples of size ni cells. Let cij denote the
clone with chains αi and βj, and let k
l
ij denote the number of wells of sample
size nl cells per well that contain chains αi and βj. The observed incidence
of clone cij in the data is then the set Kij = {k1ij,k2ij, . . . , ksij}. The likelihood
of the observing the data Kij for clone cij with a frequency fij within the
population is given by
L(Kij | fij) = s∏
l=1
(
wl
klij
)
(1− ql)k
l
ij q
wl−klij
l (5.3)
where ql is the probability of clone cij not being found in well l and is
ql =
(
1− fij
)nl + nl∑
m=1
(
2εm − ε2m
)(nl
m
)
fmij
(
1− fij
)nl−m . (5.4)
Here ε is the average probability that a CDR3 sequence in a cell fails to
be ampliﬁed and sequenced. For every clone cij, the algorithm ﬁnds the
maximum-likelihood estimate fˆij of Equation 5.3 to estimate its frequency,
and 95% conﬁdence intervals are deﬁned by solving for the frequencies f˜ij
that satisfy loglik
(
f˜ij
)
= loglik
(
fˆij
)−1.96. Details of the derivation of Equa-
tions 5.3 and 5.4 are given in Section 5.5.6.
This procedure is applied to every αβ pair identiﬁed in the ﬁrst phase
of the algorithm. These estimated frequencies are then used to distinguish
TCRβ-sharing clone pairs from single TCR clones expressing two TCRα,
described in Section 5.5.4.
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When a dual-TCRα clone is identiﬁed, we revise the frequency estimation
as follows. Let c(ij)t denote a clone with chains αi, αj, and βt, and k
l
(ij)t denote
the number of wells of size nl that contain chains αi, αj, and βt. The likeli-
hood of the observations given that clone c(ij)t has a frequency f(ij)t ∈ (0,1]
is
L(observed incidence of clone c(ij)t | f(ij)t) =
s∏
l=1
(
wl
kl(ij)t
)
(1− ql)k
l
(ij)t q
wl−kl(ij)t
l
(5.5)
where ql is the probability of clone c(ij)t not being found in well l and is given
by
ql =
(
1− f(ij)t
)nl + nl∑
m=1
(
3εm − 3ε2m + ε3m
)(nl
m
)
fm(ij)t
(
1− f(ij)t
)nl−m (5.6)
where ε is the mean drop rate as described above. For every clone c(ij)t, the
algorithm ﬁnds the maximum-likelihood estimate fˆ(ij)k for Equation 5.5, and
again loglik
(
f˜(ij)t
)
= loglik
(
fˆ(ij)t
)−1.96 is used to calculate 95% conﬁdence
intervals.
5.5.4 Discriminating between dual-TCRα and shared TCRα chains
If the algorithm pairs two clones that appear to share a CDR3β (e.g. αiβ and
αjβ), we must decide whether this is indeed a CDR3β-sharing pair of clones
or that the association derives from one dual-TCRα clone (e.g. αiαjβ). To do
this, we use the likelihoods of observed co-occurrences of the three chains
to assess the relative support for the two alternatives.
Suppose cij = (αi, βj) and ckj = (αk, βj) are two putative clones with a
common β chain βj. We count the number of wells containing all three-way,
two-way, and single appearances of the three chains. We then calculate the
“full” likelihoods of this pattern of occurrences under two hypotheses:
HX: cij and ckj are indeed two β-sharing clones, with frequencies fij and fkj
estimated using Equation 5.3
HY: The chains derive from one dual-TCRα clone c(ij)k present at frequency
f(ij)k, estimated using Equation 5.5.
175
If the difference between the log-likelihoods under these two hypothesis
is greater than or equal to 10, i.e. loglik
(
data|HY
)− loglik(data|HX) ≥ 10,
we assume the three chains derive from a dual-TCRα clone. Thus, if chains
αi, αk, and βj are identiﬁed to derive from a dual-TCRα clone, then clones
cij and ckj are removed from the list of TCR pairs and replaced with a dual-
TCRα clone αiαkβj.
These full likelihoods (derived in Section 5.5.6) are computationally in-
tractable for wells with greater than 50 cells due to the need to calculate
large multinomial coefficients. The full-likelihood method is therefore only
appropriate for estimating frequencies of relatively abundant clones since
they are more likely than rare clones to be found in the wells with smaller
sample sizes.
As an alternative, we use a more restricted likelihood-based approach for
discriminating CDR3β-sharing and dual-TCRα among rare clones, which
tend to appear only in wells of larger sample sizes. Let clones cij = (αi, βj)
and ckj = (αk, βj) be two clones with a common beta chain βj, and let fij
and fjk be their respective estimated frequencies. The algorithm calculates
the ratio rjik of the observed to the expected number of wells in which all
three chains from the putative β-sharing pair cij and cjk co-appear, under the
hypothesis that they are indeed two clones and not a dual-TCRα clone.
This results in a set R of ratios
R =
{
rjik =
A
(
cij, ckj
)
E
(
cij, ckj
) : i ̸= k, i, j ∈ 1,2, . . . ,Nβ
}
(5.7)
where A(cij, ckj) is the number of times clones cij and ckj are observed to
appear in the same well and Nβ is the number of distinct β chains, and the
expected number is
E
(
cij, ckj
)
=
s∑
l=1
wl
(
1− (1− fij)nl − (1− fkj)nl + (1− fij − fkj)nl) . (5.8)
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Equations 5.7-5.8 are derived in Section 5.5.6. We then partition the set
of ratios R into two groups C1 and C2 using k-means clustering, where the
mean of ratios of C1 is greater than the mean of the ratios of C2. The clones
associated with the ratios in C1 are chosen as dual TCR clones, such that if
rjik ∈ C1, then clones cij and ckj are removed from the list of TCR pairs and
replaced with a dual-TCRα clone αiαkβj.
The frequencies of the dual-TCRα clones identiﬁed by these procedures
are then estimated using Equation 5.5, and the ﬁnal output of the algorithm
is a list of single and dual-TCRα clones and their clonal frequencies.
5.5.5 Creation of in silico data sets for validation
We created synthetic data sets reﬂecting the properties of antigen-speciﬁc T
cell populations and sequencing errors. The data sets were sampled from
a population of T cell clones where a signiﬁcant proportion of α and β
chains are shared and 10%-30%of clones have dual-TCRα chains (e.g. three
clones can have the following chains: αiβk, αjβk, and αjαhβl). The sharing
of CDR3α and CDR3β sequences were set at levels shown in Table 5.1. We
determined these levels of sharing by averaging those from the published
single-cell data shown in Table 5.1.
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The frequencies of the N clones were drawn from a skewed distribution
in which ns clones comprise a proportion ps of the population and the other
N−Ns clones evenly represent 1− ps of the population. The clone ranked
ith in abundance then has frequency fi where
fi =
f1 + r (i− 1) if i = 1, 2, . . . , nsps/(N− ns) if i = ns + 1, ns + 2, . . . , N (5.9)
where the frequency of the largest clone f1 and the step size r are determined
by solving the equations
ns∑
i=1
fi = ps, fns = 1.1×
ps
N− ns . (5.10)
The frequency of the smallest clone in the top 50%, fns , is set to be 10%
higher than the frequency of the clones in the tail. All simulations were based
on ps = 0.5. We varied the number of top clones ns between 5 to 50 to test
how skew in the antigen-speciﬁc T cell population affects the performance
of the algorithm.
In order to make the simulated data more realistic, experimental noise
was included in the forms of ‘dropped’ chain errors and in-frame sequencing
errors. Dropped chains are CDR3 sequences that fail to be sequenced due
to PCR errors and/or sorting problems, and studies utilizing both single-cell
and many-cell techniques have reported average drop rates of 8% to 10%
[69, 1]. In the simulations, each clone was assigned a drop rate from a log-
normal distribution with a mean of 0.15 and standard deviation of 0.01, and
every TCRα and TCRβ chain belonging to that clone was assigned that drop
rate. In-frame errors cause a CDR3 sequence to be falsely identiﬁed with an
incorrect productive nucleotide and/or amino acid sequence. In the simula-
tions, each distinct sequence was assigned an in-frame error rate drawn from
a lognormal distribution with a mean of 0.02 and a standard deviation of
0.005. The error model was simulated as follows: when a cell is sampled into
a virtual well, each of its chains fails to be sequenced with probability equal
to the pre-assigned, clone-speciﬁc drop rate. Every surviving chain produces
one of three randomly chosen, distinct, and chain-speciﬁc false sequences
with probability equal to that chain’s pre-assigned in-frame error rate.
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5.5.6 Derivations
Derivation of the frequency estimation likelihood
The maximum likelihood approach for clonal frequency estimation involves modeling how
a clone is sampled in the wells of the plates. Since we assume conservatively that sequencing
does not give any quantitative information about the number of times a clone is sampled in
a well, the data fed to alphabetr indicate only whether a given CDR3α or CDR3β sequence
is present in each well. Let s denote the number of distinct sample sizes placed in the wells,
N = {n1, n2, . . . , ns} be the set of s distinct sample sizes where ni is number of cells per
well, and W = {w1, w2, . . . ,ws} be the set where wi represents the number of wells with
sample size ni. Let cij denote the clone with chains αi and βj, and let k
l
ij denote the number
of wells of size nl cells per well that contain αi and βj.
The likelihood of clone αiβj appearing in k
l
ij wells of sample size nl cells for l = 1, . . . , s
is the probability of the clone being sampled in klij out of the wl possible wells, which is
P
(
klij wells | frequency fij
)
=(
wl
klij
)
P
(
clone sampled in well of size nl
)klij×
(
1− P(clone sampled in well of size nl))wl−klij
(5.11)
We deﬁne ql = 1 − P(clone sampled in well of size nl), which the probability of clone αiβ
not being sampled in a well of size nl. We then rewrite Equation 5.11 as
P
(
klij wells | frequency fij
)
=
(
wl
klij
)
(1− ql)k
l
ij q
wl−klij
l (5.12)
Since the klij appearances are independent, the probability of observing is determined by
summing Eq (5.11) for all sample sizes and is given by
P(k1ij, k
2
ij, . . . , k
s
ij wells | frequency fij) =
s∏
l=1
(
wl
klij
)
(1− ql)k
l
ij q
wl−klij
l , (5.13)
which is Equation 5.3.
The probability ql is calculated by adding the probabilities of all of the events that would
result in the clone not being sampled in the well, which are:
• A: clone αiβj not being sampled at all
• B: clone αiβj is sampled m ≤ nl times (resulting in m copies of chains αi and βj), all
m copies of αi are dropped, and at least 1 copy of βj is not dropped
• C: clone αiβj is sampled m ≤ nl times, at least 1 copy of αi chain is not dropped, and
all m copies of βj are dropped
• D: clone αiβj is sampled m ≤ nl times, and all m copies of αi and m copies of βj are
dropped.
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The probability of event A is given by
P(A) = (1− fij)nl (5.14)
Events B and C are symmetric, and the probability of these events is the probability that the
clone will be sampled m ≤ nl times multiplied by the probability of dropping all of one of
the chains and not dropping at least one of the other chains. This is given by
P(B) = P(C) =
nl∑
m=1
(
nl
m
)
(fij)
m (1− fij)nl−m εm (1− εm) (5.15)
where εm is the probability of dropping m of one of the component chains. The probability
of event D is derived similarly:
P(D) =
nl∑
m=1
(
nl
m
)
(fij)
m (1− fij)nl−m εmεm. (5.16)
Summing these yields Equation 5.4.
The likelihood for dual clones is obtained in a similar fashion, where ql is calculated by
summing the probabilities of the clone not being sampled at all and of being sampled but
dropping one, two, or all three of the clone’s chains.
Derivation of k-means approach
The ratios in calculated in Equation 5.7 involve the expected number of wells in which the
three chains αiαjβ co-occur under the assumption that they derive from two CDR3β-sharing
clones αiβ and αjβ. Let cij and ckj be two clones that share βj. Let A
l
ij and A
l
kj denote the
events of sampling clones cij and ckj in a well of size nl cells respectively and A
l C
ij and A
l C
kj
denote the complement of these events. The probability of sampling both clones in a well of
nl cells is then
P(Alij ∩ Alkj) = 1− P(Al
C
ij ∪ Al
C
kj )
= 1−
(
P(Al
C
ij ) + P(A
l C
kj )− P(Al
C
ij ∩ Al
C
kj )
) (5.17)
In calculating Eq (5.17), including the effect of stochastic dropping of chains results in large
multinomial coefficients that cannot be computed efficiently for wells with larger sample sizes
(approximately ≥ 50 cells per well). Heuristically, however, neglecting the drop rate has no
impact on discrimination of CDR3β-sharing and dual-TCRα clones. We then have
P(Al
C
ij ) = (1− fij)nl (5.18)
P(Al
C
ik ) = (1− fkj)nl (5.19)
P
(
Al
C
ij ∩ Al
C
kj
)
=
(
1− (fij + fkj)
)nl (5.20)
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By substituting Eqs (5.18)-(5.20) into Eq (5.17) and multiplying by wl (the total number of
wells of size ni), we obtain the expected number of wells of size ni that contain both clones:
E
(
cij, ckj
)
= wl
(
1− (1− fij)nl −
(
1− fkj
)nl + (1− fij − fkj)nl). (5.21)
By summing this quantity over all wells and sample sizes, we obtain Equation 5.8, which
forms the denominator of the ratios in R (Equation 5.7). With inclusion of the drop rate,
this ratio should be close to 1 for a true β-sharing pair; neglecting dropping shifts this ratio
to higher values, as seen in the left-hand cluster in Figure 5.6, but discrimination of CDR3β-
sharing and dual-TCRα is still possible. The computational limitation on the calculation of
multinomial coefficients does not exist for wells with smaller sample sizes, and so likelihoods
can be directly calculated for clones that appear in these smaller wells, which explore in the
next section.
Derivations of the full likelihoods
Discriminating between relatively abundant CDR3β-sharing clones and dual-TCRα clones
requires comparing the likelihoods of the data under these two hypotheses. Let αqβ and αrβ
be a pair of candidate TCRs that share the same βchain with frequencies fq and fr respectively.
Given the data have wells of s distinct sample sizes, we record the numbers of wells of each
sample size that contain all three chains (αq, αr, β) or contain only two of the three.
For i ∈ {1, 2, . . . , s}, let
• k1i = the number of wells of sample size ni containing chains β and αq only
• k2i = be the number of wells of sample size ni containing chains β and αr only
• k3i = be the number of wells of sample size ni containing chains αq and αr only
• kdi = be the number of wells of sample size ni containing all three chains β, αq, and
αr
• koi = wi − k1i − k2i − k3i − kdi be the number of wells of sample size ni that contain
none of the chains or only one of the three chains.
For chains a, b, and c, letWiabc,W
i
ab,W
i
a, andW
i
∅ denote the events of ﬁnding exactly chains
a, b, c, ﬁnding exactly chains a and b, ﬁnding exactly chain a, and ﬁnding none of the chains
in a well of sample size ni respectively. As before, let wi denote the number of wells with
sample size ni cells per well, and let s be the number of distinct sample sizes.
The likelihood of observing the data
K =
{
k1i , k
2
i , k
3
i , k
d
i , k
o
i : k = 1, 2, . . . , s
}
under the hypothesis that αqβ and αrβ represent two β-sharing clones is
L(K|clone αqβ with frequency fq, clone αrβ with frequency fr) =
s∏
i=1
wi!
k1i !k
2
i !k
3
i !k
d
i !k
o
i !
P(Wiαqβ)
k1i P(Wiαrβ)
k2i P(Wiαqαr)
k3i P(Wiαqαrβ)
kdi × (5.22)
P(Wiαq ∪Wiαr ∪Wiβ ∪Wi∅)k
o
i
181
where
P(Wiαqβ) =
ni∑
k=1
(
ni
k
)
fkq (1− fq − fr)ni−k
(
1− εk
)2
+
ni−1∑
n1=1
ni−n1∑
n2=1
ni!
n1!n2! (ni − n1 − n2)! f
n1
q f
n2
r (1− fq − fr)ni−n1−n2 (1− εn1)2 εn2+
ni−1∑
n1=1
ni−n1∑
n2=1
ni!
n1!n2! (ni − n1 − n2)! f
n1
q f
n2
r (1− fq − fr)ni−n1−n2 (1− εn1) εn1 (1− εn2) εn2
P(Wiαrβ) =
ni∑
k=1
(
ni
k
)
fkr (1− fq − fr)ni−k
(
1− εk
)2
+
ni−1∑
n2=1
ni−n2∑
n1=1
ni!
n1!n2! (ni − n1 − n2)! f
n1
r f
n2
q (1− fq − fr)ni−n1−n2 (1− εn2)2 εn1+
ni−1∑
n2=1
ni−n2∑
n1=1
ni!
n1!n2! (ni − n1 − n2)! f
n1
r f
n2
q (1− fq − fr)ni−n1−n2 (1− εn1) εn1 (1− εn2) εn2
P(Wiαqαr) =
ni−1∑
n1=1
ni−n1∑
n2=1
ni!
n1!n2! (ni − n1 − n2)! f
n1
q f
n2
r (1− fq − fr)ni−n1−n2 εn1 (1− εn1) εn2 (1− εn2)
P(Wiαqαrβ) =
ni−1∑
n1=1
ni−n1∑
n2=1
ni!
n1!n2! (ni − n1 − n2)! f
n1
q f
n2
r (1− fq − fr)ni−n1−n2 εn1 (1− εn1) (1− εn2)2+
ni−1∑
n1=1
ni−n1∑
n2=1
ni!
n1!n2! (ni − n1 − n2)! f
n1
q f
n2
r (1− f1 − f2)ni−n1−n2 (1− εn1)2 (1− εn2)2+
ni−1∑
n1=1
ni−n1∑
n2=1
ni!
n1!n2! (ni − n1 − n2)! f
n1
q f
n2
r (1− fq − fr)ni−n1−n2 (1− εn1)2 εn2 (1− εn2)
P(Wiαq ∪Wiαr ∪Wiβ ∪Wi∅) = 1− P(Wiαqβ)− P(Wiαrβ)− P(Wiαqαr)− P(Wiαqαrβ)
The likelihood of observing the data K =
{
k1i , k
2
i , k
3
i , k
d
i , k
o
i : k = 1, 2, . . . , s
}
under the
hypothesis that αqβ and αrβ represent one dual TCRα clone αqαrβ is
L(K|clone αqαrβ with freq fd) =
s∏
i=1
wi!
k1i !k
2
i !k
3
i !k
d
i !k
o
i !
P(Wiαqβ)
k1i P(Wiαrβ)
k2i P(Wiαqαr)
k3i P(Wiαqαrβ)
kdi
P(Wiαq ∪Wiαr ∪Wiβ ∪Wi∅)k
o
i
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where the terms are given by
P(Wiαqβ) = P(W
i
αrβ) = P(W
i
αqαr) =
ni∑
k=1
(
ni
k
)
fkd (1− fd)ni−k εk
(
1− εk
)2
P(Wiαqαrβ)
kdi =
ni∑
k=1
(
ni
k
)
fkd (1− fd)ni−k
(
1− εk
)3
P(Wiαq ∪Wiαr ∪Wiβ ∪Wi∅) = 1− P(Wiαqβ)− P(Wiαrβ)− P(Wiαqαr)− P(Wiαqαrβ) .
The derivation of P(Wiαqβ) term for the two β-sharing clone hypothesis is shown below,
and the other terms can be derived in a similar fashion. We begin by writing down the events
that would result in a well containing the chains αq and β exactly (illustrated in Figure 5.14):
• Ai: clone αqβ is sampled in the wellwi and at least 1 αq and β not dropped from clone
αqβ, clone αrβ not sampled
• Bi: clone αqβ is sampled in the well wi and at least 1 αq and β not dropped from clone
αqβ, clone αrβ is sampled and all αr are dropped and at least 1 β not dropped from
clone αrβ
• Ci: clone αqβ is sampled in the wellwi and at least 1 αq not dropped and all β dropped
from clone αqβ, clone αrβ is sampled and all αr are dropped and at least one β not
dropped
For event Ai, we ﬁrst calculate the probability of the two independent events of (i) sam-
pling clone αqβ without sampling clone αrβ and (ii) not dropping all of the αq and β chains
of the sampled αqβ clone. For the former, we calculate the probability of sampling clone αqβi
from 1 to ni times while not sampling αrβi. Each of ni cells in the well has a probability of fq
of being clone αqβi and a probability 1− fq− fr of not being clone αqβi or αrβi, which follows
a binomial distribution. For the latter, each chain has a probability ε of being dropped, so if
i cells are sampled as clone αqβ, then the probability of dropping all αq chains from those i
cells is 1− εi (and similarly 1− εi for the β chains. Combining these, we get
ni∑
k=1
(
ni
k
)
fkq (1− fq − fr)ni−k
(
1− εk
)2
We then calculate the probability of (i) sampling clone αqβ n1 times, sampling clone αrβ n2
times, and sampling any other clone ni − n1 − n2 times, (ii) not dropping all of the αq and β
chains of the sampled αqβ cells, and (iii) dropping all of the αr and β chains of the sampled
αrβ cells. This is a multinomial distribution of the three sampling events multiplied by the
probability of not dropping all of the chains of clone αqβ while dropping all of the chains of
αrβ, which is
ni−1∑
n1=1
ni−n1∑
n2=1
ni!
n1!n2! (ni − n1 − n2)! f
n1
q f
n2
r (1− fq − fr)ni−n1−n2 (1− εn1)2 ε2n2
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αrβ:
Clone 2 sampled,
at least one αr and
one β not dropped
αqβ:
Clone 1 sampled,
at least one αq and
one β not dropped
β:
Clone 2 sampled,
all αr dropped,
at least one β
not dropped
β:
Clone 1 sampled,
all αq dropped,
at least one β
not dropped
αr:
Clone 2 sampled,
all β dropped,
at least one αr
not dropped
αq:
Clone 1 sampled,
all β dropped,
at least one αq
not dropped
none:
Clone 2 not sampled
  or
Clone 2 sampled,
drop all chains
none:
Clone 1 not sampled
  or
Clone 1 sampled,
drop all chains
No chains
in well
αr αqαrαrβ αqαrβ
β αqββ αqβ
αrβ αqαrβ αqαrβαrβ
αqβ αqβ
Events of clone αrβ
Events of
clone αqβ
Event Ai
Event BiEvent Ci
Chains found in the well
Figure 5.14: Sample space for calculating likelihoods of two- and three-way co-
occurrences of chains under the hypotheses of CDR3β-sharing. The events labeled
in red represent all of the possible ways a well could contain the chains αq and β from
two β-sharing clones αqβ and αrβ.
Adding these two together, we get
P(Wiαqβ) =
ni∑
k=1
(
ni
k
)
fkq (1− fq − fr)ni−k
(
1− εk
)2
+
ni−1∑
n1=1
ni−n1∑
n2=1
ni!
n1!n2! (ni − n1 − n2)! f
n1
q f
n2
r (1− fq − fr)ni−n1−n2 (1− εn1)2 ε2n2
For event B, we calculate the probability of n1 cells being sampled as αqβ, n2 cells being
sampled as αrβ, and ni − n1 − n2 cells being sampled as neither of the two clones, where
n1 ≥ 1, n2 ≥ 1, n1 + n2 ≤ n. This looks like a multinomial distribution of three events with
probabilities fq, fr, and 1−fq−fr occurring n1, n2, and ni−n1−n2 times. This is multiplied by
the probability of not dropping all of the chains from the n1 cells of clone αqβ, not dropping
all of the β chains from the n2 cells of clone αrβ, and dropping all αq chains from the n2 cells
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of clone αrβ. Then
ni−1∑
n1=1
ni−n1∑
n2=1
ni!
n1!n2! (ni − n1 − n2)! f
n1
q f
n2
r (1− fq − fr)ni−n1−n2 (1− εn1)2 εn2 (1− εn2) (5.23)
For event C, we calculate a similar multinomial probability as above and multiply it by
the probability of dropping all β chains from the n1 cells of clone αqβ, not dropping all αq
chains from the n1 cells of clone αqβ, dropping all of the αr chains from n2 cells of clone αrβ,
and not dropping all of the β chains from the n2 cells of clone αrβ. From this,
ni−1∑
n1=1
ni−n1∑
n2=1
ni!
n1!n2! (ni − n1 − n2)! f
n1
q f
n2
r (1− fq − fr)ni−n1−n2 (1− εn1) εn1 (1− εn2) εn2 (5.24)
Since P(Wiαqβ) = P(Ai) + P(Bi) + P(Ci), we add all three expressions to obtain the term as
stated above.
We assessed empirically that if the difference between the logarithms of the likelihoods
in Eq (5.23) and Eq (5.22) is greater than or equal to 10, then chains αq, αr, and β should
be assumed to comprise a dual-TCRα clone. As noted before, the multinomial coefficients
contained in these equations are computationally limiting for wells of large sample sizes,
and so calculations of these likelihoods include only wells of sample sizes less than 50 cells
per well. Since these wells are most likely to contain the common clones, this approach is
applicable to distinguishing common CDR3β-sharing and dual-TCRα clones.
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C H A P T E R  6

Identifying paired TCR sequences with the stable
matching problem
6.1 introduction to matching problems
Before alphabetr was developed, we imagined a process that would match
TCRα and TCRβ chains together to ﬁnd a set of “optimal” partnerships
for all chains that would result in the identiﬁcation of correct TCR pairs.
This idea appeared analogous to a class of algorithms used to solve prob-
lems called matching under preferences [142, 143]. The agents involved in
these matching processes have preferences for each other, and the algorithms
assign a globally optimal set of partnerships for all agents.
These algorithms have been applied to many important problems, such
as matching kidney patients to donors and assigning students to universities
[142]. A well-known application of these algorithms is used in the National
Resident Matching Program (NRMP), a process that pairs graduating medi-
cal students to residency training programs in the United States.1 The intro-
duction of the NRMP transformed a chaotic and competitive process into
a formal, methodical procedure for ﬁnding a set of matchings that is ‘op-
timal’ for both the trainees and the hospitals. Before the NRMP, hospitals
would compete with each other for desirable candidates by offering posi-
tions as early as possible while applicants would delay accepting positions
as late as possible in hopes of getting better offers. This resulted in mayhem
that included contracts being made up to two years before the start of the
training programs and offers that would expire as soon as 12 hours to co-
erce trainees to accept. In the NRMP, medical students rank their preferred
training programs, the hospitals rank their preference of students, and the
NRMP algorithm determines an optimal matching that is given to all par-
ticipants at the same time.
The classic version of these problems is known as the stable marriage
problem, which attempts to ﬁnd one-to-one matches between two equally-
sized groups that is optimal for all participants. In its original formulation,
1Recently graduated medical students who are working in training programs (called resi-
dencies) are called residents, a term signifying trainees who are approximately equivalent to
junior doctors in the United Kingdom who are undertaking their ﬁrst few years of training.
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the stable marriage problem matches a group of men to a group of women,
where each man has an ordered list of his preferences of all of the women
and each woman has an ordered list of her preferences of all of the men. An
algorithm called the Gale-Shapley algorithm ﬁnds an optimal solution by
ﬁnding a stable matching. Deﬁning stability forms the foundation of these
algorithms; in the stable marriage problem, a stable matching is one that is
not unstable, and an unstable matching occurs when a pair of unmatched
participants can undermine the matching by choosing each other over their
matched partners. A surprising but elegant result of the Gale-Shapley algo-
rithm is it guarantees at least one stable matching for any instance of the
stable marriage problem.
The hospital-residents (HR) problem generalizes the stablemarriage prob-
lem and, and hospital-oriented Gale-Shapley (HGS) algorithm solves the
matching problem for graduating medical students and hospitals. Hospitals
specify the maximum number of residency spots and thus multiple residents
can be matched to a single hospital. Residents rank only their preferred hos-
pitals in their preference lists, and hospitals rank only their preferred resi-
dents. These partial preference lists contrast with the stable marriage prob-
lem, where each person has to rank every person of the other group. The
HGS algorithm also always guarantees at least one stable matching (depen-
dent on an appropriate deﬁnition of stability deﬁned later).
We adapted the same data used for alphabetr to draw an analogy be-
tween the hospital-residents problem andmatching TCRβ and TCRα chains.
The chains have partial preference lists for each other based on their co-
occurrences, and the possibility of matching multiple partners theoretically
allows for the identiﬁcation of dual-TCRα clones. We ﬁnd that our adap-
tation works only the case where CDR3α-sharing, CDRβ-sharing, and dual
TCRs do not occur in the repertoire, but we discuss the potential for these
algorithms to be extended for pairing TCRs of naive T cell populations.
We will begin by overviewing the details of the stable marriage problem
and the hospital-residents problem in Sections 6.1.1–6.1.2. We then describe
how the sequencing data is processed as input for the hospital-residents
problem in Section 6.2. Sections 6.3.1–6.3.3 describe simulations that test
the accuracy and precision of this approach and what its limitations are. Fi-
nally, Section 6.4 will wrap up the chapter with a discussion about possible
extensions of these algorithms.
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6.1.1 Gale-Shapley algorithm and the stable marriage problem
The stable marriage problem attempts to ﬁnd a stable matching between a
group of nmen and a group of n women. Each person has a strictly ordered
preference list of all the members of the opposite group. If person A prefers
b over c, then b precedes c on the preference list of person A. A match-
ing M is a one-to-one correspondence between the group of men and the
group of women; namely, each man is matched with exactly one woman
and each woman is matched with exactly one man. If man m and woman
w are matched together in M, then we denote this as m = pM(w) (read as
m is the partner of w in matchingM) and w = pM(m). A matching is unsta-
ble if there exist a blocking pair, which is a man m and woman w who are
unmatched in M but prefer each other over their partners under M (in our
notation, m prefers w over pM(m) and w prefers m over pM(w)).
For example, consider the following instance of the stable marriage prob-
lem of 2 men and 2 women with these preference lists:
• Woman 1: Man 2, Man 1
• Woman 2: Man 2, Man 1
• Man 1: Woman 1, Woman 2
• Man 2: Woman 2, Woman 1
Suppose we have a matchingMu in which
• Man 1 to Woman 2 are matched
• Man 2 to Woman 1 are matched
Man 2 and Woman 2 are a blocking pair since they would prefer each other
over their matched partners. Man 1 and Woman 1 are not a blocking pair
because although Man 1 would prefer Woman 1 over his partner Woman
2, Woman 1 is happy to be matched to Man 2 over Man 1. Because of the
blocking pair Man 2 and Woman 2, Mu is an unstable matching. Instead,
the matchingMs
• Man 1 to Woman 1
• Man 2 to Woman 2
is a stable matching with no blocking pairs.
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The fundamental theorem proved by Gale and Shapley states that there is
always at least one stable matching for every instance of the stable marriage
problem [144]. The proof is given by the Gale-Shapley algorithm, which
always provides a stable matching for any instance of the stable marriage
problem. The algorithm is imagined as a series of “proposals” from the men
to the women, where the men propose to the women in the order of their
preference lists and the women accepts or rejects depending on the desir-
ability of the proposing man. Each person has a state of being either free
or engaged, and a woman will always accept a proposal if she is free. She
is always in a state of engaged after that ﬁrst engagement, but she chooses
another ﬁancé if a more desirable man proposes.
The ﬁrst man proposes to the woman highest on his preference list, and
she accepts since she is free. The next man then proposes to the woman high-
est on his preference list. If she free, then she accepts, but if she is engaged,
she accepts the proposal only if the proposing man is preferable over to her
current ﬁancé. If the latter happens, then the man with the broken engage-
ment is considered free again, and he then proposes to the next woman on
his preference list. This continues until everybody is engaged and results in
a stable matching.
The Gale-Shapely algorithm is shown in the following pseudocode [143]:
set each person to be free
while some man m is free
w = first woman on m's list to whom m has not yet proposed
if w is free
assign m and w to be engaged to each other
else
if w prefers m to her fiancé m′
assign m and w to be engaged
set m′ to be free
else
w rejects m (and m remains free)
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The algorithm presented here is the man-oriented version, which results
in the man-optimal matching where every man is matched with the best
partner he can obtain in any stable matching and every woman is matched
with the worst partner she can obtain in any stable matching. It also always
terminates in the same stable matching regardless of the order in which the
men propose. These results are summarized and proved in Reference [143].
6.1.2 Hospital-residents problem
The hospital-residents problem is an asymmetric extension of the stable mar-
riage problem where the members of one group can have multiple partners
and the members of the other group have exactly one partner. In the ap-
plication of matching residents to hospitals, residents are matched to one
hospital (or not at all), and hospitals choose the number of available spots
for residents. This problem is more general in that the number of residents
does not necessarily equal the total number of spots available from all hos-
pitals, multiple residents can be matched to a hospital, and preference lists
need not contain every single hospital or resident. A hospital said to be ac-
ceptable to a resident if the hospital is in the resident’s preference list (and
vice versa).
A matching M is then a mapping from the set of residents to the set of
hospitals where the number of residents does not exceed the number of spots
provided by each hospital. The deﬁnition of stability needs to be generalized
for this problem, and so a matching is unstable if there exists a resident r
and hospital h such that the following three conditions hold:
1. h is acceptable to r and r is acceptable to h
2. either r is unmatched or r prefers h to their assigned hospital
3. either h has open spots in the matching or h prefers r to at least one
of its assigned residents
This deﬁnition describes all of the ways a blocking pair r and h can unravel
a hospital-residents matching. First, r and h must be on each others’ prefer-
ence list to even be a blocking pair. In order for the resident r to undermine
a matching by partnering with another hospital h, the resident must not be
matched at all (in which the resident will then take any willing hospital, par-
ticularly hospital h), or the resident must have a hospital h that is preferable
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over their matched hospital. If that hospital h has an open spot, then r can
undermine the matching by partnering with h. Or if that hospital h prefers
r over any of its assigned residents, then r and h again can undermine the
matching by ditching that assigned resident for resident r.
The hospital-oriented Gale-Shapley (HGS) algorithm provides a stable
matching that favors the preferences of the hospitals. The hospitals play a
role analogous to the men of the Gale-Shapley algorithm and offer a place
to residents in preference order until all of its available spots are ﬁlled or
until no more acceptable residents remain on its list. The residents accept an
offer if they are “free” and accept new offers only if the proposing hospital
is preferable over its current hospital. The HGS algorithm is guaranteed to
terminate in a stable matching.
Before the algorithm begins, only mutually acceptable hospitals and res-
idents are found in preference lists. So, if resident r does not have hospital h
on their list, then r is removed from h’s list. We use the term assignment in-
stead of engagement in the hospital-resident context, and a hospital is said
to be undersubscribed if it is assigned fewer residents than the number of
spots available.
The HGS algorithm gives the hospitals the role of the men in the Gale-
Shapley algorithm for the stable marriage problem. Each hospital offers a
spot to residents in the order of its preference lists until all of its spots are
ﬁlled or until there are no available residents acceptable to the hospital.
When a resident is assigned to a hospital, the resident trims their prefer-
ence list by removing hospitals less preferable to their assigned hospital.
Trimming down the preference list is possible because a resident will never
be assigned to a hospital worse than its assigned one, which is analogous
to the women in the Gale-Shapley, who refuse men not preferable to their
engaged man and break an engagement only if a more preferable man pro-
poses. When a hospital is removed from a resident’s preference list, the same
hospital removes that resident from its own preference list (if the resident
was on its preference list at all). This procedure is all summarized in the
following pseudocode [143]:
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set each resident to be free
set each hospital to be totally unsubscribed
while (some hospital h is undersubscribed) AND
(h's list contains a resident r not assigned to h):
r = first such resident on h's list
if r is already assigned to hospital h′
break the provisional assignment of r to h′
assign r to h
for every hospital hˆ less preferable than h on r's list
remove hˆ and r from each other's lists
The HR algorithm terminates with a stable matching that is not depen-
dent on the order of the hospitals used in the assignments.
6.2 from hospital-residents to t cell receptors
We saw a possible application of the HGS algorithm for pairing CDR3α
and CDR3β sequences from the sequencing data obtained using the same
experimental setup utilized by alphabetr. The sequencing data and the co-
occurrences between α chains and β chains serve as a basis for creating pref-
erence lists. The level of association between chain αi and βj is measured by
the score used by alphabetr deﬁned in Equation (5.1), and then preference
lists for each chain are created by ranking these scores in descending order.
Each unique sequence αi has a preference list of
Pαi =
(
βk1 , βk2 , . . . , βkn
)
where Sikj ≥ Sikj+1 > 0 for j = 1, . . . , n− 1, and n is the number of unique
β chains that co-occur with αi.
Each unique sequence βj has a preference list of
Pβk =
(
αl1 , αl2 , . . . , αlm
)
where Sklj ≥ Sklj+1 > 0 for j = 1, . . . , n−1 andm is the number of unique α
chains that co-occur with βj. In the case where there are ties in the scores, the
chains with those scores are randomly ordered within their spots on the pref-
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erence list.2 These preference lists are the inputs into the hospital-oriented
HR algorithm, where α chains play the role of the residents and β chains play
the role of the hospitals. We specify capacities of 1 for each β chain, which is
equivalent of hospitals having exactly one spot. This prevents the discovery
of dual-TCRα clones and chain sharing. In order to be able to identify dual-
TCRα clones, we would need some procedure to determine which CDR3β
sequences derive from dual-TCRα clones and which are shared among many
clones. This information would then be an input to the HGS algorithm, and
as we will discuss later, this is an open problem that cannot be solve with
currently available algorithms. Thus, we can at best discover one of the two
chains of a dual-TCRα expressing clone and cannot identify CDR3α- and
CDR3β-sharing clones.
We provide an implementation of the HGS algorithm in the matchmaker
package, which was used for the simulations shown in this chapter.3
6.3 results
6.3.1 The HGS algorithm shows high depth and low false pairing rates in
populations with no shared chains.
We ﬁrst tested the HGS algorithm approach by simulating data with the
same skewed immunodominance hierarchies used in the alphabetr simula-
tions, the 5-plate “highmixed” sampling strategy (Table 5.3), and lognormal
dropping errors with either (i) no in-frame sequencing errors or (ii) in-frame
sequencing errors identical to those used in the alphabetr simulations. The
simulations used T cell populations containing no shared chains and either
(iii) 0% or (iv) 15% of clones expressing dual TCRα chains.
Figures 6.1–6.4 show the results of the simulations using the HGS algo-
rithm. The left columns show the results of simulations of populations with
no dual-TCRα clones, and the right columns show results of simulations of
populations with 15% dual-TCRα clones. The bottom row of plots simu-
lated in-frame sequencing errors while the top row simulated no in-frame
2Algorithms that deal with ties within the preference lists exist, but the different kinds
of stability that can be deﬁned for these problems suffer a lack of interpretability for our
sequencing application, and the computational requirements of these algorithms add another
difficult hurdle for their use.
3Available on github.com/edwardslee/matchmaker
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Figure 6.1: Depth of the common clones representing the top 50% of the pop-
ulation in frequency. We performed simulations using the HGS algorithm on pop-
ulations with 500, 100, and 2000 clones with 0% or 15% dual-TCRα clones and with
in-frame or without in-frame sequencing errors (averaged over 100 simulations). The
HGS algorithm is able to identify practically all common clones in populations with
0% dual-TCRα clones, and 79–92% of common clones in populations with 15% dual-
TCRα clones. We see no discernible effect on top depths with the presence of in-frame
sequencing errors.
sequencing errors. Figure 6.1 shows high depth of the top clones in all sce-
narios of errors. The HGS algorithm is able to identify practically all com-
mon clones when populations have no dual-TCRα clones. For populations
with 15% dual-TCRα clones, top depths ranged from 81.6% to 91.7% in
populations with no in-frame sequencing errors and ranged from 79.1% to
92.1% in populations with in-frame sequencing errors. The majority of the
decrease in top depth seems to be due to the fact that the HGS algorithm
cannot identify both TCRs of a dual-TCRα clones, so automatically the al-
gorithm cannot achieve 100% depth. Simulations of populations with 2000
unique clones and in-frame sequencing errors were not performed due to
computational limitations.
197
0% Dual 15% Dual
N
o Infram
e Errors
Infram
e Errors
100 100 100 100
100 100 100 100
 99.7  99.8  99.9  99.8
100 100 100 100
100 100 100 100
 86.7  86.5  85.8  84.8
 86.8  86.7  86.4  85.8
 86.2  86.3  86.2  85.8
 86.8  86.4  85.8  84.9
 86.8  86.8  86.3  85.9 0
25
50
75
100
Depth
5 10 25 50 5 10 25 50
500
1000
2000
500
1000
2000
Number of clones in the top 50% of population
N
um
be
r o
f u
ni
qu
e 
cl
on
es
 in
 th
e 
po
pu
la
tio
n
Depth of tail clones
Figure 6.2: Depth of the rare clones representing the bottom 50% of the pop-
ulation in frequency. We performed simulations using the HGS algorithm on pop-
ulations with 500, 100, and 2000 clones with 0% or 15% dual-TCRα clones and with
in-frame or without in-frame sequencing errors (averaged over 100 simulations). The
HGSalgorithm is able to identify practically all rare clones in populationswith 0%dual-
TCRα clones, and ~85% of rare clones in populations with 15% dual-TCRα clones. We
see no effect on tail depths with the presence of in-frame sequencing errors.
Similar patterns can be seen in the tail depths in Figure 6.2. With no
dual-TCRα clones, practically all simulations result in 100% recovery of
rare clones. With the presence of dual-TCRα clones, tail depths were ap-
proximately 86%, which again reﬂects the fact that the algorithm cannot
identify both chains of dual-TCRα clones. Figure 6.3 shows the same pattern
in overall depth of all clones. Figure 6.4 shows the HGS algorithm makes
very few mistakes with false pairing rates ≤ 1%.
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Figure 6.3: Depth of all clones in the simulated populations.We performed simu-
lations using the HGS algorithm on populations with 500, 100, and 2000 clones with
0% or 15% dual-TCRα clones andwith in-frame or without in-frame sequencing errors
(averaged over 100 simulations). The overall depth performance of the HGS algorithm
shows the same patterns for the top and tail depths.
6.3.2 The HGS algorithm cannot reliably pair TCR sequences in popula-
tions with CD3α- and CDRβ-sharing
Althoughwe could not identify TCRs from clones sharing CDR3α andCDR3β
sequences, we wanted to see the effect on depth and false pairing rates when
chain sharing occurs in the sampled population.We repeated the simulations
with populations exhibiting sharing at the “medium level” described in Ta-
ble 5.1 and 15% dual-TCRα clones with dropping errors and no in-frame
sequencing errors. In Figure 6.5A–C, we see that the simulations resulted
in lower top, tail, and overall depths. More strikingly, Figure 6.5D shows
that the false pairing rates jumped to 17.9–21.6%, which is unacceptable
for accurate pairing. Thus, the HGS algorithm is unable to handle all of the
features found in epitope-speciﬁc T cell populations.
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6.3.3 Samples of T cells from the naive pool are unlikely to exhibit signiﬁ-
cant levels of shared chains
Although the HGS algorithm cannot handle populations that exhibit the
sharing of CDR3α and CDR3β sequences, its ability to reliably identify TCR
pairs in populations with no chain-sharing begs the question of whether it
could have utility in TCR sequencing analysis. Here, we show that samples
of the naive αβ T cell repertoire from standard blood samples from humans
will not exhibit signiﬁcant CDR3β sharing.
Let B be the number of unique TCRβ chains found in the naive αβ T cell
repertoire. Supposed we collectN αβ T cells in a sample of human blood, as-
suming N≪ 1011, the total naive T cell population size. How many unique
β chains Uβ are expected to be found in a sample of N naive T cells? This
problem is equivalent to randomly sampling with replacementN times from
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Figure 6.4: False pairing rates in the simulated populations.We performed simu-
lations using the HGS algorithm on populations with 500, 100, and 2000 clones with
0% or 15% dual-TCRα clones andwith in-frame or without in-frame sequencing errors
(averaged over 100 simulations). The false pairing rates of the HGS algorithm are very
low in all simulated conditions, never going above 1%.
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Figure 6.5: Results from simulations of populations exhibiting medium levels of
sharing. Simulations were performed to test the effect on depth and false pairing
rates due to the presence of CDR3α- and CDR3β-sharing. The simulated experiments
had dropping chain errors and no in-frame sequencing errors. The number of clones in
the populations were varied (500, 1000, and 2000), and different levels of skew were
tested by changing the number of clones in the top 50% of the population by clonal
frequency. (A) The overall depth of all clones in the population. (B) The depth of the
common clones that make up the top 50% of the population by frequency. (C) The
depthof the rare clones thatmakeup thebottom50%of thepopulationby frequency.
(D) The false pairing rates associatedwith each set of simulations. These results are the
average of 100 simulations.
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a set of B different β chains labeled β1, β2, . . . , βB and asking how many
of them appear in that sample on average. This is straightforward to cal-
culate if one assumes that each distinct β chain is present roughly at equal
frequency within the naive T cell pool. For any non-uniform distribution
of naive TCRβ clone sizes [145, 146], the following calculation provides a
lower bound on the sample size required to achieve a given level of coverage
of the repertoire.
Let Ii be a random variable equal to 1 if chain βi appears in the sample
at least once and 0 otherwise. P
(
Ii = 0
)
is
(
(B−1)/B)N, and so its expected
value E(Ii) is 1−
(
(B− 1)/B)N. The expected number of different β chains
in the sample is then
Uβ = E
(
B∑
i=1
Ii
)
=
B∑
i=1
E(Ii) = B
(
1−
(
B− 1
B
)N)
. (6.1)
Similarly, let Ji be a random variable that is equal to 1 if clone i appears only
once in the sample, and zero otherwise. P(Ji = 1) is (N/B)(1 − 1/B)N−1,
and so the expected number of chains that appear only once is B · E(Ji) =
N(1 − 1/B)N−1. Figure 6.6 shows the dependence of these quantities on
sample size using the current best estimate of B in humans, 108 [20]. Since
1/B is very small, we expected the number of chains recovered from N cells
to be approximately N.
We can then estimate typical TCRβ clone size distributions obtained
from bulk sequencing of T cells recovered from human blood samples. One
milliliter of human blood yields typically 0.5× 106 to 1.8× 106 αβ T cells,
of which 0.1 × 106 to 0.8 × 106 are naive CD4+ T cells and 0.03 × 106 to
0.2× 106 are naive CD8+ T cells. A standard 10 mL blood sample will then
contain between 106 and 107 naive αβ T cells. Equation 6.1 predicts that this
will yield 1–10% of the β chain repertoire, with correspondingly 99.5% and
95% of the identiﬁed chains will have come from a sample size of a single
cell of the clonotypes and thus a majority of the β chains come from one cell.
In a 50 mL sample, we expect to cover between 5% and 40% of the β chain
repertoire, with correspondingly 98% and 80% of the chains deriving from
only one cell. We would expect to see very little chain sharing in the T cells
sampled in a sample of blood. Thus, the HGS algorithm potentially could
be used in T cells obtained from a standard 10 mL blood sample. In fact,
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Figure 6.6: Expected number of unique β chains recovered from a large population
with a repertoire of 108 different CDR3β chains, for varying sample sizes (assuming
sampling with replacement). (A) The number of unique CDR3β expected to be recov-
ered in a given number of sampled T cells from the naive pool. (B) The number of
chains we expect to come from exactly one T cell given a ﬁxed number of T cells that
are sampled.
because any given clone would be sampled only a few times, preference lists
would be very short and would allow the HGS algorithm to efficiently ﬁnd
stable matchings.
A practical limitation to using the HR algorithm for naive populations
is the long computational time needed for solving large instances of the
hospital-residents problem. The HGS algorithm determines stable resident-
hospital pairs in O(m) time, where m is the number of acceptable resident-
hospital pairs. This means that the time required by the computer to solve
an instance of the hospital-residents problem increase linearly with the num-
ber of acceptable pairs, given that the implementation uses appropriate data
structures.4 Since a reasonable or large sample of blood from humans might
contain tens or hundreds of thousands of unique CDR3α and CDR3β se-
quences, an application of the HGS algorithm could take an unreasonable
about of computing time to determine αβ pairs. Our simulations indicate
4The matchmaker package that we have written is not guaranteed to be this efficient, and
our testing shows that our implementation is most likely slower thanO(m) time. Other less
cleverly named R packages such as the matchingR and matchMarkets packages may provide
more efficient implementations.
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that the HGS algorithm could accurate identify TCR pairs, but computa-
tional advances will need to be made in order for the algorithm to be prac-
tical for sequencing T cells from the naive repertoire.
6.4 discussion
Matching algorithms have the potential to efficiently and accurately iden-
tify paired TCR sequences without using single-cell approaches. We demon-
strated that in special situations, the HR algorithm outperforms alphabetr
with very high depths and very low false pairing rates. However, we also
showed that the HGS algorithm fails to work for populations with shared
chains, a feature that is prominent in many epitope-speciﬁc T cell popu-
lations. Thus, the HGS algorithm in its current form cannot be used for
epitope-speciﬁc T cell populations.
The simulated populations used in Section 6.3.1 do reﬂect the features
of a sample of T cells obtained from the naive repertoire, and the success of
the HGS algorithm in these simulations points to a possible application for
sequencing T cells from the naive repertoire. However, the HGS algorithm
is practically not useable at the scale needed for sequencing the many tens
or hundreds of thousands of CDR3 sequences found in samples of naive T
cells. Advances in the algorithm and in computing may allow for the iden-
tiﬁcation of pairs at this scale in the future. Another limitation of the HGS
algorithm is the inability to identify dual-TCRα clones. In order to do so,
we would need to allow the CDR3β sequences of the the dual-TCRα clones
to pair with two CDRα sequences (equivalent to a hospital having two spots
for residents). This would require a priori knowledge of which CDR3β se-
quences belong to dual-TCRα clones. Of course, we would like the pairing
algorithms themselves to discover dual-TCRα clones, and this dilemma is
an open problem that is not straightforward to solve. A similar issue oc-
curs for discovering shared chains; we need to know beforehand how many
clones share a given CDR3α or CDR3β chain as an input to the HGS al-
gorithm. Although the HGS algorithm pairs TCR sequences successfully in
limited special cases, we do not believe that the algorithm in its current form
is usable for epitope-speciﬁc populations nor practical for naive T cell pop-
ulations without computational and/or algorithmic advances.
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The deﬁnition of stability in the application of TCR sequence pairs has
a slightly unnatural interpretation. What does it mean for a set of CDR3α
and CDR3β sequences to form a stable matching? In the context of sta-
ble marriages and hospital/residents, stability is a desired property since no
unmatched pair can undermine a matching by choosing each other rather
than their matched partners. In the CDR3α/CDR3β setting, a stable match-
ing of TCR pairs does not have an analogous type of interpretation. What
does it mean for a β chain to be matched with its best α chain partner such
that they cannot undermine the whole matching? Although our simulations
show that using stability provides good results, this issue does suggest that
other approaches to matching problems might be more appropriate for our
sequencing problem. One approach might involve matching problems that
utilize cardinal utilities rather than the ordinal preferences used the stable
marriage problem and the hospital-residents problem; in our problem, this
approach would use the association scores directly instead of converting
them into ranked preference lists. Such problems like the Assignment prob-
lem and maximum weight matching in graphs could have extensions that
pair TCR sequences in epitope-speciﬁc populations. These problems would
use the association scores directly rather than converting these to ordinal
preference lists and ﬁnd a set of pairings that optimizes for the scores in
some way.5
Both chapters 5 and 6 demonstrate the undeniable advantage of fre-
quency-based pairing techniques: thousands of paired TCRs can be identi-
ﬁed without large single-cell sequencing experiments. alphabetr is able to
identify many common clones and over a thousand rare clones of an epitope-
speciﬁc population with an experiment using ﬁve 96-well plates, whereas an
equivalent single-cell experiment would identify at best 480 TCRs and we
estimate in practice would recover on the order of 100 TCRs. The HGS al-
gorithm shows the potential to identify thousands of clones at the same scale
as well. We believe that fully characterizing T cell repertoires requires paired
sequencing information and the discovery of both common and rare clono-
types. Current single-cell technologies are too cost-prohibitive to achieve
5The conversion from scores to ordinal preferences is not necessarily a problem since
this approach has been used successfully in many applications. For example, junior doctors
are matched to hospitals in Scotland by calculating scores for the junior doctors from exam
marks and application assessments and converting them to ordinal preferences.
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these goals, and so frequency-based approaches can provide answers to our
questions about repertoires until single-cell sequencing becomes more eco-
nomical and ubiquitous.
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C H A P T E R  7

Discussion and Conclusions
The protection conferred by adaptive immunity results in part from a
large population of T cells with a vast repertoire of TCRs. In this thesis,
we have combined experimental and mathematical modeling techniques to
probe these properties of T cell populations. We set out to quantify the num-
ber of T cells and its subsets in the SLOs, to characterize the development
of these T cells from neonates to adults, and to develop tools to quantify αβ
T cell clonotypes and measure their frequencies.
Identifying T cell clonotypes with TCR sequencing has become an in-
creasingly important tool in understanding the role and function of T cells
in infections and in diseases [147, 148, 62]. The community has been actively
working to standardize and improve the pipeline for TCR sequencing: this
includes standardizing ﬁle formats [149], creating software for processing
and aligning the raw reads [150, 151, 102, 152, 153, 154], and develop-
ing new experimental protocols for sequencing samples of T cells (described
in Section 1.5). In Chapters 5–6, we described experimental and statisti-
cal approaches that can identify thousands of paired TCR sequences with-
out having to resort to single-cell sequencing. Both approaches—alphabetr
and the application of the hospital-oriented Gale-Shapley algorithm—pair
CDR3α and CDR3β sequences obtained from multiple bulk-sequenced sub-
samples of T cells from the parent population of interest. We designed al-
phabetr to identify TCRs from antigen-speciﬁc populations and to identify
TCRs with shared CDR3α or shared CDR3β sequences. Chain sharing is
found in many antigen-speciﬁc repertoires (Table 5.1) and has not been ex-
plicitly considered by other frequency-based pairing approaches. The HGS
algorithm identiﬁes paired TCR sequences very efficiently in special cases
but fails when a signiﬁcant degree of chain-sharing occurs in the reper-
toire of interest. We demonstrated that the performance of alphabetr with
480 subsamples outperforms sequencing of several thousands of single cells
(Figure 5.13). Although the newest single-cell technologies are starting to
scale to tens and hundreds of thousands of single cells (demonstrated in a
preprint paper [155]), we believe that frequency-based pairing is currently
the most cost-effective and efficient way to identify paired TCRα and TCRβ
sequences. We believe these techniques could provide much insight in the
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context of cancer and in vaccine design by identifying important clonotypes
for designing effective immunotherapies and vaccines.
The diversity of the αβ T cell repertoire is distributed across roughly 108
T cells in mice, resulting in approximately 100–1000 T cells in the naive
repertoire that can respond to a given antigen [52, 2]. We set out to more
accurately characterize the numbers of αβ T cells and their subsets in the
secondary lymphoid organs of the mouse. In Chapter 4, we used thoracic
duct cannulations to drain recirculating T cells from SLOs and and then
used T cell counts of the collected lymph and the SLOs to calculate total
numbers. This approach was based on a simple idea that assuming free and
constant recirculation, all SLOs would lose the same proportion of cells and
that this loss would be represented by the number of cells collected by the
cannulation (Figure 4.2). The data showed that SLOs were affected differ-
ently by the TD cannulation (Figures 4.5–4.6), presumably due to different
lymphatic connections, and this resulted in too many unknown parameters,
which prevented us from estimating T cell numbers accurately. In addition,
we discovered -that the stress from the surgical procedure, in addition to the
cannulation itself, caused a strikingly profound loss of cells in lymph nodes.
Although previous studies have shown changes in T cell counts and propor-
tions [120, 119, 122, 121], we showed that the loss of cells occurs across
many different subsets of T cells and B cells. These ﬁndings may impact
the interpretation of studies that use invasive procedures. Procedures such
as intravital imaging or lymphadenectomies potentially cause T cell and B
cell numbers to decrease and may fundamentally change immune responses.
We characterized these changes in our thoracic duct cannulation system, but
further work will be needed to see if the magnitude of changes that we ob-
served generalizes to other surgical procedures. Future studies could explore
the effect of different anesthetics, different dosages of anesthetic, and differ-
ent duration of anesthesia and/or surgery.
Finally, we used mathematical modeling to characterize the development
of CD4+ T cells from the DP2 thymocyte stage to the peripheral naive CD4+
T cell compartment and the development of DP3 thymocyte stage through
to the export of SP8 thymocytes. By confronting models with cell count
and Ki67 expression data in thymocyte subsets and peripheral T cell sub-
sets in neonatal mice, we were able to characterize the shifting dynamics of
T cell development in the thymus and the periphery. We elucidated the pat-
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tern of differentiation in SP4 and SP8 thymocytes—particularly, how imma-
ture SP4/SP8 thymocytes differentiate to mature SP4/SP8 thymocytes—and
found evidence of changing per capita division rates in both the SP4 and
SP8 compartments in the neonatal mice. We were also particularly inter-
ested in determining whether lymphopenia-induced proliferation plays an
important role in the development of naive CD4+ T cell populations. Al-
though the neonatal mouse can support LIP [46], we showed that a simple
mathematical model could explain the dynamics of mature SP4 thymocyte
and naive CD4+ T cell compartments from soon after birth without recourse
to LIP; high Ki67 expression in naive cells early in life is largely inherited
expression from transiently high levels of intrathymic proliferation. Thus,
our work supports the conclusion that the development of a healthy naive
CD4+ T cell compartment results mainly from the thymic output of T cells
during ontogeny without a signiﬁcant amount of peripheral expansion. Fur-
ther work will be performed to (i) quantify how the distribution of αβ T cell
clone sizes emerging from the thymus changes with age, (ii) perform a similar
analysis to assess whether LIP occurs in naive CD8+ T cells during develop-
ment, and (iii) characterize the development of CD4+ and CD8+ memory T
cells in neonates.
In this thesis, we employed a wide range of mathematical and statistical
techniques in the analysis and interpretation of our data. We used ODEs
and Bayesian analysis to describe the dynamics of T cell ontogeny in detail,
and the conclusions made regarding the cannulation experiments derived
from a simple experimental idea and elementary algebra. The TCR pairing
study attempted to extend existing algorithms as well as develop new ones
and employed maximum likelihood estimation. In all cases, the quantitative
tools were crucial in helping us to encode and understand the immunology
underlying our data. By combining these quantitative approaches with care-
ful experimental design, we were able to make richer conclusions and draw
more information from the data that would not have been possible with
experiments alone.
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